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“The fairest thing we can experience is the mysterious. It is the fundamental 
emotion which stands at the cradle of true science. He who knows it not, and can no 
longer wonder, no longer feel amazement, is as good as dead. We all had this priceless 
talent when we were young. But as time goes by, many of us lose it. The true scientist 
never loses the faculty of amazement. It is the essence of his being.” -Hans Seyle 
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Social stress is a significant risk factor for the emergence of psychiatric disorders 
including depression and anxiety. While there are a number of commercially available 
therapeutic options for the treatment of these disorders, these treatments require weeks of 
continuous use to produce behavioral efficacy. It has also been suggested that these 
traditional therapies are only marginally effective in producing complete remission, 
suggesting that our understanding as it pertains to the mechanisms underlying stress-
induced behavioral dysfunction is still in its infancy. In the last few years, inflammation 
has become a major focus in the field of stress and depression as clinical and pre-clinical 
models have shown that stress results in an enhancement of inflammation in the periphery 
and the brain. While the field of stress-induced inflammation is rapidly growing, there is 
still a vast amount that remains unknown. Therefore, the primary goal of the work 
described in this dissertation was to elucidate mechanisms underlying stress-induced 
depressive like behaviors as it pertains to inflammation. Using the resident-intruder 
paradigm of social defeat, the following studies demonstrate that repeated stress exposure 
results not only in the enhancement of inflammation but also sensitizes inflammatory 
responses in the periphery and the brain. While these inflammatory responses are largely 
indiscriminate as evidenced by enhancement of both pro- and anti-inflammatory cytokines, 
expression profiles in the brain demonstrated significant regional specificity. Strikingly, 
these inflammatory responses differed greatly between animals that demonstrated 
resilience or susceptibility to the behavioral consequences of stress. Rats that exhibited 
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active coping defensive behaviors during the stress exposure demonstrated resilience to the 
behavioral and inflammatory effects of social defeat. In contrast, rats demonstrating 
passive coping behaviors during the stress exposure and subsequent susceptibility to the 
depressogenic effects of social defeat exhibited robust neuroinflammation within the locus 
coeruleus (LC). Peripheral administration of resveratrol, a natural anti-inflammatory, seven 
days prior to and during the 5-day social defeat period was able to dose dependently inhibit 
these behavioral and inflammatory effects in susceptible rats. Importantly, only the highest 
dose which achieved complete inhibition of stress-induced inflammation was associated 
with complete inhibition of depressive-like behaviors. A follow-up study demonstrated that 
stress-induced inflammatory effects in the periphery and the brain were directly dependent 
upon norepinephrine (NE) derived from the LC. In the periphery LC-derived NE was found 
to potentiate and sensitize stress-induced inflammation as evidenced by enhanced cytokine 
concentrations in the plasma. While the effects of LC derived NE in the plasma were clear, 
the effects of LC-NE on the brain were highly dependent upon the brain region analyzed. 
For example, loss of NE in the central amygdala (CeA) in response to stress or 
pharmacological NE lesion of the LC, resulted in a significant enhancement of 
inflammation within this region. In contrast, inflammatory responses in the dorsal raphe 
were largely independent of LC-NE. Inflammation in the brain is known to result in 
significant shift in neuronal function and with respect to the CeA has been shown to engage 
signaling cascades associated with tyrosine receptor kinase (Trk)B, which has been 
suggested to underlie the emergence of anxiety-like behaviors and cardiovascular 
abnormalities. To elucidate the specific involvement of this receptor in stress-induced 
behavioral and cardiovascular responses, a small molecule TrkB inhibitor was injected 
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directly into the CeA 30-minutes prior to social defeat on days 1, 3, and 5. Notably, CeA 
TrkB signaling was directly associated with the expression of defensive behaviors and 
cardiovascular reactivity during defeat. These effects were associated with enhanced TrkB 
phosphorylation and were accompanied by preferential activation of the extracellular 
signal-regulated kinase (ERK) pathway. Surprisingly, these effects in cellular signaling 
occurred independently of the TrkB ligand brain derived neurotrophic factor (BDNF). 
While CeA TrkB signaling was critical for the expression of behavior and cardiovascular 
responses during stress, behaviors and cardiovascular measurements obtained after stress 
exposure were largely independent of the CeA and TrkB. Taken together, the studies 
outlined in this particular document function to (1) directly implicate inflammatory 
processes in the emergence of stress-induced behavioral dysfunction, (2) suggest that these 
responses are driven by LC derived NE, and (3) begin to probe inflammatory sensitive 
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 note that traditional antidepressants can also fail to produce remission in certain 
populations of depressed patients. Taken together these data suggest that our understanding 
of the neurobiological mechanisms that underlie stress-induced psychosocial disorders is 
still in its infancy. Therefore, the research described herein is focused on elucidating the 
discrete mechanisms that may be involved in the emergence of stress-induced psychiatric 
disorders with the hopes that it may be used as the foundation for future studies that could 
lead to the development of novel therapeutics. 
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1.1 Social Stress and the development of depression and anxiety 
  “I am feeling overwhelmed.” “I need a vacation.” “I am stressed out.” Phrases such 
as these are common in today’s society. However, our modern understanding of stress is 
relatively new. First described in 1940 by Hans Selye (Szabo et al., 2012), stress was used 
as a general term indicating a noxious agent capable of producing the general adaptation 
syndrome (GAS) (Selye, 1950). According to Selye’s description, GAS was a 
physiological syndrome which occurred across three distinct phases and was characterized 
by tissue catabolism and activation of secretory granules in the adrenal glands (Selye, 
1950). In line with our current understanding of stress physiology, Selye believed that GAS 
was the body’s inherent defense mechanism and was largely beneficial, but in excess could 
be involved in the development and worsening of disease (Selye, 1950). Since this initial 
article, thousands of reports have been published expanding our understanding of stress as 
well as the physiological response to stress. 
  By todays standard, stress is a broad term designed to convey the feeling of 
emotional, mental, or physical strain. Unlike the 1940s and 50s where chemical and 
physical agents were considered to be the primary source of stress (Selye, 1950), in today’s 
society social adversity such as bullying, abuse, divorce, taking care of a terminally ill 
loved one, or witnessing traumatic events are considered to be the most common source of 
stress (Almeida, 2005). Social standing is well known to influence an individual’s sense of 
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self-worth and esteem (Kraus and Park, 2014). Therefore it is not surprising that social 
stressors which not only disrupt social standing but also decrease self-worth and self-
esteem (Kemeny et al., 2004; Kesting et al., 2013) are subjectively perceived to be more 
impactful than other forms of stress (Almeida, 2005). Generally classified as acute, 
episodic, or chronic based its duration, social stress encompasses any situation that may 
jeopardize an individual’s relationships or sense of belonging. As with other forms of 
stress, acute occurrences of social stress are often associated with feelings of anger (Lupis 
et al., 2014), fear (Lupis et al., 2014), and reductions in pleasure (Vors et al., 2018). While 
shifts in mood caused by acute social stress exposure are largely transient, exposure to 
episodic and chronic social stress is well known to promote the emergence of psychosocial 
disorders such as depression and anxiety (Almeida, 2005).  
According to the World Health Organization (WHO), depression and anxiety are 
the most prevalent mental health disorders affecting a respective 322 and 264 million 
people worldwide (Organization, 2017).  These disorders are long lasting and are estimated 
to have a lifetime prevalence of 20.6% (Hasin et al., 2018)  and 6.8% (Kessler et al., 2005). 
Strikingly, it has been suggested that the magnitude of disability caused by these disorders 
is as great if not greater than several common physical medical conditions. Specifically, it 
has been reported that depressed patients spend a greater number of illness-related days in 
bed and have lower physical functioning compared to patients suffering from a physical 
disorder such as hypertension, diabetes, and arthritis (Wells et al., 1989). In addition to 
affecting physical ability, these disorders also have the potential to significantly disrupt an 
individual’s daily life. For example, adults with depression and anxiety are more likely to 
be absent from work and exhibit poor or reduced work performance (Lerner et al., 2010; 
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Plaisier et al., 2010). In addition, these disorders are anecdotally associated with 
disruptions in social relationships due to self-induced social withdrawal and isolation 
(Kenneth and Burgess, 2001; Matthews et al., 2016).  
Currently, there are a number of treatment options for patients suffering from these 
disorders. However, remission rates for traditional anti-depressant therapies, such as 
selective serotonin reuptake inhibitors (SSRIs), selective noradrenergic re-uptake 
inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), and tricyclic anti-depressants 
(TCAs), are approximately 40% (Machado et al., 2006; Rush et al., 2006; Trivedi et al., 
2006). Similar (20-40%) remission rates have also been reported in patients with post-
traumatic stress disorder (PTSD) (Berger et al., 2009) and general anxiety disorder 
(Bandelow et al., 2013) where the primary pharmacological treatments are traditional anti-
depressants and anxiolytics. These primary therapeutics were created based on the 
monoamine hypothesis of mood disorders. This hypothesis states that mood disorders such 
as depression and anxiety are caused by deficiencies in serotonin (5-hydroxytryptamine, 5-
HT), NE (NE), and dopamine (DA) (Delgado, 2000). However, recent research has 
suggested that stress-induced alterations of monoamines may be a secondary occurrence. 
This suggestion largely stems from findings that these anti-depressants produce immediate 
enhancement of neurotransmitter concentrations in the synaptic cleft but require weeks of 
continuous use to relieve behavioral symptoms (Liu et al., 2017). Taken together, these 
data suggest that our understanding of the mechanisms that underlie the emergence of these 





1.2 Behavioral coping mechanisms and stress susceptibility 
Virtually everyone will experience social stress in their lives. However, only a 
small portion of the population go on to develop psychosocial disorders, suggesting that 
there is significant individual variability in the vulnerability to susceptibility to stress. In 
humans, it has been suggested that stress susceptibility and resiliency are largely driven by 
an individual’s coping style (Henry and Stephens, 1977). While there are a number of 
different methods for coping with stress, these activities and behaviors are broadly 
categorized as either active or passive (Henry and Stephens, 1977). As originally described 
by Walter Cannon (Cannon, 1929), active coping applied to behaviors that were directly 
associated with fight or flight responses. In contrast, passive coping behaviors were 
originally characterized by low levels of aggression and heightened immobility (Engel and 
Schmale, 1972). These original reports were focused on the behavioral responses during 
stress. However, more recent reports have broadened both of these classifications, as we 
now know that coping responses not only include the primary but also secondary appraisal 
and behavioral responses to the stress. By today’s standard active coping also includes 
seeking support, engaging in problem solving, as well as adopting positive attitudes and 
maintenance of humor (Christen et al., 1986; Cairns et al., 2014). While passive coping 
includes behaviors such as avoidance, withdrawal, excessively seeking reassurance 
(Cambron et al., 2009; Cairns et al., 2014), and rumination (Nicolai et al., 2013).  
It is important to note that adoption of either passive or active coping strategies is 
a dynamic process (Orzechowska et al., 2013) and is highly dependent upon the stress type 
and severity (Lazarus and Folkman, 1987). However, it is generally understood that people 
who more readily adopt passive coping strategies are more susceptible to the behavioral 
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consequences of stress exposure (Lazarus and Folkman, 1987; Cambron et al., 2009; Cairns 
et al., 2014). Conversely, those who more readily adopt active coping strategies tend to 
exhibit resilience to the behavioral consequences of stress (Cairns et al., 2014). In addition 
to mediating the behavioral response to stress, an individual’s coping style can also impact 
the physiological response to stress. For example, it has been demonstrated that heart rate 
and blood pressure are enhanced to a greater extent in individuals exhibiting active coping 
during a rapid response task compared to individuals that readily gave up in this task (Light, 
1981). 
Similar effects have also been reported with regard to the primary stress hormone 
cortisol. In 2017 Sladek et al conducted a study in which diurnal cortisol levels were 
tracked across 3 days in 122 adolescent girls (Sladek et al., 2017). In addition to obtaining 
cortisol samples, the girls were asked to complete a standard coping survey. Sladek et al 
determined that during instances of low interpersonal stress, coping responses played an 
integral role in diurnal cortisol levels. Specifically, individuals that self-reported the use of 
passive coping strategies exhibited overall greater diurnal cortisol levels compared to 
individuals who reported using active coping strategies. Interestingly, diurnal cortisol 
levels did not differ between active and passive coping individuals in instances of high 
interpersonal stress. However, passive coping during these high stress experiences was 
associated with the highest baseline (waking) concentrations of cortisol compared to all 
other stress and coping groups (Sladek et al., 2017). The authors of this particular study 
concluded that these findings suggested that the release of stress hormones in individuals 
prone to passive coping strategies is more reactive than individuals prone to active coping 
(Sladek et al., 2017).  
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These findings regarding the release of cortisol in active versus passive coping 
humans are of particular importance as enhanced concentrations cortisol are reported in 
patients with depression (Murphy, 1991) and anxiety (Mantella et al., 2008).  Cortisol, the 
terminal hormone released after activation of the hypothalamic-pituitary-adrenal axis 
(HPA), exerts broad influence over nearly every major organ system during a stress 
response. Whether it is mobilization of glucose, modifying fat and protein metabolism in 
the central nervous system (CNS), enhancing sensitivity of the cardiovascular system to 
catecholamines, or reducing histamine secretion (Stephens and Wand, 2012), this hormone 
is a critical mediator in what is commonly known as the fight or flight response. Typically, 
the release of cortisol is well regulated by a number of negative feedback mechanisms. 
However, in instances of chronic stress these feedback mechanisms can become 
dysregulated resulting in an overall increase in resting levels and facilitation and delayed 
shut-off of stress-induced cortisol secretion (Herman et al., 2016).  Based on the broad 
physiological effects of cortisol, it has been suggested that these dysregulations may 
underlie the emergence of mood disorders. However, much of what we know regarding 
hypercortisolemia have come from studies analyzing patients that were already suffering 
from these disorders (Ozbolt and Nemeroff, 2013). Therefore, it is unclear if 
hypercortisolemia is causal to the development of these disorders or a biproduct of 
dysregulation in other converging systems. Regardless of the specific mechanism driving 
the emergence of depression and anxiety, the findings from Sladek et al. in combination 
with the known relationship between cortisol and mood disorders, suggests that the 
physiological reactivity associated with passive coping may predispose these individuals 
to develop mood disorders.   
 
 7 
1.3 Modeling social stress and coping in rodents 
 Much of what is known today with regard to stress, stress physiology, and resulting 
behavioral dysfunction has come from studying these processes in animals. While there are 
a number of ways to model stress in rodents, social stress is primarily studied using the 
resident-intruder paradigm of social defeat. Originally developed by Claus Miczek 
(Miczek, 1979), the resident-intruder paradigm involves placing a male, termed the 
“intruder”, into the home cage of a larger more aggressive male termed the “resident”. Rats 
(Flannelly and Thor, 1976), mice (Kikusui, 2013), and prairie voles (Gobrogge and Wang, 
2011) are extremely territorial in nature and will readily defend their territory from 
intruders. In the context of the resident-intruder paradigm, this results in the resident 
repeatedly attacking the intruder, until the intruder exhibits a supine posture signaling 
behavioral submission or until physical separation by the experimenter. Notably, these 
rodent species are highly social and readily establish stable social hierarchies (Hoshaw et 
al., 2006; van den Berg et al., 2014; Sadino and Donaldson, 2018).  
Similar to findings in primates (Michopoulos et al., 2012), this long-term and 
repeated subordination in rodents has been shown to produce detrimental effects in the 
overall health of the animal. Specifically, these acute episodes (minutes to hours) of social 
defeat have been shown to result in significant enhancement of the HPA axis (Bhatnagar 
et al., 2006), robust activation of the sympathetic nervous system (Sgoifo et al., 1996), 
increases in blood pressure and heart rate (Meehan et al., 1995), enhanced susceptibility to 
cardiac arrhythmias (Tornatzky and Miczek, 1993, 1994), and enhanced inflammation in 
the periphery (Niraula et al., 2019) and the brain (Gao et al., 2019). In addition to producing 
robust physiological effects, social defeat readily induces depressive- and anxiety-like 
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behavioral states.  This is most commonly evidenced by reductions in social interaction 
(Trainor et al., 2011; Greenberg et al., 2013; Andoh et al., 2019; Aubry et al., 2019; Jiang 
et al., 2019; Zhang et al., 2019), reductions of sucrose preference (Bowens et al., 2012; 
Carrier and Kabbaj, 2012; Spierling et al., 2017; Deng et al., 2018; Jiang et al., 2019), 
increases in behavioral despair (Bowens et al., 2012; Carrier and Kabbaj, 2012; Deng et 
al., 2018; Jiang et al., 2019), and avoidance of high risk areas  (Heinrichs et al., 1992; 
Kinsey et al., 2008; Andoh et al., 2019; Aubry et al., 2019). Notably, stress responsivity 
and susceptibility in rodents can be highly variable depending on the duration and intensity 
of social defeat.  
In many cases these variable behavioral and physiological responses have been 
attributed to the emergence of individual differences in the susceptibility to social defeat. 
Similar to humans, ethologically relevant stress coping behaviors have been described in 
birds (Verbeek et al., 1994), fish (Mather and Anderson, 1993; van Raaij et al., 1996), 
rodents (Korte et al., 1992; Fokkema et al., 1995; Gomez-Lazaro et al., 2011; Chaijale et 
al., 2013; Reyes et al., 2015; Wood et al., 2015), pigs (Hessing et al., 1994; Ruis et al., 
2000), cattle (Hopster, 1998), and non-human primates (Von Holst, 1986; Suomi, 1991). 
These coping behaviors and the resulting behavioral and physiological effects have been 
best characterized in rodents with the use of social defeat. Several labs have found that 
quantification of behavior during defeat, such as immobility (De Miguel et al., 2011; 
Gomez-Lazaro et al., 2011), social and non-social exploration (De Miguel et al., 2011; 
Gomez-Lazaro et al., 2011), fleeing (De Miguel et al., 2011), duration spent in upright 
defensive postures (Wood et al., 2012; Wood et al., 2015), and latency to submit (De 
Miguel et al., 2011; Wood et al., 2012; Reyes et al., 2015; Wood et al., 2015), can be 
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effectively utilized to statistically separate socially defeated rodents into susceptible and 
resilient subpopulations.  Specifically, rodents characterized as passive coping exhibit high 
levels of immobility (De Miguel et al., 2011; Gomez-Lazaro et al., 2011), low social and 
non-social exploration (De Miguel et al., 2011; Gomez-Lazaro et al., 2011), short durations 
of upright defensive postures (Wood et al., 2012; Wood et al., 2015), and short latencies to 
submit to the attacking resident (De Miguel et al., 2011; Wood et al., 2012; Reyes et al., 
2015; Wood et al., 2015). Adoption of these behaviors during defeat are associated with 
the emergence of depressive-like behaviors following the cessation of defeat (Wood et al., 
2010; Gomez-Lazaro et al., 2011; Perez-Tejada et al., 2013).   
In contrast, active coping rodents that exhibit resiliency to the behavioral 
consequences of social defeat demonstrate short bouts of immobility (De Miguel et al., 
2011; Gomez-Lazaro et al., 2011), enhanced exploratory behaviors (De Miguel et al., 2011; 
Gomez-Lazaro et al., 2011), long durations of upright defensive postures (Wood et al., 
2012; Wood et al., 2015), and generally resist defeat (Wood et al., 2010; De Miguel et al., 
2011; Reyes et al., 2015; Wood et al., 2015). In addition to affecting long-term behavioral 
outcomes, physiological responses during stress also differ between active and passive 
coping rodents. For example, plasma corticosterone (CORT), the rodent analogue of 
human cortisol, is enhanced to a greater extent during social defeat in passive coping 
rodents compared to their active coping counterparts (Korte et al., 1992; Wood et al., 2010; 
De Miguel et al., 2011; Perez-Tejada et al., 2013). Passive coping during social defeat has 
also been associated with enhanced plasma epinephrine (Korte et al., 1992), blunted NE 
(Korte et al., 1992; Perez-Tejada et al., 2013), and enhanced cardiac reactivity as evidenced 
by increased heart rate variability (Wood et al., 2012).  
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 However, determination of susceptibility and resiliency can also be determined 
using behavioral responses prior to and following social defeat. Other labs have 
successfully demonstrated that susceptibility and resiliency can also be determined by 
analyzing post-hoc social behavior and behavioral responses to novel nonsocial stressors. 
Social interaction is one popular method for post-hoc determination of susceptible and 
resilient subpopulations. Studies using this method have shown that social interaction 
following social defeat is bimodally distributed (Krishnan et al., 2007). Animals that 
demonstrate social avoidance as evidenced by low interactions with a conspecific target 
mouse are classified as susceptible (Krishnan et al., 2007; Hodes et al., 2014). In contrast, 
animals that are classified as resilient demonstrate similar interaction profiles with that of 
non-stress controls (Krishnan et al., 2007; Hodes et al., 2014). Interestingly, it has also 
been shown that it is possible to predict resilient and susceptible subpopulations prior to 
social defeat exposures. This has been accomplished by placing the rodent in a novel 
environment (Calvo et al., 2011; Duclot et al., 2011; Hollis et al., 2011; Duclot and Kabbaj, 
2013). Animals that readily explore this novel environment are termed high responders 
while those that demonstrate reduced locomotor activity and do not explore this 
environment are termed low responders (Calvo et al., 2011; Duclot et al., 2011; Hollis et 
al., 2011; Duclot and Kabbaj, 2013). Rats and mice are naturally neophobic (Meddock and 
Osborn, 1968; Stryjek and Modlinska, 2016) and it is thought that the behavioral responses 
during exposure to a novel environment is indicative of an animals trait anxiety (Steimer, 
2011). Based on these data it stands to reason that animals that exhibit low exploratory 
behaviors would be more susceptible compared with rodents that readily explore. However, 
findings using the high/low responders has been equivocal with some studies reporting 
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high responder groups as displaying resilience (Calvo et al., 2011) while others have 
reported resilience in low responder groups (Duclot et al., 2011; Hollis et al., 2011; Duclot 
and Kabbaj, 2013). These differences are likely due to variances in protocol, however these 
conflicting reports highlight the necessity for the inclusion of post-stress behavioral assays 
to verify resilient and susceptible phenotypes.    
While there are a number of methods for determining individual differences as they 
pertain social defeat and each has inherent advantages and disadvantages, studies powered 
to visualize these individual differences are critical to truly understand the neurobiological 
mechanisms that underlie the emergence of stress-induced behavioral dysfunction in 
susceptible phenotypes.  
 
1.4 Stress, mood disorders, and the brain 
 Up until this point, there has not been significant discussion regarding the effects 
of stress in the brain. However, the brain is exquisitely sensitive to stress and demonstrates 
rapid and long-lasting adaptation to these challenges. While these stress-induced 
adaptations are wide spread and highly region specific, studies in animals and humans have 
shown that there are a few key brain regions that are consistently dysregulated. This 
includes the prefrontal cortex (PFC), hippocampus, amygdala, locus coeruleus (LC), and 
dorsal raphe (DR) (Bremner, 2006; Bremner, 2007; Lucassen et al., 2014).  
 
The PFC has been studied for the better part of a century. Interest in this brain region was 
initially sparked in 1848 with the land mark case of Phineas Gage (Steegmann, 1962; Stuss 
and Knight, 2013). Gage, who was working as a railroad construction foreman, survived a 
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freak accident in which a rail road spike was driven completely through the left portion of 
his frontal lobe (Steegmann, 1962; Stuss and Knight, 2013). Initially it was his survival 
that astounded doctors. However, that soon changed as his friends and loved ones noted 
dramatic shifts in Gages personality (Steegmann, 1962; Stuss and Knight, 2013). Prior to 
the accident Gage was considered to be hard-working, responsible, and generally amiable 
(Steegmann, 1962; Stuss and Knight, 2013). Following the accident, he demonstrated 
indifference, impatience, obstinance, and would easily become enraged (Steegmann, 1962; 
Stuss and Knight, 2013). These observations were the first lines of anecdotal evidence to 
suggest that the structures found within the frontal lobe were critical for what we consider 
to be the manifestation of personality. Since then our understanding of the function, 
structure, and connectivity of the PFC has significantly broadened.  
 Functionally speaking, the PFC is critical for executive function. This includes 
complex processes such as sustained attention, planning, flexibility, initiating and 
executing complex behaviors, and active problem solving (Siddiqui et al., 2008). It has also 
been shown to play a significant role in memory (Fletcher et al., 1998; Luria, 2012), 
language (Siddiqui et al., 2008), gaze control (Luria, 2012), and contributes to intelligence 
(McFie and Thompson, 1972; Drewe, 1974). Notably, exposure to stress differentially 
affects these executive functions. Specifically, meta-analysis of 51 studies assessing a total 
of 2,486 participants has shown that stress significantly impairs working memory and 
cognitive flexibility while other control functions, such as inhibition, remain largely intact 
(Shields et al., 2016). Impairments in these executive functions have also been denoted in 
patients with depression (Channon and Green, 1999; Ajilchi and Nejati, 2017) and anxiety 
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(Ajilchi and Nejati, 2017) suggesting that these conditions are likely associated with 
abnormalities in PFC functionality.  
Several studies have begun to shed light on the functional changes that occur in the 
PFC using functional magnetic resonance imaging (fMRI) and positron emission 
tomography (PET). These studies have shown that exposure to acute stress results in an 
overall increase in the activity of the PFC (Tillfors et al., 2002; Sinha et al., 2016). This 
acute stress-induced PFC activity was shown to be significantly reduced in passive coping 
individuals who self-reported emotional eating, alcohol consumption, and argumentative 
tendencies exhibited lower PFC activity during stress (Sinha et al., 2016). Although human 
studies determining functional changes in the PFC following chronic stress are lacking, 
studies in depressed patients has shown that there is a dynamic dysregulation within 
specific subdivision of the PFC. Specifically depressed patients exhibit abnormally high 
resting activity of the medial PFC (Drevets et al., 1992; Biver et al., 1994; Mayberg et al., 
2005; Greicius et al., 2007) and concurrent reductions of activity in the dorsolateral PFC 
(Baxter et al., 1989; Biver et al., 1994; Galynker et al., 1998). These alterations in resting 
PFC activity have also been reported during tasks assessing working memory and 
planning/cognitive flexibility. In line with previous findings, a study conducted by 
Fitzgerald et al. determined that depressed patients exhibited widespread enhancement of 
PFC activity during completion of both of these tasks which well exceeded that of healthy 
controls (Fitzgerald et al., 2008).  
Similar PFC activity patterns have also been reported in animal studies using social 
defeat (Kumar et al., 2014). Currently there are several different hypotheses regarding the 
mechanism by which social defeat stress may cause this PFC dysregulation. Most directly, 
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it has been shown that social defeat results in glutamate-induced internalization of 
membrane bound GluR1 and GluR2 (Yashiro and Seki, 2017). Both GluR1 and 2 are 
subunits of the excitatory AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic 
acid) receptor and are critical for the induction of long term potentiation (LTP) (Zamanillo 
et al., 1999; Jensen et al., 2003) and the maintenance of basal excitatory tone (Shi et al., 
2001; Kolleker et al., 2003; Lee et al., 2004). It has been suggested that defeat-induced 
internalization of these subunits may represent a compensatory mechanism to normalize 
otherwise aberrant increases of excitatory tone within the PFC (Yashiro and Seki, 2017). 
This is particularly relevant to humans where post-mortem PFC tissue analyses indicated 
accumulation of glutamate (Hashimoto et al., 2007). 
Glutamate is known to work in concert with several other neurotransmitter systems 
and growth factors including BDNF (Martin and Finsterwald, 2011). BDNF is well known 
for its role in promoting the growth and survival of neurons. Notably, BDNF has been 
suggested to exert these functions through the modification of both pre- and post-synaptic 
terminals that enhance the overall sensitivity of neurons to excitatory amino acid 
neurotransmitter glutamate  (Martin and Finsterwald, 2011). It is through these indirect 
actions that BDNF is suggested to contribute to LTP and the strengthening of specific 
neural pathways (Martin and Finsterwald, 2011).  While findings in rodents using social 
defeat are largely equivocal, with some groups indicating enhanced expression of BDNF 
transcripts (Mallei et al., 2018) and others reporting direct reductions of BDNF protein 
(Dong et al., 2018), post-mortem studies in humans have shown that BDNF is reduced 
within the PFC of patients with major depression (Dwivedi et al., 2003). Structurally, this 
has been associated with reductions in neuronal size, density, and loss of dendritic spines 
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(Rajkowska, 2000; Kang et al., 2012), suggesting that these structural abnormalities may 
result in loss or reductions of PFC function.  
The Hippocampus, a bilateral temporal lobe structure, is traditionally known for its role 
in mediating the formation and maintenance of short-term and long-term memories (Bird 
and Burgess, 2008). However, it has been suggested that the hippocampus may also play 
an intricate role in cognitive flexibility and social behavior. It has been well documented 
that disruptions in the hippocampus can lead to amnesia and produce disturbances in 
declarative memory (Cohen and Squire, 1980; Squire, 1992; Cohen and Eichenbaum, 
1993; Gabrieli, 1998; Eichenbaum and Cohen, 2004), that is memory of people, places, 
and things. However, a component of these declarative memories are also the interactions 
between these elements, one’s own personal awareness, and the overall social context 
(Cohen and Eichenbaum, 1993; Eichenbaum and Cohen, 2004; Yonelinas, 2013). This 
relational information has also been shown to be disrupted in patients with hippocampal 
dysfunction (Cohen and Eichenbaum, 1993; Eichenbaum and Cohen, 2004; Yonelinas, 
2013), suggesting that the hippocampus is not only critical for the formation of new 
memories, but also for encoding the relationship between the individual components that 
comprise a memory. In addition to the formation of memories, the hippocampus has also 
been implicated in recall, reconstruction, and re-encoding of memories (Rubin et al., 2014). 
It is thought that this flexibility in memory is a key component in successful spatial 
navigation, exploration of novel environments, imagination, creativity, decision making, 
development of social relationships, and empathy (Rubin et al., 2014). With respect to 
social relationships and empathy, hippocampal dysfunction has been associated with 
difficulties in forming new and maintaining old social bonds (Duff et al., 2008; Davidson 
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et al., 2012; Warren et al., 2012) and a general loss of empathy (Beadle et al., 2013). 
Depression is also marked by breakdown of social bonds (Shahar, 2001), impairments in 
empathy (Wilbertz et al., 2010), and alterations in declarative memory  (Matt et al., 1992; 
Burt et al., 1995; Ramponi et al., 2004; Köhler et al., 2015). Generally, these impairments 
in depressed patients are associated with reductions in the activity (Milne et al., 2012) and 
volume (Videbech and Ravnkilde, 2004) of the hippocampus.  
Strikingly, hippocampal loss as it pertains to depression has been reported to persist 
for decades after remission (Sheline et al., 1996; Bremner et al., 2000). However, studies 
in humans have suggested that these effects may be reversible in humans (Starkman et al., 
1999). Notably, this persistent hippocampal atrophy in depressed patients has also been 
suggested to potentiate the emergence of age related cognitive decline (Sawyer et al., 
2012). There are a number of neuronal mechanisms that have been suggested to contribute 
to these effects. Under normal healthy conditions, BDNF is quite prominent in the 
hippocampus and serves to facilitate LTP and remodeling of pre and post-synaptic 
terminals (Leal et al., 2017). These molecular effects have been suggested to underlie 
processes such as short and long-term memory formation (Alonso et al., 2002). In response 
to stress, several studies in rodents have demonstrated that BDNF is largely reduced in the 
hippocampus (Lee and Kim, 2010). Notably, his reduction of BDNF in the hippocampus 
has also been reported in humans (Dwivedi et al., 2003) suggesting that this mechanism is 
largely conserved across species. Although it is currently unclear if stress-induced loss of 
BDNF is the initiating factor involved in hippocampal atrophy, it has been suggested that 
the loss of BDNF enhances the vulnerability of neurons to processes such as excitotoxicity 
(Campbell and Macqueen, 2004).  
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The Amygdala has long been recognized to be a key brain region involved in the 
acquisition and processing of fear. The role of the amygdala in fear and emotional 
processing has been studied over the past 6 decades. Disease states induced experimentally 
(Klüver-Bucy syndrome) and those occurring naturally (Urbach-Wiethe disease) were key 
in the initial characterization of amygdala function.  For example, the classic case study of 
patient S.M. demonstrated that bilateral calcification of the amygdala completely disrupted 
the intrinsic feeling of fear. Notably, these lesions were also associated with an inability to 
recognize fearful emotions in others. Beyond the immediate role of the amygdala in the 
expression of fear, this region has also been suggested to play a key role in mediating 
discrete social behaviors including subjective assessments of trustworthiness (Purves et al., 
2012).  
 The amygdala can be anatomically separated into a number of different sub nuclei. 
Of the suggested 13 subnuclei, the central, basal, and lateral divisions of the amygdala are 
the most clearly defined and best characterized. In general, it is thought that the basal and 
lateral divisions serve as the major input for emotionally salient information. In contrast 
the central division is considered to be the major output and is thought to be directly 
responsible for the expression of fear related behaviors and somatic responses (Ressler, 
2010). This, however, is a very simplistic view of the connectivity and function of the 
amygdala. In addition to mediating behavioral and somatic responses to fear, the amygdala 
has also been implicated in the emergence of coping responses during stress (Fadok et al., 
2017). Stress is associated with a robust activation of the amygdala (Roozendaal et al., 
1997; Bryant et al., 2008; Roozendaal et al., 2009; Pitman et al., 2012). In terms of acute 
stress exposure, these responses are thought to be largely adaptive. However, in response 
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to chronic stress and stress-induced disease states such as depression and anxiety, these 
adaptations result in persistent enhancements of amygalar activation even in the absence 
of a perceived threat (Liberzon and Sripada, 2008; Yang et al., 2010).  
There are a number of different mechanisms by which stress has been suggested to 
enhance amygdala activation. These putative mechanisms are the subject of investigation 
in chapter 5 of this document. 
 
The LC is the major source of NE to the entire neuroaxis. As such the LC has been directly 
implicated in the emergence of depression (Wong et al., 2000) and anxiety (Southwick et 
al., 1997). Under normal resting conditions, the LC functions to regulate arousal, attention, 
and autonomic function (Samuels and Szabadi, 2008). These processes are directly 
associated with tonic LC neuronal activity. Studies in cynomolgus monkeys have 
demonstrated that an alert wakeful state is associated with moderate and irregular activity 
of the LC (Rajkowski et al., 1994). In contrast, prolonged pauses in LC activation are 
associated with drowsiness and loss of attention (Rajkowski et al., 1994). Stress has been 
shown to temporarily shift LC activity from this tonic firing pattern to a high frequency 
phasic firing pattern (Rajkowski et al., 1994). This shift in LC firing has been suggested to 
play a key role in the emergence of the sympathetic fight or flight response. While this 
process is adaptive in the short term, several studies have suggested that chronic exposure 
to stress and disease states such as depression and anxiety are related to an increase in the 
tonic firing of the LC (Atzori et al., 2016).  
While this seems contradictory as depression has been associated with overall 
reductions in NE, it has been suggested that this enhancement of LC firing is likely 
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accompanied by depletion of NE in LC projections (Atzori et al., 2016). In addition to the 
idea of depletion, it has been suggested that stress may enhance the activity of sirtuin-1 
(Sirt-1). Sirt-1 is a histone deacetylase. As such, this particular protein has been shown to 
indirectly regulate neuronal function by increasing the transcription of a number of targets. 
Of relevance to NE and mood disorders, Sirt-1 has been shown to promote the activation 
of monoamine oxidases (MAO) through deacetylation of the transcription factor nescient 
helix-loop-helix 2. MAOs are well known for their role in the degradation of NE and 5-
HT. Moreover, their involvement in the pathogenesis of mood disorders has been well 
established and has led to the emergence of a class of anti-depressant therapeutics that 
specifically target MAOs (Fujita and Yamashita, 2018).    
 
The DR, like the LC, is a long-standing target for the study of mood disorders. The DR, a 
largely heterogeneous cell population, is a predominant site for 5-HT synthesis in the brain. 
With both ascending and descending projections, the DR has been implicated in practically 
every type of behavior including those corresponding to appetite, arousal, emotion, and 
cognition (Frazer and Hensler, 1999). Similar to findings with the LC, the DR demonstrates 
slow tonic activity that is directly associated with arousal and wakefulness (Jacobs and 
Fornal, 1993). In contrast, stimuli such as stress which provoke arousal are accompanied 
by a stark increase in DR firing rates (Jacobs and Fornal, 1993). Under states of chronic 
stress, the 5-HT system becomes dysregulated and is often associated with reductions in 5-
HT neurotransmission (Mahar et al., 2014). In many instances this reduction in 5-HT is 
associated with enhanced activity of presynaptic serotonin transporters that function to 
remove 5-HT from the synaptic cleft (Mahar et al., 2014). SSRIs are thought to improve 
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mood disorders by directly inhibiting these presynaptic receptors thereby increasing the 
amount of 5-HT available for neurotransmission. Another putative mechanism by which 
stress has been shown to reduce 5-HT is through the induction of indoleamine 2,3-
dioxygenase (IDO). IDO is the rate limiting enzyme that converts tryptophan to kynurenine 
(Greenhill, 2018). Since the amino acid tryptophan is also the primary precursor for the 
synthesis of serotonin, enhanced activation of IDO effectively reduces 5-HT synthesis by 
creating direct competition for this critical precursor.    
 
1.5 The implication of inflammation in mood disorders 
From the previous discussion, it is clear that there are a number of mechanisms that 
are suggested to contribute to the onset of social stress-induced mood disorders. One 
relatively new area of research in the field of depression, anxiety, and stress is 
inflammation. Inflammation is generally thought to be associated with physical illness, 
infection, and disease. However, stress is well known to activate the inflammatory system. 
In terms of acute stress responsivity, activation of the inflammatory system is considered 
to be adaptive by promoting wound healing through the recruitment of leukocytes 
(Dhabhar, 1998; Viswanathan and Dhabhar, 2005) and enhancing both adaptive (antigen-
specific) and innate (non-specific) immune responsivity (Dhabhar and McEwen, 1996; 
Dhabhar, 1998; Dhabhar and McEwen, 1999; Dhabhar et al., 2000; Viswanathan and 
Dhabhar, 2005). Typically, these inflammatory responses return to resting levels after the 
cessation of stress. But in situations of chronic stress, the immune system can become 
dysregulated (Glaser and Kiecolt-Glaser, 2005) and has been suggested to contribute to the 
development of mood disorders including depression and PTSD.  
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The putative involvement of the inflammatory system in mood related disorders 
was first described in 1927 by Julius Wagner-Jauregg, who went on to win the Nobel Prize 
for this seminal discovery. Since its initial discovery, several hundreds of papers have been 
published on the topic (Loftis et al., 2010). This vast body of literature has demonstrated 
that depressed individuals exhibit increases in the number of inflammatory competent cells 
in the plasma (Zorrilla et al., 2001), decreased lymphocyte proliferation (Zorrilla et al., 
2001), and decreased adaptive (antigen-specific) immune reactivity (Irwin et al., 1998). 
Additionally, these patients often exhibit increases in resting plasma concentrations of 
interleukin (IL)-1 (Anisman et al., 1999), IL-6 (Zorrilla et al., 2001), IL-12 (Zorrilla et al., 
2001), tumor necrosis factor (TNF)-a (Anisman et al., 1999), and C reactive protein (CRP) 
(Lanquillon et al., 2000; McDade et al., 2006; Miller et al., 2008) the acute phase protein 
that follows IL-6 secretion. Notably, these inflammatory effects are not isolated to the 
periphery. Increases in the concentration of IL-1b (Miller et al., 2019), IL-6 (Sasayama et 
al., 2013; Kern et al., 2014b), and IL-8 (Kern et al., 2014b) have also been documented in 
the cerebrospinal fluid (CSF) of depressed patients. It could be argued that cytokine 
measures in the CSF do not accurately represent inflammatory processes in the brain due 
to the significant cross talk that occurs between the plasma and the CSF at the site of the 
blood-CSF barrier in the choroid plexus (Engelhardt and Sorokin, 2009). However, a 
seminal study published by Setiawan et al. in 2015 demonstrated for the first time that 
patients with major depressive disorder exhibit increases in activated microglia, the innate 
immune cells of the brain (Setiawan et al., 2015). This study suggests that depression is 
indeed associated with increased inflammatory potential in the brain. Importantly, similar 
inflammatory profiles have also been described in patients with PTSD (Wang and Young, 
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2016), suggesting that disruptions in the inflammatory system are common features of 
stress-related mood disorders and is not isolated to depression. 
Enhancements of the inflammatory system have also been reported using social 
defeat in rodents. In general, it has been shown that defeat-induced depressive-like 
behaviors in rodents is not only associated with enhanced release and transcription of 
cytokines (Powell et al., 2013) but also results in an increase in the number and reactivity 
of peripheral macrophages (Wohleb et al., 2012; Wohleb et al., 2014b). These peripheral 
macrophages have the potential to traffic to the brain where they have been suggested to 
contribute to neuroinflammation (Wohleb et al., 2012; Wohleb et al., 2014b). Just as coping 
during stress has been shown to drive susceptibility to subsequent behavioral deficits, 
coping has also been shown to differentially affect stress-induced inflammation. Our group 
has specifically shown that adoption of passive coping behaviors during defeat and 
resulting depressive-like behaviors were associated with significant increases of IL-1b 
within the LC 24 hours after the final social defeat exposure (Wood et al., 2015). Notably, 
these effects were absent in rats demonstrating active coping during the defeat exposure 
and subsequent behavioral resilience (Wood et al., 2015). This particular study further 
demonstrated that the defeat-induced inflammatory profile of the LC was not ubiquitous 
throughout the brain and was not specific to IL-1b.  In this regard, concentrations of IL-1b 
in the DR were significantly reduced following social defeat. Moreover, analysis of 
monocyte chemoattractant protein (MCP)-1 in these same tissues indicated that while this 
cytokine exhibited similar protein profiles to that of IL-1b in the DR, social defeat did not 
alter MCP-1 concentrations in the LC (Wood et al., 2015).  
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1.6 Stress-induced inflammation as a putative mechanism in the pathogenesis of 
mood disorders 
 The studies discussed thus far have clearly demonstrated a relationship between 
inflammation and depression. However, inflammation is not just a physiological 
consequence of stress exposure that correlates with behavioral dysfunction. Over the last 
decade, strong evidence has been collected that directly implicates inflammation in the 
pathogenesis of depression. Some of the first lines of causal evidence in humans resulted 
from clinical studies administering cytokines for the treatment of cancer, viral hepatitis, 
and autoimmune disorders (Pinto and Andrade, 2016). The interferon (INF) superfamily 
has long been utilized in these studies for their antiviral, antiproliferative, apoptotic, and 
immunomodulatory effects (Rizza et al., 2015; Pinto and Andrade, 2016). However, these 
treatments are frequently associated with the emergence of depression in approximately 
30-70% of patients (Schaefer et al., 2012) and demonstrate peak depression-inducing 
effects at approximately 4-16 weeks of treatment (Ehret and Sobieraj, 2014). While it is 
difficult to discern whether these depression-inducing effects are due to the administration 
of these treatments, as a result of these illnesses, or a combination of both, it has been 
demonstrated that anti-inflammatory treatments can exert anti-depressive efficacy. 
Specifically, a study conducted by Raison et al in 2013 demonstrated that infliximab, a 
TNF-a inhibitor, could produce remission in depressed patients who previously 
demonstrated resistance to traditional anti-depressants (Raison et al., 2013). Importantly, 
this study determined that this particular subgroup of patients were admitted to the study 
with high baseline CRP concentrations in the plasma (Raison et al., 2013). Other groups 
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have demonstrated similar findings (Mehta et al., 2013; Kopschina Feltes et al., 2017), 
providing clear causal evidence for the involvement of inflammation in depression.  
 The putative contribution of inflammation in the onset of depressive-like behaviors 
has also been demonstrated in rodent studies. For example, a study by Hodes et al. 
illustrated that bone marrow transplantation from susceptible rats induced in susceptibility 
in otherwise resilient mice (Hodes et al., 2014). Others have demonstrated that behavioral 
resilience can be induced by genetic removal and knockdown of the IL-1 receptor (Wohleb 
et al., 2014b). Finally, our group has demonstrated that daily infusion of an IL-1 receptor 
antagonist 30 minutes prior to the onset of defeat inhibited the emergence of depressive-
like behaviors in passive coping rats (Wood et al., 2015).  
 
1.7 The impetus for this work 
 Extraordinary effort has been exerted by numerous individuals, labs, and research 
groups to understand the mechanisms by which stress promotes the emergence of 
depressive- and anxiety-like behavioral dysfunction. Moreover, studies in humans and 
rodents alike have suggested that targeting the inflammatory system may represent a viable 
and yet untapped therapeutic option for the treatment of these disorders.  However, there 
is still much that we do not know: 
1. While stress is known to result in complex dysregulation of the inflammatory 
system, what specific cytokines are implicated? How broad are these inflammatory 
effects? How do stress-induced inflammatory profiles differ between the periphery 
and the brain and how do they differ between brain regions?  
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2. Similarly, we know that stress can promote the activation of the inflammatory 
system, but it remains unclear which systems contribute to this activation and how 
this relates to the aforementioned stress-induced inflammatory profiles.  
3. Lastly, it is still unknown how stress-induced inflammation ultimately promotes 
depressive- and anxiety-like behaviors. Are these direct effects of cytokine 
signaling? Or are these effects due to secondary shifts in distinct neurotransmitter 
systems, receptors, and intracellular signaling cascades? 
The goal of all of the work described in the following chapters has been designed to answer 
these specific questions. By understanding the “what”, “why”, and “how” underlying 
stress- and inflammatory-induced behavioral dysfunction, it will be more plausible to 
develop targeted therapeutics for those exhibiting resistance to traditional 
pharmacotherapies.  
 






 While the work described in each of the subsequent chapters has unique aims and 
foci, there are several methods that were held constant throughout these studies. The 
purpose of this chapter is to outline these specific methods thereby eliminating repetition 
of otherwise superfluous information. Any deviations from the core methods detailed here 
are noted in the appropriate subsections in the subsequent chapters. 
 
2.1 Care and use of animals 
 In order to determine the broad consequences associated with social defeat 
exposure, the use of freely moving, fully intact animals was required. Based on a previous 
study conducted by our group (Wood et al., 2010), a minimum of 8 rats is required in each 
stress x coping x treatment group in order to accurately identify individual differences. 
Every attempt was made to minimize the number of animals required for the completion 
of a particular study. Further, great care was taken to alleviate discomfort and eliminate 
pain for all of the procedures conducted in these studies. Aseptic techniques during surgery 
were strictly enforced to minimize possible exposure to infection and all surgeries were 
conducted under general anesthetic. The analgesic Flunixin (2.5 mg/kg; Henry Schein; 
Melville, NY) and dietary support of Bacon Softies (Bio-Serv; Flemington, NJ) and Diet 
Gel (Clear H2O; Portland, ME) were administered on the day of surgery and 24 hours 
following surgery to minimize discomfort from surgical procedures. The care and use of 
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animals in these studies was approved by the University of South Carolina’s IACUC and 
were maintained in accordance with the Animal Welfare Act, the DHHS “Guide for the 
Care and Use of Laboratory Animals”, and the NIH guidelines for the Care and Use of 
Laboratory Animals. Veterinary care was under the direction of a full-time resident 
veterinarian boarded by the American College of Laboratory Animal Medicine. Additional 
veterinary staff and technicians were also available and provided a complete 
comprehensive program of diagnostics, preventive, and clinical medicine at our facilities.  
  Use of social defeat required 2 distinct rodent populations: “residents” and 
“controls”/ “intruders”. Our resident colony consisted of Long-Evans retired breeders 
(650-850g; Charles River, Durham NC). Prior to inclusion in the study, each resident was 
carefully screened for his aggressive tendencies. Inclusion criteria consisted of (1) 
exhibiting an attack latency of less than 60s, (2) total number of attacks ³ 4 within the first 
5 minutes of exposure, and (3) effective attacks that did not result in injury. Any rats that 
did not meet these criteria or those whose behaviors became unpredictable or overly violent 
were excluded from these studies and were subsequently euthanized using CO2. In each of 
these cases death was verified via induction of a bilateral pneumothorax. All of the 
behavioral, molecular, and cardiovascular analyses conducted in these studies were 
collected from our “control”/ “intruder” population which exclusively consisted of male 
Sprague Dawley rats (225-250g; Charles River, Durham NC).  
 Residents, controls, and intruders were maintained on a standard 12-hr (7am-7pm) 
light/dark cycle with ad libitum access to water and standard chow. Importantly, these 
rodent groups were individually housed. This particular housing method was chosen as 
group housing in the context of stress can be subject to social buffering (Kikusui et al., 
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2006). Social buffering is a process by which a familiar conspecific mitigates and in some 
cases completely eliminates the behavioral and physiological responses to stress (Kikusui 
et al., 2006). As these behavioral and physiological responses to stress are critical in the 
studies conducted within, social buffering represents a significant confound in the study of 
stress. In addition to concerns regarding the effectiveness of social defeat exposure in our 
“control”/ “intruder” group, there were concerns that group housing of “residents” would 
not only affect resident behavior but could also lead to significant injury resulting in the 
needless loss of animal life.  
 
2.2 Social defeat and control manipulations 
 The resident-intruder paradigm of social defeat was utilized for the completion of 
all of the studies discussed in the following chapters. For these particular studies, the male 
Sprague Dawley rats were randomly assigned into “intruder” and “control” groups. Social 
defeat and control manipulations for each of these studies were conducted for 30 minutes 
on 5 consecutive days. Rats classified as “intruders” were placed into the home cage of a 
novel Long-Evans retired breeder. After a short period of investigation, the resident would 
initiate a cascade of attacks. Residents and intruders were allowed to physically interact for 
a maximum of 15 minutes or until the intruder exhibited a supine submissive posture, 
whichever came first. At this point, residents and intruders were separated with a perforated 
Plexiglas partition for the remainder of the 30-minute defeat exposure. Notably, this 
separation still allows for olfactory, visual, and auditory contact with the resident but does 
not allow for physical interaction. Rats classified as “controls” were placed in a novel cage 
behind a perforated Plexiglas partition for the entire 30-minute period on each day. 
 
 29 
Importantly, “control” rats were not in the room during the time of social defeat in order to 
avoid potential confounds from stress-induced ultrasonic vocalizations and pheromones. 
For a more detailed discussion of the resident-intruder paradigm, please refer to Chapter 1: 
“Modeling social stress and coping in rodents”.  
 
2.3 Quantification of during defeat behaviors 
 In order to determine specific drug effects and for the accurate separation of 
intruders into active and passive coping subpopulations social defeat exposures on day 1 
and 5 were video recorded. These recordings were subsequently analyzed to determine the 
duration of time that each intruder spent in upright defensive positions. These data were 
hand scored by an experimenter blinded to each rats treatment designation. These 
recordings were further utilized to validate notes taken during the defeat exposure 
regarding the total number of attacks as well as the amount of time required for the intruder 
to exhibit submission (defeat latency). 
 
2.4 Determination of anhedonic-like behaviors 
 Anhedonia (i.e. reduced enjoyment of otherwise pleasurable stimuli) is a core 
feature of depression (Gorwood, 2008) and has been described in a number of other mood 
related disorders such as schizophrenia (Andreasen and Olsen, 1982; Blanchard et al., 
2001), substance abuse (Ahmed and Koob, 1998; Volkow et al., 2002), and PTSD (Frewen 
et al., 2012). In rodents, the emergence of depressive-like anhedonic behaviors have been 
primarily evaluated with the use of the two-bottle sucrose preference test. In this test, rats 
are given free access to either 1% sucrose or water. Both bottles are weighed periodically 
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and the preference for sucrose is calculated as the volume of 1% sucrose consumed divided 
by the total volume of water and 1% sucrose consumed (Grillo et al., 2014; Eagle et al., 
2016). Our group has previously shown that exposure to social defeat results in a significant 
reduction of sucrose preference selectively in rats demonstrating a passive coping 
phenotype during defeat (Wood et al., 2015). In contrast, controls and active coping rats 
demonstrated normal sucrose preference of approximately 90-95% (Wood et al., 2015). 
Importantly, sucrose preference represents a relatively non-invasive measure of 
depressive-like behavior. This is of particular importance as other widely used measures 
of depressive-like behaviors in rodents such as the forced swim test, an acute inescapable 
stress, often result in robust activation of the inflammatory system (Altenburg et al., 2002; 
Llorens-Martin et al., 2016).  
 Based on the ease, utility, and non-invasive nature of this behavioral assay, 
depressive-like behaviors in the studies described in the subsequent chapters were 
determined using the sucrose preference test. Since rats are naturally neophobic to both 
novel objects (Ennaceur et al., 2009) and food (Modlinska and Stryjek, 2016; Stryjek and 
Modlinska, 2016), successful completion of the sucrose preference test requires some 
degree of training. At 9 am, 48 hours prior to testing, a second bottle with filtered water is 
placed into the cages of each rat. On the following day at 9 am, the bottles of each rat are 
emptied, and filled with a 1% solution of D-sucrose (Fisher Scientific; Waltham, MA) in 
filtered water. The inclusion of this two-day training period allows the rats to first become 
accustomed to the presence of the second water bottle and secondly to become familiar 
with the taste of the 1% sucrose solution. In addition to this pre-test training period, water 
deprivation on test day has also been shown to be critical in the overall success of the 
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sucrose preference test (Cohen and Burtt, 1979). Our group begins water deprivation at 
9am on test day.  
Ten hours later at 7 pm, the time of lights out, the sucrose preference test begins. 
Labeled bottles containing 1% sucrose and water are weighed, recorded, and placed into 
the cages of each rat. At 8 pm, both bottles are briefly removed, weighed, recorded, and 
placed back into the appropriate rats cage. Importantly, during this weighing the position 
of the water and sucrose bottles are switched to ensure that the exhibited hedonic effects 
are not due to a rats innate side bias (Castellano et al., 1987; Andrade et al., 2001). Water 
bottles are weighed a final time at 10 pm. Following this final weighing, a single bottle 
containing filtered water is placed into the cage of each rat. Great care is taken during each 
of these times to minimize the disruption caused by the experimenter. To accomplish this 
all work is conducted under red light and noise is kept to a minimum (i.e. no talking, gentle 
insertion of water bottles, and movements of cage lids).   
 
2.5 Euthanasia and tissue collection 
 The timepoint at which tissue was collected varied for each study discussed in the 
subsequent chapters. Each chapter has an associated study design which clearly indicates 
the day of tissue collection. Although the timepoint varies due to differences in the overall 
goals of each study, the methods by which tissues were collected did not differ. On the day 
of tissue collection, rats were lightly anesthetized with Isothesia Isoflurane (Henry Schein; 
Melville, NY) prior to uniform instantaneous decapitation with a Guillotine. This method 
of euthanasia was selected as it is in accordance with the recommendations of the Panel on 
Euthanasia, AVMN (JAVMA 188:252, 1986). At this time, hearts, brains, adrenals, spleen, 
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and blood were collected. Brains were blocked into anterior and posterior sections, flash 
frozen with 2-Methylbutane (Acros Organics, Morris, NJ), and stored at -80oC. Spleens 
and adrenals were cleaned of excess fat and tissue, weighed, and discarded. Blood was 
centrifuged at 4oC for 15 minutes at a speed of 3200 rpm. The resulting plasma was 
collected, transferred to microfuge tubes, and stored at -80oC.  
 
2.6 Collection, verification, and homogenization of the CeA, hippocampus, LC, and 
DR tissue 
 Each of the studies discussed in the subsequent chapters required collection of the 
CeA, hippocampus, LC, and/or DR. Similar to tissue collection, the specific brain regions 
collected for subsequent analysis varied between the studies discussed hereafter based on 
the overall goal of that particular study. However, the methods by which these brain areas 
were collected and homogenized did not differ. Across all studies, frozen anterior and/or 
posterior brains were sliced using a Leica CM3050 S Research Cryostat. The cryostat was 
kept between -15 and -20 oC to facilitate minimal tissue thawing during the slicing process. 
Flash frozen brains were transported and temporarily stored on dry ice during the slicing 
process. To ensure that brains would not shred during the slicing process, each brain was 
removed from the dry ice and placed into the cryostat for approximately 1 minute. 
Following this 1-minute temperature equilibration, brains were embedded in O.C.T. 
compound (Fisher Scientific; Waltham, MA) to facilitate slicing.  
Frozen anterior brains were coronally sliced until reaching the most rostral level of 
the CeA (Bregma -1.72 ) and the hippocampus (Bregma -2.92) in accordance with the Rat 
Brain Atlas by Paxinos and Watson (Paxinos and Watson, 2007). In a similar fashion, 
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posterior brains were sliced until the most caudal level of the LC (Bregma -10.8) and DR 
(Bregma -8.40) (Paxinos and Watson, 2007). These specific brain regions were isolated 
and removed using a 1 mm wide tissue biopsy punch (Harvard Apparatus; Holliston, MA). 
The entirety of the CeA, hippocampus, and LC were obtained using a depth of 1 mm, while 
DR acquisition required a 2 mm depth. Punches were placed into a chilled and labeled 
Safe-Lock microfuge tube and stored at -80oC. Importantly, punch placement was 
histologically verified. To achieve this, 30 µm thick slices were collected and mounted 
onto Superfrost Plus Microscope Slides (Fisher Scientific; Waltham, MA) immediately 
prior to and following punch acquisition. Slides were then submerged in a solution of 
neutral red (Fisher Scientific; Waltham, MA) for 5 minutes. After staining, the slides were 
rinsed, and subsequently dehydrated with 1-minute submersions into baths containing 
75%, 95%, and 100% ethanol. Dehydrated slides were then fixed using Histo-Clear 
(National Diagnostics; Atlanta, GA). Following a 24-hour drying period, slides were cover 
slipped and evaluated. Any samples that were deemed inaccurate based on this verification 
method were not included for subsequent tissue analysis. Images of the Paxinos and 
Watson Brain Atlas used for reference in these studies and examples of pre- and post-punch 
slices are depicted in Figure 2.1. 
 
2.7 Tissue Homogenization 
 All of the analyses conducted in the CeA, hippocampus, LC and DR required 
homogenization of the collected tissue punches. Homogenization is a process used to 
disrupt tissue and break open cell membranes, resulting in the release of the cellular 
contents. There are a number of ways in which homogenization can be completed, however 
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these methods can all be classified as either a chemical or physical disruption. A chemical 
homogenization process typically includes some kind of detergent or emulsifier which 
breaks down the phospholipid bilayer of a cell. In contrast a physical approach, such as use 
of a sonicator or mortar and pestle, uses direct physical or mechanical force. Each of these 
approaches has their inherent advantages and disadvantages. For example, use of 
detergents high in Sodium Dodecyl Sulfate (SDS) can interfere with a number of assays 
including a simple Bradford protein assay (Friedenauer and Berlet, 1989). In contrast, 
physical disruption has been associated with denaturation and coagulation of proteins (Ye 
et al., 2017). In order to avoid some of these issues, many groups, including ours, use a 
combination of chemical and physical disruption. 
 For the purpose of homogenization, collected tissue punches were thawed on ice. 
Mechanical disruption was accomplished using Zirconium oxide beads (ZrOB05, 0.5mm 
diameter; Next Advance; Troy, NY). Beads were added to the tissue punches as outlined 
in Table 2.1. After addition of the beads, a lab made lysis buffer was added to each sample 
as outlined in Table 2.1. The lysis buffer contains 137mM sodium chloride, 20mM Tris, 
1% Igepal (NP-40), 10% Glycerol, and 1x protease and phosphatase inhibitor cocktail 
(Thermo Scientific, Waltham MD).  Samples were then placed into a Bullet Blender (Next 
Advance, Troy, NY) and physical disruption occurred at 4oC for 3 minutes on a speed of 
8. For studies in chapters 3 and 4, samples were immediately transferred to a microfuge 
(stored at 4oC) and centrifuged at 14000 rcf for 15 minutes. The resulting supernatant was 
carefully removed and transferred to a new labeled microfuge tube. For studies in chapter 
5, homogenates were transferred to a new microfuge tube prior to centrifugation in order 
to remove the zirconium oxide beads. These samples were then centrifuged as described 
 
 35 
above. The supernatant was again transferred to a new labeled tube and the resulting pellet, 
containing the containing the cell membranes, some organelles, and cellular debris, were 
resuspended. This small shift in protocol was chosen specifically for chapter 5 as this study 
required the analysis of several membrane bound proteins. Membrane bound proteins were 
not studied in chapters 3 and 4 and therefore did not require this additional step.  
 The final step the tissue homogenization protocol is the determination of protein 
concentration. This is most commonly completed with the use of a Bradford Assay. The 
Bradford assay is a colorimetric analytical procedure in which is based on an absorbance 
shift in Coomassie Brilliant Blue dye (Ninfa et al., 2009). The particular kit used by our 
group (Pierce BCA Protein Assay Kit, Thermo Scientific; Waltham MA), utilizes a neutral 
(green) variant of this dye. The dye readily forms strong non-covalent bonds with carboxyl 
groups found within the chemical structure of the amino acids that comprise a protein. It is 
the bonding of the dye to amino acids that visually result in a shift in color. Typically, 
samples with more protein, and therefore more amino acids, will have a much more 
dramatic shift in color and will generally appear darker. In addition to a shift in color, there 
is a dramatic shift in absorbance. The unbound dye is well characterized to have exhibit a 
maximum absorption of 465 nm. Once it is bound to protein, the maximum absorbance 
shifts to 595 nm. It is this dramatic shift in absorbance that allows for the accurate and 
precise determination of protein concentrations within a sample.  
 As previously mentioned, our group uses the neutral (green) variant of this dye. In 
order to determine protein concentration, 12 µL of resulting homogenate are added to 48 
µL of phosphobuffered azide. These samples are briefly vortexed to ensure proper mixture 
and 25 µL of the resulting solution is pipetted onto a 96 well plate in duplicate. 200 µL of 
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the proprietary dye solution (Working Reagent, Thermo Scientific, Waltham MA) is then 
added to each well and allowed to incubate for 30 minutes at 37oC. After this 30-minute 
incubation, absorbance of this plate is read using a Synergy 2 Multi-Mode Plate Reader 
(Bio Tek, Winooski VT).  
 
2.8 Bio-Plex 
 The primary data in chapters 3,4, and 5 were generated using a relatively new assay 
that allows for simultaneous detection of multiple different substrates within one sample. 
These assays are sold as kits by various companies including Bio-Rad (Bio-Plex) and 
Millipore (Milliplex). Whether it is the detection of cytokines (Chapters 3 and 4) or cellular 
signaling proteins (Chapter 5), these assays utilize the same general scientific principles 
that are similar to a traditional Sandwich ELISA. Sandwich ELISAs have been utilized for 
the better part of a century for the detection and quantification of a variety of targets. This 
particular assay format captures antigens (target protein) between two antibodies termed 
the capture and detection antibodies. Capture antibodies are bound to the bottom of a plate 
or a net well. When the sample is added, the target proteins bind to this capture antibody. 
A secondary antibody is then applied to each well. This secondary antibody functions to 
increase specificity and also has a specialized protein tag. Typically, this protein tag is the 
binding site for a fluorescent tag or a color changing enzyme. It is this layered binding that 
gives the Sandwich ELISA its characteristic name. The Bio-Plex functions in a very similar 
manner. However, instead of having the capture antibody bound to the bottom of the plate, 
they are bound to magnetic beads. Each magnetic bead is coated with a specific antibody 
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that can be sorted based on fluorescence. It is this specificity and sorting that allows for the 
creation of bead mixtures to quantify a number of protein targets within the same sample.  
 Based on the utility of this assay method, Bio-Plexes were used in each of the 
studies discussed hereafter. However, due to variability in the analytes utilized, a brief 
discussion is provided in each chapter regarding the specific protein targets included on the 
Bio-Plex kits as well as the protein concentration that was loaded for each kit.  While some 
things varied between studies, the general equipment utilized for the completion of these 
studies did not differ. Specifically, all 96-well plates were washed using a Bio-Rad Bio-
Plex Pro II Wash Station (Hercules, CA) and were read using the Bio-Rad Bio-Plex 
Luminex SD system (Hercules, CA).  
 
2.9 Statistics 
 Data collected in each of the studies discussed in chapters 3-5 were statistically 
analyzed to determine specific effects of stress and drug manipulation on target outcomes. 
Prior to statistical analysis, all data sets described in Chapters 3-5 were analyzed using a 
combination of 2x standard deviation and Modified Thompson Tau. The Modified 
Thompson Tau test is a particular method of outlier analysis that provides a more specific 
approach by incorporating sample size and standard deviation to determine the presence or 
absence of outliers. In this way the Modified Thompson Tau test is a more flexible 
approach compared to other methods of outlier analysis such as 2x standard deviation. In 
the current studies, values that exceeded two-times standard deviation were automatically 
excluded from all group analyses. Values flagged by the Modified Thompson Tau analysis 
were further evaluated for the presence of false positive results. Any values that were 
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deemed to have been marked from a false positive result were not excluded from group 
analyses as these values were not considered to be true outliers. 
There were three main types of statistical analyses conducted throughout these 
studies: t-test, One-, and Two-Way ANOVAs. Standard t-tests were utilized for data sets 
which directly compared behavioral or molecular responses in two specific groups. 
Importantly, these analyses were only applied to data sets to determine if the mean 
responses differed to a single variable (i.e. stress only or treatment only). In instances where 
a single variable was compared across 3 groups, a One-Way ANOVA was utilized. 
Determination of the effects of stress and treatment (2 variable analysis) prompted the use 
of a standard Two-Way ANOVA. Similarly, analyses to determine the effects of stress, 
treatment, and time as it pertained to cardiovascular measurements (3 variable; Chapter 5) 
were subjected to a standard Three-Way ANOVA. Notably, these ANOVA results were 
utilized to determine whether a particular variable produced statistically significant effects 
(a=0.05) on the measured mean responses. To evaluate statistical significance between 
specific groups (ex. drug defeat vs. vehicle defeat), post-hoc analyses were conducted. 
Post-hocs for each study were selected based on sample sizes and group variances. 
Specifically, post-hoc analyses in Chapters 3 and 5 were evaluated using the Fisher LSD 
post hoc as these data sets had unequal variances, unequal sample sizes, and were largely 
unpredictable. In contrast data collected in Chapter 4, were analyzed using the Holm-Sidak 
post-hoc analysis to account for unequal sample variance. All t-tests, ANOVAs, and 




















Table 2.1 Summary table of tissue punch size, quantity, and volumes of beads and lysis 




(L x W x D mm) 






CeA 1 x 1x 1 2 100 200 
Hippocampus 1 x 1 x 1 4 200 400 
LC 1 x 1 x 1 2 100 200 

















Figure 2.1 Histological verification of punch placement at the level of the CeA (A), 
hippocampus (B), and DR (C). The left most panel depicts the Paxinos and Watson Brain 
atlas used as a reference point for punch acquisition. The center panel depicts the pre-
punch slice obtained immediately prior to punch acquisition. The right most panel depicts 
the post punch slice obtained immediately after punch acquisition. Black circles serve as 





The “What”: Inflammation as a consequence of social defeat and its 
implication in stress-induced depressive-like behaviors 
 
3.1 Introduction 
 Findings in humans and animals have begun to implicate stress-induced 
inflammation in the pathogenesis of depressive- and anxiety-like behavioral states. These 
findings have suggested that exposure to stress results in a robust activation of the 
inflammatory system. Moreover, several of these studies have detailed the protective 
effects of cytokine inhibition in the emergence of behavioral dysfunction following stress 
exposure. However, these studies also have major drawbacks. For example, the majority 
of studies assessing inflammation as it relates to stress and the emergence of behavioral 
dysfunction have focused their attention on one or two cytokines. Based on these narrow 
assessments, it is still unclear how broad these stress-induced inflammatory effects are in 
the periphery and the brain. Similarly, use of bone marrow transplants (Hodes et al., 2014), 
genetic manipulation (Wohleb et al., 2014b), and direct drug infusion into the brain via 
permanent intracerebroventricular cannulas (Wood et al., 2015) are invasive or unethical 
for use in humans and therefore have low therapeutic translatability.  
 Several studies have attempted to circumvent these issues by using other injectable 
compounds including resveratrol (RSV). RSV is a commercially available non-flavonoid 
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polyphenol found in the skin of strongly pigmented fruits and vegetables including red 
grapes and berries (Langcake and Pryce, 1976). Several studies in humans and rodents have 
suggested that RSV may represent a useful adjuvant for the treatment of a number of 
disorders due to its strong antioxidant (Xia et al., 2017) and anti-inflammatory properties 
(Falchetti et al., 2001; Donnelly et al., 2004; Fordham et al., 2014). The anti-inflammatory 
effects of RSV have been well explored. These studies have demonstrated that RSV 
functions to inhibit the production of histamine, cytokines, proteases, and nuclear factor-
kappa B in several inflammatory cell types including mast cells, macrophages, neutrophils, 
and microglia (de la Lastra and Villegas, 2005; Zhang et al., 2010). In addition to these 
cellular effects, RSV has clearly been demonstrated to produce anxiolytic (Patki et al., 
2013) and anti-depressive effects (Xu et al., 2010; Ahmed et al., 2014; Hurley et al., 2014; 
Solanki et al., 2015) in a number of animal models.  
Based on the strong clinical and pre-clinical data implicating inflammation in the 
emergence of anxiety- and depressive-like behaviors, it was hypothesized that the 
demonstrated behavioral effects of RSV would be directly associated with its anti-
inflammatory activity in the periphery and the brain. With respect to our social defeat 
model, it was therefore expected that RSV would demonstrate anti-depressive effect in rats 
exhibiting a passive coping phenotype. Moreover, based on findings in humans that stress 
produces a general enhancement of inflammation that is not specific to one cytokine or 
cytokine family, it was further hypothesized that social defeat in rodents would produce 
similar effects resulting in the enhancement of a number of different cytokines in the brain 





 The methods outlined below represent specific details relevant to this particular 
study. Additional methods including the process of social defeat and control manipulation, 
sucrose preference, and tissue collection and homogenization are detailed in Chapter 2. 
 
3.2.1 Resveratrol Treatment 
 For the purpose of this study, trans-resveratrol (Cayman Chemical Company; Ann 
Arbor MI) was dissolved to a final concentration of 0, 10, and 30 mg/kg in a solution 
consisting of 10% ethanol (Ultra Pure; Darien, CT), 15% Cremophor (Fisher Scientific; 
Waltham, MA), and 75% saline (Abbott Laboratories; Chicago, IL). The trans- variant was 
chosen as this particular isomer has been shown to be more effective in producing 
antiproliferative (Anisimova et al., 2011) and anti-inflammatory effects following 
administration (Rius et al., 2010). In addition to enhanced efficacy, the trans- isomer is 
chemically more stable (Trela and Waterhouse, 1996) and is naturally more abundant 
(Gambini et al., 2015) than the cis- isoform. One major consideration with the use of this 
compound is its relatively low bioavailability. Oral administration of either the cis- or 
trans- isoforms are rapidly metabolized (Wenzel and Somoza, 2005) and therefore do not 
reach the brain (Shu et al., 2015). To circumvent this issue, this study utilized daily 
intraperitoneal (i.p) injections. This administration route is very similar to oral 
administration as the substances are absorbed by mesenteric vessels which drain into the 
portal veins and pass through the liver (Lukas et al., 1971). Importantly, i.p injections have 
been shown to result in significant detection of RSV in the brain (Shu et al., 2015).  Similar 
to oral gavage, these injections in rodents require significantly more handling and 
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temporary restraint during the drug administration process. To ensure that these additional 
mild stressors would not skew the results of the study, i.p. drug administration of 0, 10, or 
30 mg/kg began a week prior to the onset of social defeat or control allowing all rats to 
habituate to the handling and injection process. 
 
3.2.2 Flow Cytometry 
 Flow cytometry was utilized in this study to determine the effects of RSV on 
intracellular cytokine expression following social defeat. In general flow cytometry is a 
biochemical method that allows for the sorting, detection, and measurement of physical 
and chemical properties of cells. For the purposes of this study, flow cytometry was utilized 
to determine the relative inflammatory reactivity in CD4+ splenocytes following 
defeat/control and RSV treatment. To this end, spleens were collected on the day of 
euthanasia, weighed, and primary splenic cells were prepared. These primary splenic cells 
were treated with 2 µg/mL concancavalin-A (ConA; Sigma Aldrich; St. Luis, MO) 
overnight at 37oC and 5% CO2 to stimulate immune cell proliferation. Four hours prior to 
immunostaining, intracellular trafficking was stopped using Golgi Stop (BD Biosciences; 
San Jose, CA) per manufacturer recommendation. All samples were aliquoted to allow for 
immunostaining of four individual inflammatory cytokines. The rat FITC anti-CD4 cell 
surface antibody or isotype control were added to label T-helper cells (Biolegend; San 
Diego, CA). Cell fixation and permeabilization was completed per manufacturer 
recommendations with BD cytofix/cytoperm (BD Biosciences; San Jose, CA). The primary 
antibodies utilized to label inflammatory cytokines were PE-anti-rat TNF-a (Biolegend; 
San Diego, CA), Biotin-anti-rat IL-1b (Abcam; Caimbridge, MA), mouse-anti-rat IL-6 
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(Invitrogen; Camarillo, CA), and PE-anti-rat IL-10 (BD Bioscience; San Jose, CA) or 
appropriate isotype controls. For antibodies lacking fluorescent labels (IL-1b and IL-6), an 
appropriate fluoroconjugated secondary was used (PE-anti-Biotin and PE-anti-mouse; 
Biolegend; San Diego, CA). After immunostaining, all samples were stored in BD 
cytofix/cytoperm staining buffer and protected from light at 4oC. Analysis of these samples 
occurred the following day using the FC 500 Flow cytometry instrument (Beckman 
Coulter; Fort Collins, CO).  
 
3.2.3 Bio-Plex 
 For the purpose of this study, a cytokine Bio-Plex (BioRad; Hercules, CA) was 
conducted to determine the concentration of IL-1b, IL-2, IL-4, IL-6, IL-10, IL-13, 
granulocyte-macrophage colony stimulating factor (GM-CSF), INF-g, TNF-a, and MCP-
1. Plasma samples collected at rest on the day of tissue collection were run at a 1:4 dilution 
per manufacturer protocol. Based on findings in a preliminary pilot, it was determined that 
a final protein concentration of 275 µg/mL or 35 µg of protein is ideal for the detection of 
these cytokines in brain homogenates. Based on the large sample sizes, several Bio-Plex 
assays needed to be conducted. During the process of obtaining these data, it became 
readily apparent that these kits suffer from significant inter-kit variability as shown in Table 
3.1. To compensate for this unforeseen effect, data collected from each Bio-Plex assay 
were normalized to the vehicle control samples run on that specific plate and expressed as 





3.2.4 Additional analysis of putative mechanisms underlying the effects of RSV  
 In addition to the well documented anti-inflammatory effects of RSV, this 
compound has been shown to indirectly affect NE and 5-HT neurotransmitter systems. To 
evaluate whether this represents an additional mechanism by which RSV exerts anti-
depressive-like effects in the context of social defeat, this study included analysis of SIRT-
1 in the LC and 5-HT content and IDO enzymatic activity in the DR.  
 
SIRT-1. As described in the introduction of Chapter 1, SIRT-1 is an NAD-dependent 
deacetylase which inhibits a number of transcription factors. Important for the current 
study, SIRT-1 has demonstrated regulatory control over nuclear factor-kappa B (Borra et 
al., 2005; Bagul et al., 2015), a factor known to regulate transcription of inflammatory 
cytokines (Lawrence, 2009). Importantly, RSV has been shown to reduce SIRT-1 in 
microglial cell cultures (Zhang et al., 2017). Based on these data and our previous findings 
that social defeat enhances IL-1b in the LC while reducing IL-1b in the DR (Wood et al., 
2015), the current study assessed SIRT-1 protein concentrations in LC homogenates 
following defeat and RSV treatment. This was accomplished using a commercially 
available SIRT-1 ELISA kit (Abcam; Cambridge, MA) that was run according to 
manufacturer protocol.   
 
IDO enzymatic activity. Another major factor that is known to contribute to the onset of 
depressive-like behaviors is a reduction in 5-HT. As discussed in Chapter 1, one major 
mechanism linked to reduced 5-HT following stress is through enhancements of IDO. IDO 
is the rate limiting enzyme responsible for catalyzing tryptophan (Trp), the 5-HT precursor, 
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to kynurenine (KYN) (Lestage et al., 2002; Guillemin et al., 2003; Hochstrasser et al., 
2011). Importantly, RSV treatment has been shown to reduce IDO protein and IDO-
mediated effects (Lin et al., 2017). Based on these data and studies indicating that the raphe 
nuclei are the major sites of 5-HT production in the brain, IDO activity was measured in 
the DR of socially defeated rats receiving the various doses of RSV.  
 The assay used in this particular study is an adaptation from that described by Matin 
et al. (Matin et al., 2006). The design of this particular assay quantifies IDO activity by 
measuring the conversion of its substrate Trp into KYN. Therefore, greater IDO activity is 
indicated by increased KYN synthesis. As this was the first time this assay had been used 
with tissue homogenates, there were a number of factors that needed to be piloted. It was 
first necessary to assess whether endogenous Trp in DR homogenates would result in KYN 
synthesis. To this end several practice DR samples were homogenized per the protocol 
listed in Chapter 2.7. For this particular pilot study, 100µg of DR homogentates were 
diluted in assay buffer in the presence of absence of 200 µM Trp (Acros Organics, Morris, 
NJ). The assay buffer consisted of 50 mM potassium phosphate (pH = 6.5; monobasic: 
Acros Organics, Morris NJ; dibasic: MP Biomedicals, Solon, OH), 20 mM ascorbic acid 
(pH = 7; BDH Lab Depot, Dawsonville, GA), 10 µM methylene blue (Fisher Scientific; 
Waltham, MA), and 100 µg/mL catalase (Fisher Scientific, Waltham, MA). Standards were 
prepared from 500 µM stock solutions of L-kynurenine (Fisher Scientific, Waltham, MA) 
at a concentration of 0, 1, 5, 7.5, 10, 25, 50, 75, and 100 µM in assay buffer. Standards and 
samples were incubated at 37oC for 1 hr. After this hour incubation, 80 µL of 1 M sodium 
hydroxide was added to each sample and standard, vortexed, and incubated at 60oC for 15 
minutes to halt IDO enzymatic activity. Samples were vortexed one final time and 240 µL 
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of each sample and standard were added in duplicate to a black clear bottom 96 well assay 
plate (Corning Incorporated; Corning, NY). The fluorescence of kynurenine was 
determined using an excitation wavelength of 360 nm and emission wavelength of 460 nm 
on a Synergy 2 Multi-Mode Plate Reader (Bio Tek; Winooski, VT). This initial pilot 
demonstrated that samples stimulated with 200 µM Trp produced a 3.5 fold increase in the 
amount of KYN in DR homogenates, a significant increase above unstimulated 
homogenates (t(12)=6.3), p<0.0001; Figure 3.2A). Based on these data, it was determined 
that endogenous Trp does not greatly contribute to KYN production during the assay and 
requires stimulation with exogenous Trp.  
 With this initial pilot completed, a second pilot was conducted to determine the 
ideal concentration of L-tryptophan to use in conjunction with these analyses. This 
particular pilot was deemed necessary as the original protocol by Matin et al. was optimized 
for cell culture and it was unclear whether those conditions would be ideal for brain 
homogenates. In this particular pilot 20 µL of DR homogenate was added to assay buffer 
containing 20, 200, 500, and 2000 µM Trp. This pilot was run as outlined above and 
concentrations were normalized to BCA assay protein concentrations. The resulting dose-
response curve verified that IDO in the DR had a km of 408 µM Trp or Log km 2.611 (Figure 
3.2B). In line with the initial publication (Takikawa et al., 2001), this value was utilized 
for the completion of these studies.  
 The last and final pilot was conducted to determine the optimal volume of brain 
homogenate to be used in this assay. For this particular pilot protein volumes of 10, 20, 50, 
and 100 µL were utilized for the completion of this assay. Findings from this pilot 
determined that IDO activity as a function of DR sample volume was largely logarithmic 
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in nature (Figure 3.2C). Notably, variability between samples in this particular pilot 
increased as a factor of sample volume: the lowest 10 µL volume was associated with the 
lowest variability across 12 samples while the highest 100 µL volume was associated with 
the largest variability. Based on these data, it was determined that a volume of 20 µL would 
provide good detection with the ability to visualize relative increases and decreases in IDO 
activity without resulting in aberrant increases in variability. Based on these crucial pilot 
studies, DR homogenates in the current study were run at 20 µL in assay buffer containing 
408 µM Trp.  
 
5-HT High performance liquid chromatography (HPLC).  HPLC is a widely used 
biochemical technique to separate and quantify compounds within a mixture. This 
particular technique utilizes high pressures in excess of 1000 pounds to force a mixture of 
solvent and sample through a column (Pavia et al., 2007). The resin in the column allows 
for particles to bind (Pavia et al., 2007). As the solvent continues to flow through the 
column, particles of lower molecular weight and size are eluted off (Pavia et al., 2007). 
Larger particles remain bound to the column for longer periods of time. Once these 
particles are eluted from the column, they pass through a sample detector (Pavia et al., 
2007). This signal is then amplified and recorded by the computer. Generally the data 
collected using this method results in the formation of a curve (Pavia et al., 2007). The 
overall concentration of each particle can then be determined by quantifying the area under 
the curve (Pavia et al., 2007).  
 For this particular study, HPLC was utilized to determine the concentration of 5-
HT in DR homogenates. DR homogenates were spiked with dihydroxybenzylamine to 
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serve as an internal standard. These spiked samples were filtered using Amicon Ultra 0.5 
mL Centrifugal filters with a molecular weight cut of 3 kDA (Millipore; Billerica, MA). 
Filtrates were collected via centrifugation at 16,000 x g for 30 minutes and 4oC. The HPLC 
mobile phase consisted of 90 mM sodium phosphate monobasic, 50 mM citric acid, 1.7 
mM 1-octanesulfonic acid, 50 µM disodium ethylenediaminetetraacetic acid (EDTA), and 
10% acetonitrile. Stock 5-HT (Sigma Aldrich; St. Luis, MO) was diluted with a lab made 
antioxidant solution (350 µL perchloric acid, 200 µL EDTA, 1.3 g sodium bisulfate in 300 
mLs deionized water) to a final concentration of 500, 200, 100, and 10 nM. All HPLC data 
were normalized to BCA protein values.  
 
3.2.5 Statistics 
 Statistical analysis was conducted as outlined in Chapter 2. However, in order to 
determine individual differences in behavioral responses during defeat, a k-means cluster 
analysis of defeat latency was utilized to statistically separate rats into passive and active 
coping phenotypes using JMP (Version 10; SAS, Cary, NC) as previously reported (Wood 
et al., 2015). 
 
3.3 Results 
3.3.1 The effect of RSV on social defeat behavior an anhedonia 
 Defeat latencies, or the amount of time required for the intruder to demonstrate 
behavioral submission, were recorded on each day of defeat and averaged. This average 
was utilized to statistically separate rats into passive and active coping phenotypes using a 
k means cluster analysis (Table 3.2). Two-way ANOVA analysis of these data sets 
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indicated an anticipated effect of coping phenotype such that rats classified as passive 
coping exhibited lower defeat latencies compared to their active coping counterparts. In 
addition to the effect of coping, this analysis revealed an overall effect of treatment (F(2,39)= 
4.4, p<0.05) such that active coping rats treated with 30 mg/kg RSV exhibited overall 
higher defeat latencies compared to active coping rats treated with 0 or 10 mg/kg RSV. 
While RSV dose-dependently enhanced defeat latency of active coping rats, treatment did 
not affect defeat latencies in passive coping rats. To further explore the effects of coping 
and RSV on behaviors during defeat, upright defensive postures on day 1 and day 5 were 
quantified. In line with our previous findings, upright postures during defeat differed 
greatly between coping phenotypes. On both day 1 (F(1,26)=12.6, p<0.01) and day 5 
(F(1,28)=12.3, p<0.01; Figure 3.3A) of defeat, rats exhibiting active coping behaviors 
demonstrated greater upright postures compared to rats classified as passive coping. Unlike 
defeat latency, various doses of RSV did not affect upright posture (F(2,28)=1.3, p=0.3; 
Figure 3.3A).  
After assessing behaviors during defeat, the emergence of depressive-like 
anhedonic behaviors were determined by calculating sucrose preference four days after the 
final social defeat exposure. As discussed in Chapter 2.4, sucrose preference is a non-
stressful behavioral assay to determine depressive-like behaviors without resulting in 
cytokine release (Llorens-Martin et al., 2016). Findings from the current study indicated 
that there was a significant stress x treatment interaction (F(4,40)=2.8, p<0.05; Figure 3.3B). 
In vehicle-treated animals, sucrose preference was selectively reduced in rats 
demonstrating a passive coping phenotype. In line with our previous publication (Wood et 
al., 2015), sucrose preference in rats demonstrating an active coping phenotype were 
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unchanged from that of rats exposed to the control exposure. Interestingly, treatment with 
RSV resulted in a dose dependent increase in sucrose preference in passive coping rats. 
However, only the highest, 30 mg/kg, dose completely blocked the development of 
depressive-like anhedonia.  No significant differences were detected across doses for active 
coping rats or rats with a history of control. Importantly, based on the sucrose preference 
test conducted prior to the defeat/control exposure, there were no pre-existing differences 
between coping (F(2,30)=1.8, p=0.2) or treatment (F(2,30)=1.2, p=0.32) groups nor were there 
significant variations in the total volume consumed (stress x coping: F(2, 61)=0.67, p=0.51; 
treatment: F(2,61)=1.8, p=0.2). 
 
3.3.2 The effect of RSV on peripheral inflammation 
 To determine the effects of social defeat on plasma cytokine levels, trunk blood 
collected at rest at the time of euthanasia was run on a 10-Plex as previously described. 
Bio-Plex analysis of plasma obtained at this timepoint revealed that there were no 
significant alterations in cytokine concentrations between stress and treatment groups 
(Table 3.3). Although the resting cytokines in the plasma were unaltered, it remained 
possible that the peripheral inflammatory system requires stimulation in order to visualize 
stress-induced increases in circulating cytokines. Since the spleen is a major site of 
initiation of the peripheral immune response, splenic cells were harvested and stimulated 
with ConA. Subsequent analysis using flow cytometry confirmed that cytokine production 
was indeed enhanced in stimulated splenic cells. Specifically, ConA stimulation resulted 
in enhanced expression of TNF-a (Figure 3.4, p<0.0001) and IL-1b (Figure 3.5, p<0.0001) 
selectively in vehicle-treated rats demonstrating a passive coping phenotype. Importantly, 
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the effects of stress on TNF-a in passive coping rats was completely blocked by treatment 
with 10 and 30 mg/kg RSV (Stress x Treatment interaction: F(4,49)=7.0, p=0.0001; Figure 
3.4).  Similar treatment effects were also evident for IL-1b (Stress x Treatment interaction: 
F(4,50)=3.9, p=0.007; Figure 3.5). It is important to note that not all cytokines demonstrated 
these trends. For example, splenic IL-6 was not enhanced in either coping group following 
stimulation with ConA. However, 30 mg/kg RSV treatment repressed IL-6 in all rats 
regardless of stress history (Effect of treatment (F(2,50)=31.8, p<0.0001; data not shown). 
In contrast, IL-10 was unaffected by both stress and treatment, further highlighting the idea 
that cytokine responses following stress exposure are highly cytokine specific.  
 
3.3.3 The effect of RSV on inflammation in the LC 
 There was great interest to determine the effects of stress and RSV treatment on 
inflammation in the LC at this extended time point, especially given findings in the 
periphery. Consistent with previous findings (Wood et al., 2015), cytokine levels at rest 5 
days following the final defeat exposure were elevated in the LC of passive coping rats 
(Figure 3.6). Specifically, IL-1b (effect of stress group: F(2,58)=10.6, p<0.0001; Figure 
3.6A), GM-CSF (effect of stress group: F(2,60)=8.2, p<0.001; Figure 3.6B), and TNF-a 
(effect of stress group: F(2,55)=5.2, p<0.01; Figure 3.6C) exhibited stress-induced increases 
that were directly dependent of coping style. The present study further determined that 
RSV treatment prior to and during social stress exposure significantly blocked stress-
induced increases cytokine concentrations within the LC. However, only the 30 mg/kg dose 
resulted in complete inhibition of stress-induced inflammation in the LC (effect of 
treatment IL-1b F(2,58)=11.0, p<0.0001; GM-CSF F(2,60)=12.0, p<0.0001; TNF-a 
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F(2,55)=13.9, p<0001). Similar to findings in the periphery, stress and treatment-induced 
cytokine profiles in the LC varied greatly between cytokines. For example, IL-2, IL-6, IL-
10, and MCP-1 were unaffected by stress (Table 3.4). However, these cytokines were 
responsive to RSV treatment such that the 30 mg/kg dose resulted in significant reductions 
in these cytokines (effect of treatment: IL-2 F(2,45)=11.3, p<0.001; IL-6 F(2,65)=5.0, p<0.05; 
IL-10 F(2,41)=12.6, p<0.0001; MCP-1 F(2,53)=20.3; p<0.0001; Table 3.4). Notably, RSV did 
not result in a reduction of all cytokines tested. Specifically, a significant stress x treatment 
interaction was evident for IL-4 (F(4,58)=2.5, p<0.05; Figure 3.6D). Unlike all of the other 
cytokines measured, IL-4 demonstrated a dose dependent increase in cytokine 
concentration such that the 30 mg/kg dose of RSV enhanced IL-4 across all stress groups. 
Interestingly, active coping rats were more sensitive to this RSV-induced increase in IL-4 
demonstrating a significant enhancement at the 10 mg/kg dose.  
 In order to determine a putative mechanism by which stress and RSV may result in 
these alterations, the concentration of SIRT-1 was assessed in the LC of all stress and 
treatment groups. SIRT-1 seemed a likely suspect as it directly regulates nuclear factor-
kappa B. However, in the present study, there were no differences in SIRT-1 expression 
within the LC between control (335.4 ± 12.3 pg/mL, n=5) and passive coping (311.6 ± 10.0 
pg/mL, n=6) rats. Furthermore, prior treatment with 30 mg/kg RSV did not alter SIRT-1 
expression (control: 302.5 ± 10.0, n=6; passive coping: 308.1 ± 11.1, n=5).  
 
3.3.4 The effect of RSV on inflammation in the DR 
 Our group has previously reported that social stress results in down regulation of 
IL-1b and MCP-1 in the DR (Wood et al., 2015). Consistent with this, in the present study, 
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expression of select cytokines were decreased in the DR of socially defeat rats (Table 3.5). 
Specifically, stress and RSV treatment produced a significant interaction resulting in 
reduced IL-2 (F(4,38)=7.5, p<0.001) and IL-4 (F(4,44)=4.6, p<0.01) expression regardless 
of coping style. There was also a general effect of treatment for the remaining 7 analytes 
(Table 3.5; IL-1b F(2,42)=12.4, p<0.0001; IL-6 F(2,45)=17.7, p<0.0001; IL-10 
F(2,40)=16.9, p<0.0001; IL-13 F(2,43)=13.0, p<0.0001; GM-CSF F(2,40)=4.5, p<0.05; 
TNF-a F(2,43)=7.1, p<0.01; MCP-1 F(2,42)=8.3, p<0.001) such that RSV treatment 
functioned to lower cytokine levels regardless of stress history. The only exception is IL-
6, which demonstrated a dose-dependent increase. Treatment effects for IL-6, TNF-a, and 
MCP-1, although statistically significant, likely are not biologically relevant due to the 
modest changes exhibited by these cytokines. Importantly, while no general effects of 
stress were detected for IL-1b and IL-10, vehicle-treated passive coping rats did exhibit 
significant reductions of these cytokines within the DR as compared to their control and 
active coping counterparts (Table 3.5). 
 Stress and inflammation are well known to result in a shift in 5-HT metabolism 
towards the production of KYN through increased IDO activity (Lestage et al., 2002; 
Guillemin et al., 2003; Hochstrasser et al., 2011). Therefore, the present study conducted 
an IDO enzymatic activity assay and measured 5-HT levels via HPLC within the same DR 
samples that were used to quantify cytokine levels. Using the adapted IDO assay, it was 
determined that there were no significant effects of treatment or stress history on IDO 
activity levels (Table 3.6). Importantly no differences were determined between vehicle-
treated control, passive, and active coping groups (F(2,3)=0.3, p=0.8). Subsequent HPLC 
analysis of 5-HT concentrations within DR homogenates further indicated that neither 
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stress nor RSV treatment produced significant alterations in 5-HT levels at rest 5 days after 
the completion of social defeat (Table 3.6). 
 
3.4 Discussion 
 The findings in this particular study were the first to explore the effects of the 
natural anti-inflammatory agent RSV on susceptibility to social stress-induced 
inflammation and depressive-like behavior. Moreover, this study was one of the first to 
broadly characterize inflammation in the periphery and the LC and DR. Findings from the 
current study demonstrated that circulating cytokines were not elevated at rest 5 days after 
the final social defeat episode. However, data from stimulated splenic CD4+ T-cells 
revealed that socially defeated rats characterized as passive coping did exhibit sensitized 
release of IL-1b and TNF-a. This sensitized splenic release was blocked by both doses of 
RSV. Unlike findings in the periphery which required stimulation with ConA, long lasting 
neuroinflammation was detected under resting conditions selectively in the LC of passive 
coping rats. Only the highest dose of RSV inhibited the depressive-like anhedonia and 
remarkably, this was also the only dose that completely inhibited LC neuroinflammation 
in passive coping rats. These data suggest that LC neuroinflammation plays a key role in 
the susceptibility to social stress-induced depressive-like responses. These data also 
highlight the importance of differentiating between peripheral and central inflammation. 
Furthermore, the contrast between enhanced proinflammatory cytokines in the LC and 
suppression in the DR illustrates the brain region specificity of stress-induced changes in 
inflammation and further underscores the concept that changes in the plasma may not 
represent the state of inflammation in the brain.  
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 One key feature of the resident-intruder paradigm is that it can produce depressive-
like behaviors in rodents (Wood et al., 2010; Gomez-Lazaro et al., 2011; Perez-Tejada et 
al., 2013; Hammels et al., 2015; Wood et al., 2015). In the current study, resilient and 
susceptible subpopulations were determined using behavioral responses during defeat. In 
line with previous findings (Wood et al., 2010; Wood et al., 2015), rats demonstrating 
enhanced upright defensive postures during defeat and longer defeat latencies later 
exhibited resilience in the sucrose preference test. In contrast, rats demonstrating low 
upright defensive postures and short defeat latencies later exhibited susceptibility in the 
sucrose preference test. While RSV did not shift the behavioral responses during social 
defeat, it was capable of producing a dose-dependent increases in sucrose preference. 
These data outlining an anti-depressive potential of RSV has also been reported by several 
other groups using pharmacological manipulation (Ahmed et al., 2014), single prolonged 
stress  (Solanki et al., 2015), genetic models of depressive-like behavior (Hurley et al., 
2014), and the forced swim test (Xu et al., 2010).  
 Much of what is known regarding the relationship between depression and 
inflammation in humans has shown that specific subpopulations of depressed patients 
present with enhanced IL-6, TNF-a, and C-reactive protein. Moreover, these protein 
concentrations have been positively correlated with symptom severity (Maes et al., 1997; 
Musselman et al., 2001; Miller et al., 2002; Alesci et al., 2005; Motivala et al., 2005). In a 
previous publication, our group demonstrated that peripheral inflammation was enhanced 
24 hours after the final social defeat exposure (Wood et al., 2015). The current study was 
aimed at expanding these findings. However, Bio-Plex analysis revealed that circulating 
cytokines at rest 5 days after the final social defeat were unchanged from that of controls. 
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This is not particularly surprising as many cytokines including TNF-a, GM-CSF, and IL-
2 reach complete clearance between 25 and 58 hours (Gillies et al., 1993; Foxwell et al., 
1998).  
 Although resting cytokine levels were normalized 5 days following the final social 
defeat episode, data collected from stimulated splenic cells at this same time point indicated 
that social defeat did enhance peripheral inflammatory potential selectively in passive 
coping rats. These data further suggest that a secondary stress or immune challenge prior 
to euthanasia would likely have resulted in a robust stimulation and release of cytokines in 
the periphery. This particular phenomenon is often referred to as inflammatory priming. In 
general, inflammatory priming refers to the process by which inflammatory responses can 
become sensitized resulting in a faster and more robust release of cytokines following a 
secondary challenge. There is a vast body of literature demonstrating that inflammatory 
priming can occur following stress exposure (Frank et al., 2011; Frank et al., 2012; Weber 
et al., 2013; Wohleb et al., 2014a; Fonken et al., 2016). However, the mechanism by which 
this occurs is yet unclear.  
It has been suggested that one major player in the emergence of inflammatory 
priming is the spleen. In normal healthy individuals the spleen functions to recycle old red 
blood cells with assistance from the inflammatory cells that naturally reside within the 
spleen (Bronte and Pittet, 2013). Additionally, under these conditions, the spleen does not 
produce inflammatory cells (Bronte and Pittet, 2013). However, it has been demonstrated 
that exposure to stress can shift the function of this particular organ and promote 
extramedullary hematopoiesis (McKim et al., 2018). Extramedullary hematopoiesis refers 
to the generation of inflammatory cell types that occurs outside of the medulla of the bone. 
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In addition to the generation of new inflammatory cells, the CD4+ T-cells found within the 
spleen are highly morphologically flexible and can rapidly secrete cytokines into the 
circulation upon stimulation (DuPage and Bluestone, 2016). Although the current study 
did not determine the relative number of splenic CD4+ T-cells across stress and treatment 
groups, the findings regarding ConA-induced stimulation of IL-1b and TNF-a support the 
idea that inflammatory cell priming has occurred. Moreover, RSV treatment at 10 and 30 
mg/kg was capable of completely inhibiting the exaggerated release of these cytokines 
following ConA stimulation, suggesting that this compound is protective against the 
peripheral inflammatory effects induced by defeat. However, these data also suggest that 
inflammation in the periphery does not directly drive depressive-like behaviors.  
If depressive-like behaviors were directly dependent on peripheral inflammation or 
peripheral inflammatory potential, rats treated with the 10 mg/kg dose of RSV that exhibit 
normal peripheral inflammatory responsivity would also exhibit normal hedonic behaviors. 
While this dose did produce a nominal increase in hedonic behavior during sucrose 
preference, these values were well below that of control and active coping rats. Hedonic 
behaviors following social defeat in passive coping rats only returned to normal control 
levels following treatment with the 30 mg/kg dose of RSV. Notably, this dose of RSV was 
also the only dose to result in complete inhibition of stress-induced inflammation in the 
LC. These data suggest that inflammation in the LC directly mediates the emergence of 
depressive-like behaviors. However, it should be noted that increased proinflammatory 
cytokines are not necessarily selective for vulnerable phenotypes, but rather are dependent 
upon the brain region. For example, De Miguel and colleagues identified greater IL-1b 
expression within the hypothalamus of active coping rats (De Miguel et al., 2011).  
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Limited information exists on inflammation in the brains of depressed patients. 
However, cytokine expression has been found to be increased in the cerebrospinal fluid of 
a subset of depressed patients compared with non-depressed controls (Sasayama et al., 
2013; Kern et al., 2014a; Devorak et al., 2015). A recent advance in this field revealed 
greater microglial activation in the brains of depressed patients (Setiawan et al., 2015), 
demonstrating a potential mechanism for this neuroinflammation. Many parallels have 
been found between these studies in humans and neuroinflammatory changes that occur as 
a consequence of social stress in rodents. For example, social defeat has been shown to 
increase the number of immune competent cells in the brain (Audet et al., 2011; De Miguel 
et al., 2011; Wohleb et al., 2012). Importantly, these effects are not isolated to microglia. 
Several studies have shown that stress results in a breakdown of the blood brain barrier 
(Menard et al., 2017) which allows for peripheral macrophages to penetrate into the brain 
(Wohleb et al., 2012; Wohleb et al., 2013; Wohleb et al., 2014a). Although the current 
study did not assess the composition of inflammatory types within the LC, the findings 
from the current study do suggest that inflammatory potential in the LC is enhanced 
following social defeat. 
This and other studies have demonstrated the anti-depressant efficacy of RSV. 
Findings from the current study and others suggest that a strong mechanism for these 
effects are likely driven through its potent anti-inflammatory properties. It has been well 
established that inflammation is capable of producing a wide range of effects on neuronal 
function. For example, cytokines promote excitability of LC-NE neurons (Borsody and 
Weiss, 2004). This effect is likely mediated by activation of the glutamatergic system 
(Kamikawa et al., 1998). Notably, exaggerated activation of the LC-NE system is 
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associated with the pathophysiology of depression (Wong et al., 2000). Therefore, RSV’s 
potent inhibitory effects on neuroinflammation within the LC may inhibit exaggerated 
activation of this depressogenic brain region. Alternatively, as identified in the brains of 
RSV-treated rats in the present study, RSV has also been shown to increase the release of 
the anti-inflammatory cytokine IL-4 in isolated peripheral mononuclear cells (Falchetti et 
al., 2001). These data suggest that RSV may also function through the recruitment of 
endogenous anti-inflammatory pathways.  
 In addition to RSV’s potent anti-inflammatory effects, it has also been suggested 
to inhibit nuclear factor kappa B through histone deacetylation by SIRT-1 (Borra et al., 
2005; Bagul et al., 2015). In the present study there were no differences in SIRT-1 protein 
concentrations between stress and treatment groups. However, it is possible that stress and 
RSV treatment could have affected SIRT-1 activity rather than blatantly altering protein 
levels. Currently, studies determining a mechanistic basis by which RSV may effect SIRT-
1 are limited to cell culture (Borra et al., 2005), round worms, and fruit flies (Wood et al., 
2004). These studies have demonstrated that RSV binds to SIRT-1 resulting in a 
conformational shift that alters SIRT-1 binding affinity (Borra et al., 2005). Taken together 
with the anti-inflammatory effects, it is likely that there are a number of different 
intersecting mechanisms underlying the efficacy of RSV in producing anti-depressive 
effects. 
Distinct from stress effects on neuroinflammation in the LC, it has previously been 
reported that social defeat results in downregulation of IL-1b and MCP-1 protein in the DR 
24 hours after stress exposure (Wood et al., 2015). Findings from this previous study 
demonstrated that these inhibitory effects were more robust in active coping rats compared 
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to those demonstrating passive coping phenotypes (Wood et al., 2015). The current study 
expanded on these findings showing that these effects are not restricted to these two 
particular cytokines. Furthermore, RSV functioned to reduce cytokine expression even 
further in this brain region regardless of stress history. These opposing adaptations in 
neuroinflammation within the LC and DR indicate the intricate nature of stress-induced 
neuroinflammation and highlight the region specificity and temporal regulation of stress-
induced neuroinflammatory phenotypes.  
Although neuroinflammation in the DR was suppressed following social defeat, it 
is known that the DR is also sensitive to proinflammatory cytokines. Stress and cytokines 
have both been shown to shift catabolism of 5-HT to KYN through increasing the activity 
of IDO (Lestage et al., 2002; Guillemin et al., 2003; Hochstrasser et al., 2011). In the 
current study it was hypothesized that stress-induced reductions of cytokines and further 
reductions produced by RSV treatment may serve as a protective mechanism to maintain 
or increase 5-HT levels in the face of stress. However, in the present study resting levels 
of IDO enzymatic activity and 5-HT concentrations within the DR were unchanged. There 
are a number of potential reasons for these effects. It is probable that use of Trp 
concentrations at the km concentration induced significant variability and could have 
masked some of the stress and treatment effects. Therefore, future studies should be 
designed to use the vmax, which is estimated to be approximately 800 µM. It is also probable 
that while elevated levels of proinflammatory cytokines such as TNF-a and INF-g increase 
IDO enzymatic activity (Robinson et al., 2005), reductions in proinflammatory cytokines 
below non-stressed/resting levels may not necessarily exhibit regulatory control over IDO 
activity. It is also plausible that effects in IDO may occur in close temporal proximity to 
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social defeat rather than resulting in long lasting shifts in reactivity. In support of this, 
studies evaluating the IDO-KYN pathway at 24 hours after the final social defeat exposure 
have successfully indicated that social stress-induced increases in KYN production in the 
DR (Fuertig et al., 2016).  
From the study described in this chapter, it is clear that RSV may have significant 
therapeutic potential based on its broad anti-inflammatory effects in the periphery and the 
brain. Moreover, it has been clearly demonstrated that RSV is well tolerated by patients, 
even at high doses (la Porte et al., 2010). While there is a lot of preclinical data to support 
the use of RSV as an anti-depressive therapeutic, there are several issues that will need to 
be addressed before this compound will be seriously considered for the treatment of 
depression in humans. The primary issue with this treatment is the lack of mechanistic data. 
By all accounts RSV is considered to be a “dirty” drug, affecting multiple systems without 
a succinct mechanism of action. In addition to the noted effects on inflammation, oxidation, 
SIRT-1, and IDO, RSV has also been shown to inhibit 5-HT and NE (NE) uptake (Yanez 
et al., 2006), and inhibit monoamine oxidase activity (Yanez et al., 2006; Xu et al., 2010). 
Therefore, understanding how RSV intervenes in stress-induced adaptations within the 








Table 3.1 Comparison of average concentrations of cytokines detected over multiple Bio-Plex plates of 
vehicle-treated control rats. Significant inter-kit variability was detected ranging from 14-75%CV in the brain 
and 47-140%CV in the plasma across cytokines. Therefore, vehicle-treated control rats were run on each plate 
and data included in the manuscript data was normalized to percent of vehicle-treated controls run on each 
respective plate. Data in the table below are represented as the average absolute concentration in pg/mL ± SEM 
for all vehicle-treated rats across multiple plates (2-3 as indicated below). 
 
Plasma: samples run over 2 kits with the same vehicle controls on each. 




















Locus coeruleus: samples run over 3 kits with the same vehicle controls on each. 




















Dorsal raphe: samples run over 2 kits with the same standards and vehicle control on each. 



































Table 3.2 Quantification of passive and active coping 
phenotypes. K-means cluster designations of defeat latency are 
reported as average (s) ± SEM. Post-hoc analysis indicated 30 
mg/kg treated active coping rats had significantly higher defeat 
latencies compared to 0 and 10 mg/kg treated active coping rats 
(* p<0.05). 
 
Dose of RSV Cluster 1 (Passive) Cluster 2 (Active) 
0 208.7 ± 47.3 651.3 ± 50.4 
10 230.3 ± 21.8 702.1 ± 27.2  












Table 3.3 Resveratrol and stress do not affect resting plasma cytokine levels. Data expressed as 
percent of vehicle (0 mg/kg) control, average ± SEM for control (con), passive coping (PC), and 




0 mg/kg RSV 10 mg/kg RSV 30 mg/kg RSV 
Con PC AC Con PC AC Con PC AC 
















































































































































Table 3.4 Resveratrol dose dependently decreases neuroinflammation in the LC. Social 
stress exposure did not alter the expression of IL-2 (3A) or IL-6 (3B) but did alter cytokine 
release of IL-10 (3C) and MCP-1 (3D) within the LC. Treatment with 30 mg/kg RSV reduced 
all cytokine concentrations within the LC. Data expressed as percent of vehicle (0 mg/kg) 
control, average ± SEM for control (con), passive coping (PC), and active coping (AC) 





0 mg/kg RSV 10 mg/kg RSV 30 mg/kg RSV 
Con PC AC Con PC AC Con PC AC 
IL-2 93.9    ± 11.1 
76.4     
± 12.1 
85.1    
± 7.7 




90.1   
± 6.8 
61.5    
± 7.2 
66.2   
± 1.0 
54.8    
± 1.8 
IL-6 98.3    ± 3.6 
96.6     
± 5.5 
94.1    
± 2.1 
98.1    
± 4.6 




88.5    
± 7.3 
88.9   
± 8.5 
69.9    
± 6.2 
IL-10 
99.8    
± 4.2ƒ 
127.7   
± 1.2 
123.8   
± 3.6 






103.6   
± 4.8 
96.6   
± 7.2 
67.6    
± 14.8α 
MCP-1 108.2   ± 8.4 








95.1   
± 9.7 
66.7    
± 13.0 
58.1   
± 9.4 







Table 3.5 Stress and resveratrol reduce cytokine expression in the DR. RSV treatment reduced cytokine 
expression in a dose dependent manner. Furthermore, a history of social defeat stress reduced cytokine 
expression of IL-1β, IL-2, IL-4, and IL-10. Data are expressed as percent of vehicle (0 mg/kg) control 
(average ± SEM) for control (Con), passive coping (PC), and active coping (AC) groups. ƒp<0.05 vs. 0 mg/kg 




0 mg/kg RSV 10 mg/kg RSV 30 mg/kg RSV Tx Effect 
Con PC AC Con PC AC Con PC AC 


































































































































±4.1 p < 0.05 
















±0.5 p < 0.01 


























Table 3.6 Resting IDO and 5-HT concentrations in the DR. Data are expressed as average ± SEM of 
control (Con), passive coping (PC), and active coping (AC) groups. 
 
 
0 mg/kg RSV 10 mg/kg RSV 30 mg/kg RSV 





















































Figure 3.1 RSV study design and timeline. Rats were treated with 0 (Vehicle), 10, or 30 mg/kg RSV for 7 days 
prior to the start of social stress and throughout the social stress period (D -7 - D5). Two days prior to the onset of 
social defeat or control exposure (D-2) rats were exposed to a sucrose preference test. Sucrose preference was 
conducted 4 days after social defeat or control (D9, 7-8pm) and approximately 14 (±2) hours later (D10), all rats 





51 9 10-7 -2
Daily Social Defeat/Control
RSV/Vehicle Treatment









Figure 3.2 IDO assay pilot data. (A) Stimulation of dorsal raphe brain homogenates with 200 µM L-Tryptophan (Trp) 
produces a 3.5-fold increase in Kynurenine (KYN) detection over that of 0 μM. (B) Tryptophan dose dependently increased 
KYN and demonstrated an km of 408 µM (2.611, dotted line). (C) 20 µL of DR homogenate produced higher IDO activity as 

















































Figure 3.3 Effects of stress and RSV treatment on behavior. (A) 
Active and passive coping rats exhibited distinctly different time 
spent in upright posture regardless of treatment (* p<0.05 vs. 
within treatment active coping group). (B) Decreased sucrose 
preference in passive coping rats was dose dependently blocked 
by RSV treatment (** p<0.01 vs. 0 mg/kg control and active 
coping, α p<0.001 vs. 30 mg/kg passive coping; β p<0.01 vs. 30 










Figure 3.4 RSV decreased expression of the pro-inflammatory cytokine TNFα 
following Con-A stimulation in splenic cells of passive coping rats. Data are 
expressed as the percentage of total CD4+ cells expressing TNFα.  (A, B, C) Data 
shown are flow cytometry dot plots from one representative animal in each group 
shown. (D) Graph of combined data from all experiments. ƒp<0.0001 vs. control + 











Figure 3.5 RSV decreased Con-A stimulated splenic IL-1β expression in passive 
coping rats.  Data are expressed as the percentage of total CD4+ cells expressing IL-
1β.  (A, B, C) Data shown are flow cytometry dot plots from one representative animal. 
(D) Graph of combined data from all experiments. ƒp<0.0001 vs. control + vehicle; 


















Figure 3.6 RSV dose dependently reduces neuroinflammation in the LC. Social defeat 
resulted in elevated levels of inflammatory cytokines in vehicle and 10 mg/kg RSV 
treated passive coping rats as evidenced by increased (A)IL-1β, (B)GM-CSF, and (C) 
TNF-α in LC homogenates. Importantly, only treatment with 30 mg/kg RSV 
completely blocked social stress induced inflammation in passive coping rats. 
Surprisingly, 30 mg/kg RSV also resulted in increased concentrations of anti-
inflammatory IL-4 (D). Active coping rats were more sensitive to this effect as they 
exhibited a significant increase from controls and passive coping rats when treated 
with 10 mg/kg RSV. Within treatment comparisons: α p<0.05 passive vs. control and 
active; β p<0.05 passive vs. control; γ p<0.05 passive vs. active; ƒ p<0.05 active vs. 






The “Why”: Determining which immediate stress-induced mechanism 
is capable of promoting inflammation 
 
4.1 Introduction 
One particularly notable effect discussed in the final paragraphs of Chapter 3 are 
the effects of RSV on NE. Depression has long been associated with complex dysregulation 
of the NE system (Klimek et al., 1997; Ressler and Nemeroff, 2000; Moret and Briley, 
2011; Serafini, 2012). This long history has resulted in the creation of a number of 
therapeutics and has resulted in the generation of the monoamine hypothesis of mood 
disorders. However, anti-depressive therapeutics that target the NE system take several 
weeks of continuous use in order to produce behavioral effects. This has led to the 
suggestion that NE may not be the primary mechanism that is involved in the emergence 
of depressive-like behaviors. It has been suggested that inflammation may be a more viable 
target for the treatment of depression. These suggestions stem from a variety of studies 
indicating the therapeutic efficacy of anti-inflammatory agents in producing anti-
depressive effects. One such study indicated that infusion of infliximab was not only 
capable of producing nearly immediate and sustained suppression of inflammation but also 
improved depressive-like behavioral symptoms following the second acute injection of this 
compound (Raison et al., 2013). Notably, these effects were strongest in patients exhibiting
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treatment resistance and enhanced inflammation at the beginning of the study (Raison et 
al., 2013).  
While it seems that long term dysregulation of the NE system may be a secondary 
effect, it is important to note that NE is well known to regulate the inflammatory system. 
In the periphery, NE has been well documented to act on a and b adrenergic receptors on 
the cell surface of macrophages and neutrophils to stimulate cytokine release (Flierl et al., 
2009; Li et al., 2015). Moreover, NE signaling through these receptors in the periphery are 
capable of augmenting the peripheral immune response to a subsequent immune challenge 
(Spengler et al., 1990; Kavelaars et al., 1997; Grisanti et al., 2010). Although less is 
understood regarding the inflammatory effects of NE in the brain, it has been reported that 
NE does play a distinct role in neuroinflammation (Johnson et al., 2005; Jardanhazi-Kurutz 
et al., 2011; Gyoneva and Traynelis, 2013; Bharani et al., 2017) by acting on b adrenergic 
receptors on the cell surface of microglia (Johnson et al., 2005).  
Notably, separate lines of evidence have demonstrated that stress-induced NE and 
inflammatory responses do demonstrate temporal overlap. Studies in humans have 
indicated that, in general, NE peaks approximately 20 minutes after the initiation of stress 
and remains elevated above that of non-stressed controls for up to 40 minutes (Kuebler et 
al., 2013). While this timepoint does not line up with inflammatory responses following an 
initial stress exposure which peak at 8-12 hours following stress, this time point does line 
up with inflammatory responses following repeated stress (peak concentrations at 
approximately 30 min to 1 hour after stress) (Cheng et al., 2015). Taken together these data 
suggest that NE and inflammation may represent intersecting mechanisms that may lead to 




As discussed in Chapter 1, the LC serves as the major source of NE to the brain and 
is poised to contribute to peripheral NE through descending projections to sympathetic 
spinal nerves (Samuels and Szabadi, 2008; Bruinstroop et al., 2012). Importantly, 
inflammation in the LC is known to result in increased activity of the LC (Kurosawa et al., 
2016) presumably resulting in enhanced NE release to LC targets including the periphery, 
dorsal raphe (DR) and central amygdala (CeA). These data further suggest that stress-
induced NE and inflammation may exist in a positive feedback loop by which activation 
of one system potentiates the activation of another which ultimately results in dysregulation 
of both systems. Since direct studies assessing the involvement of the NE system in stress-
induced inflammation have not been completed, the current study utilized N-(2-
chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4), a noradrenergic neurotoxin, to 
selectively lesion LC NE neurons. Based on the data discussed above, it was hypothesized 
that this lesion would prevent social defeat induced inflammation in the periphery as well 
as LC projection regions such as the DR and CeA. Moreover, since social defeat is known 
to result in inflammatory priming, it was hypothesized that DSP-4 treatment may also 
inhibit defeat-induced inflammatory priming in these regions.  
 
4.2 Methods 
 Similar to Chapter 3, the methods outlined below represent specific details relevant 
to this particular study. Additional methods including the process of social defeat and 
control manipulation, behavioral quantification, tissue collection, and homogenization are 
detailed in Chapter 2. In order to guide discussion of the data and allow for ease of 





  For the purpose of this particular study, permanent guide cannulas (22 gauge; 
Plastics One; Roanoke, VA) were implanted into the right lateral ventricle. Bregma, or the 
intersection between the coronal and sagittal suture of the skull, served as the reference 
point for cannula implantation.  All cannulas were implanted -0.8 mm caudal and -1.5 mm 
lateral from Bregma at a depth of -4.2 mm from the surface of the skull as described in a 
previous publication (Wood et al., 2015). All rats received post-surgical analgesia 
(Flunixin, 2.5 mg/kg; Henry Schein; Melville, NY) and supportive therapy of Bacon 
Softies (Bio-Serv; Flemington, NJ) daily for 48 hours. Importantly, surgical implantation 
occurred 10 days prior to the first social defeat exposure. This recovery time was 
deliberately chosen as surgical procedures significantly activate the inflammatory system  
(Arias et al., 2009). This is to be expected as many of these cytokines provide beneficial 
effects at the site of surgery to promote wound healing (Szpaderska and DiPietro, 2005). 
Rodents typically reach full recovery between 5-7 days following surgery, during which 
time they are closely monitored (Pritchett-Corning et al., 2011). Despite reaching “full” 
surgical recovery at 7 days, it has been demonstrated that inflammation following surgery 
can last beyond this time. Specifically, a study in Sprague Dawley rats indicated that 
cytokines remained elevated for up to 8 days following surgery (Loram et al., 2007). 
Therefore, the 10-day recovery period was selected to ensure that latent post-surgical 







4.2.2 Drug preparation and injection 
 Seven days prior to the start of social defeat or control manipulation, all 
experimental rats (male Sprague Dawley) were randomly assigned into DSP-4 or vehicle 
treatment groups. 8 µL, the equivalent of 400 µg, of DSP-4 or vehicle (1% ascorbic acid 
in phosphobuffered saline) was infused via the implanted cannula over a period of 3 
minutes. This particular dose of DSP-4 was selected as it has been well documented to 
reduce NE in LC projection regions by 70% (Sziray et al., 2010). Importantly, DSP-4 does 
not destroy LC neurons. Instead, this particular drug specifically functions to deplete NE 
by increasing NE release (Bortel, 2014), enhancing NE turnover (Bortel, 2014), and 
downregulating tyrosine hydroxylase (Hormigo et al., 2012), dopamine b-hydroxylase 
(Wang et al., 2014), and the NE transporter (Wang et al., 2014). In this way DSP-4 
functionally reduces NE by depleting NE stores and inhibiting NE synthesis and re-uptake 
into the neuron. These cumulative effects of DSP-4 are evident as early as 6 hours after the 
injection (Grzanna et al., 1989) and are known to last for up to 40 days (Villani et al., 1996). 
Based on the extended duration of DSP-4 efficacy and the 21-day study design, only a 
single dose of DSP-4 needed to be administered. 
 It is important to note that while DSP-4 demonstrates exquisite selectivity of LC-
NE neurons (Fritschy and Grzanna, 1991), it has been suggested that DSP-4 may also 
produce minor depleting effects on serotonin (5-HT) neurons (Jonsson et al., 1981). 
Therefore, to protect against these potentially confounding effects, the selective 5-HT 
reuptake inhibitor Citalopram was administered at a dose of 10 mg/kg via an intraperitoneal 
(i.p.) injection 30 minutes prior to DSP-4 or vehicle infusion. Citalopram was specifically 




(Hiemke and Hartter, 2000) but also has been shown to protect 5-HT terminals when 
combined with DSP-4 (Howard et al., 2008). Moreover, the low dose (10 mg/kg) of 
Citalopram was selected as this particular dose is known to effectively protect against 5-
HT depletion without producing potentially confounding behavioral effects (Crowley et 
al., 2005; Howard et al., 2008; Tonissaar et al., 2008).  
 
4.2.3 Tissue collection conditions 
Validation of study design. In order to visualize whether a history of social defeat stress 
(with or without the LC lesion) was capable of producing inflammatory priming, all rats, 
regardless of prior stress history were exposed to social defeat immediately prior to tissue 
collection. However, it was first necessary to verify that this particular design would allow 
for the detection of stress-induced cytokines rather than simply reflecting an increase in 
resting inflammation. Therefore, a separate cohort of animals were generated. All animals 
in this separate cohort followed the same surgical, treatment, and 5-day social defeat or 
control design as outlined in Figure 4.1. Importantly, this particular cohort was euthanized 
under resting non-stress levels on day 11. Inflammatory data collected from these rats serve 
as a measure to identify the effect of stress and treatment on resting cytokine levels. 
Moreover, comparison of these resting levels with that of social defeat-induced levels on 
day 11 serve as validation for the overall study design. Euthanasia and tissue collection 
were followed as outlined in Chapter 2. 
 
Social defeat-induced inflammatory sensitization. As mentioned in section above, one 




produced inflammatory priming. To this end, all rats regardless of previous stress history 
were exposed to social defeat on day 11, 6 days after the 5th stress or control exposure. Rats 
were euthanized immediately after this 30-minute stress exposure as outlined in Chapter 2.  
 
4.2.4 HPLC 
 Similar to the design described in Chapter 3, the current study utilized HPLC in 
order to determine the relative concentration of NE in the plasma and hippocampal, CeA, 
and DR homogenates. All samples were spiked with 10nM dihydroxybenzylamine 
(Thermo Scientific; Waltham, MA) to serve as an internal standard. Samples were then 
filtered using centrifugation with Amicon Ultra 0.5 mL Ultracel spin filters (Millipore; 
Billerica, MA). Plasma samples were filtered using Amicon spin filters with a 50 kDA 
molecular weight cut off while all brain homogenates were filtered using spin filters with 
a 3 kDA molecular weight cut off. Regardless of the specific filter used, all filtrates were 
collected following a 30-minute centrifugation at 16,000 x g and 4oC. These filtrates were 
then run on the HPLC. All data were normalized to the dihydroxybenzylamine internal 
standard. Results from brain homogenates were further normalized to protein 
concentration.  
 
4.2.5 Bio-Plex analysis 
 Defeat-induced circulating (plasma) and brain region specific inflammatory effects 
were determined using Bio-Plex analysis (Bio-Rad; Hercules, CA). Homogenized CeA and 
DR tissues were loaded onto the plate at a concentration of 275 µg/mL. Plasma samples 




duplicate according to manufacturer protocol. Plates were read using the same Luminex 
Bio-Rad Bio-Plex system described in Chapter 2. Based on the large sample size, it was 
necessary to run several assays in order to collect these data. In order to control for inter-
kit variability, vehicle control rats were run on each plate. All collected Bio-Plex data were 
subsequently normalized to percent of vehicle. Replicate Bio-Plex values resulting from 
repeated sampling of vehicle controls were averaged following percent control calculations 
conducted across each plate. For certain cytokines this resulted in a vehicle control group 
average that was not equal to 100%. 
 
4.2.6 Plasma Cort measurements 
 In addition to HPLC and Bio-Plex analysis, plasma samples were also probed for 
the concentration of Cort following the social defeat exposure on the day of euthanasia. To 
this end, collected plasma samples were run on a Cort ELISA (Enzo Life Sciences; 
Farmingdale, NY). Plasma samples were diluted 1:40 and run according to manufacturer 
protocol. Plates were read using a Synergy 2 Multi-Mode plate reader (Bio Tek; Winooski, 
VT) and quantified using the corresponding Gen5 software (Bio Tek; Winooski, VT).    
 
4.3 Results 
4.3.1 Verification of LC-NE lesion with DSP-4 
 Prior to running the study, it was imperative to determine whether the dose of DSP-
4 administered produced significant reductions of NE in LC projection regions. The 
hippocampus was ideal for this purpose as the LC is the exclusive source of NE to this 




400 µg dose of DSP-4 reduced NE by approximately 85% (Average Hippocampal NE 
pmol/µg protein ± SEM; Vehicle: 34.5 ± 6.4; DSP-4: 4.9 ± 1.5; t(11) = 4.2, p<0.01). These 
data are comparable to studies using the standard 50 mg/kg intraperitoneal dose (Harro et 
al., 1995; Cheetham et al., 1996; Harro et al., 1999; Kask et al., 2000) and direct ICV 
injection of 400 µg of DSP-4 (Sziray et al., 2010) in which hippocampal NE was depleted 
by approximately 70 - 100%. These data verify that the drug treatment and administration 
route are effective in lesioning LC-NE projections. 
 
4.3.2 Behavior during defeat 
 To determine the effects of DSP-4 on intruder behavior during the 5 consecutive 
days of social defeat exposure, upright defensive postures were quantified from video 
recordings obtained on days 1 and 5 of defeat. Comparison of upright posture on days 1 
and 5 indicated that both DSP-4 and vehicle-treated rats exhibited greater durations of 
upright posture on the 5th exposure (Effect of day: F(1,16) = 6.0, p<0.05; Average ± SEM 
(s); Vehicle: 199.2 ± 53.3; DSP-4 120.4 ± 38.9) compared to the 1st exposure (Average 
time in upright postures ± SEM (s); Vehicle: 94.2 ± 28.9; DSP-4: 26.6 ± 16.8). These 
effects were independent of treatment designation (Effect of treatment: F(1,16) = 1.9, p=0.2) 
for both day 1 (p=0.08) and day 5 (p=0.5). In addition to quantifying upright posture, the 
amount of time required to induce behavioral submission (i.e. defeat latency) was also 
quantified across the 5-day social defeat exposure. Similar to findings in upright posture, 
DSP-4 and vehicle-treated rats demonstrated nearly identical defeat latencies across the 5-
day social defeat period (Average ± SEM; Vehicle: 215.8 ± 66.3; DSP-4: 270.7 ± 55.4), 




aggressive resident. It is important to note that these effects were not as a result of the 
relative intensity of the defeat experienced by vehicle and DSP4-treated rats. As analysis 
of resident attacks during each defeat episode indicated that both DSP-4 and vehicle-treated 
rats encountered a similar number of attacks (t(11) = 0.4).  
 
4.3.3 Validation of Study design  
It has been well established that the time course of stress- or endotoxin-induced 
release of cytokines can vary depending on the rats stress history and the cytokine being 
measured (Johnson et al., 2002; Cheng et al., 2015). Cytokine levels in response to an initial 
acute stress exposure or immune challenge can require up to 4 hours to peak. However, 
subsequent stress or immune challenges promote sensitized cytokine responses in the 
plasma and brain. This sensitization has been shown to be associated with a reduced time 
course of cytokine induction with peak responses occurring as early as 1 hour (Johnson et 
al., 2002; Cheng et al., 2015). Based on these findings, it was crucial to verify that plasma 
and brain samples collected immediately after the acute social defeat challenge on day 11 
(30 minutes after the start of defeat) were reflective of a time point at which stress-induced 
elevations in cytokines were evident. To this end, two distinct preliminary studies were 
conducted in which plasma and brain tissue were collected under resting non-stress 
conditions from a subset of vehicle and DSP4-treated rats with a history of control or 
defeat.  
Determination of resting-inflammatory tone in the CeA and DR following social 
defeat and DSP-4 treatment. In Chapter 3 it was demonstrated that social defeat-induced 




after the final social defeat exposure. However, neuroinflammation at this same timepoint 
was significantly enhanced in the LC. Based on these previous findings, it was pertinent to 
determine if a history of social defeat or DSP-4 treatment produced long-lasting increases 
in resting neuroinflammatory tone within the CeA. Additionally, findings from Chapter 3 
support stress-induced inhibition of cytokines in the DR. However, it was unclear what 
effects DSP-4 treatment may have on cytokine expression in this region. Therefore, DR 
neuroinflammatory responses were also assessed. To this end, a subset of DSP-4 and 
vehicle-treated rats were euthanized at rest 6 days after the 5th social defeat or control 
exposure. Subsequent Bio-Plex analysis of the CeA indicated that neither a history of social 
defeat nor DSP-4 treatment significantly altered resting cytokine concentrations in the CeA 
(Table 4.1). In contrast, analysis of the DR indicated that DSP-4 treatment did result in an 
overall enhancement of resting neuroinflammatory tone. Specifically, IL-1b was 
significantly enhanced in all DSP4-treated rats regardless of stress history (Table 4.2). 
Similar effects were also evident for IL2, IL-4, and TNF-a (Table 4.2). Although resting 
inflammatory tone was enhanced in DSP4-treated rats at rest within the DR, subsequent 
post-hoc analysis did not identify significant differences between specific stress and 
treatment groups.  
 
Verification of acute defeat-induced cytokine concentrations. Following determination 
of the effects of stress and DSP-4 treatment on resting inflammatory tone in the CeA and 
DR, a second validation study was conducted to confirm that stress-induced cytokine 
release could be detected at the chosen 30-minute post-stress time point. Cytokine levels 




under resting conditions and those that were subject to the acute social defeat challenge on 
day 11. Bio-Plex analyses of plasma indicated that this 30-minute stress exposure did result 
in an overall enhancement of inflammation compared to resting non-stress levels. 
However, the magnitude of these stress-induced alterations were largely cytokine specific. 
For example, plasma IL-1b, IL-4, and IL-13 demonstrated robust increases following the 
acute defeat challenge, while IL-6 remained unchanged from vehicle-treated rats 
euthanized under resting non-stress conditions (Table 4.3). Similar cytokine dependent 
enhancement following the acute defeat challenge was also evident for the CeA (Table 
4.3). In contrast, the acute defeat challenge resulted in an overall reduction in cytokines in 
the DR (Table 4.3), which nicely recapitulate findings discussed in Chapter 3.  
Taken together, these data suggest that cytokine measurements collected 30 
minutes after the acute social defeat challenge are reflective of stress-induced levels. 
However, it is important to note that these levels do not represent peak cytokine 
concentrations. Additionally, it is highly unlikely that these cytokine concentrations are 
reflective of increases in protein expression especially in vehicle-treated rats with a 
previous history of control. Instead, these data likely represent the release of cytokine 
containing vesicles from inflammatory cell types including macrophages (Arango Duque 
and Descoteaux, 2014) and microglia (Bianco et al., 2005).  
 
4.3.4 Effects of DSP-4 on release of social defeat-induced circulating cytokines in rats 
with a history of control or stress 
 After verifying the study design, Bio-plex analyses were conducted on plasma 




vehicle-treated rats, a history of social defeat resulted in the facilitation of 3 out of 10 
circulating stress-induced cytokines. Specifically, IL-6 (Effect of Stress History: F(1,18) = 
5.1, p<0.05; Figure 4.2A), INF-g (Effect of Stress History: F(1,18) = 7.3, p<0.05; Figure 
4.2B), and TNF-a (Effect of Stress History: F(1,18) = 6.3, p<0.05; Figure 4.2C) were 
significantly enhanced in vehicle-treated rats with a history of social defeat compared to 
vehicle-treated rats with a history of control. Consisted with NE’s known facilitative effects 
on immune regulation, rats receiving the noradrenergic neurotoxin DSP-4 exhibited robust 
inhibition of stress-induced release of all 10 cytokines measured (Figure 4.2 and Table 4.4) 
including IL-1b (Effect of Treatment: F(1,18) = 28.3, p<0.0001; Figure 4.2D), IL-4 (Effect 
of Treatment: F(1,18) = 28.5, p<0.0001; Figure 4.2E), and IL-13 (Effect of Treatment: 
F(1,17) = 20.1, p<0.001; Figure 4.2F). In addition to resulting in a general inhibition of 
acute defeat-induced inflammation, DSP-4 also inhibited inflammatory priming of IL-6 
(Effect of Treatment: F(1,18) = 28.3, p<0.0001; Figure 4.2A), INF-g (Effect of Treatment: 
F(1,18) = 26.9, p<0.0001; Figure 4.2B), and TNF-a (Effect of Treatment: F(1,17) = 23.3, 
p<0.001; Figure 4.2C) evidenced in vehicle-treated rats with a history of social defeat. 
These data suggest that the LC-NE system does play an intricate role in the emergence of 
stress-induced inflammation in the periphery. Moreover, the findings regarding selective 
facilitation of IL-6, INF-g, and TNF-a suggest that social defeat does not result in a general 
priming of the inflammatory system but rather produces cytokine-specific sensitization. 
 
4.3.5 DSP-4 treatment affects peripheral NE and Cort 
 In order to verify that the LC-NE system did indeed contribute to these effects, 




confirmed that DSP-4 did in fact reduce the peripheral NE response to social defeat (Effect 
of Treatment: F(1,20) = 8.9, p<0.01; Figure 4.3). Notably, plasma NE following the acute 
social defeat challenge were positively correlated to with the expression of several plasma 
cytokines including IL-6 (r = 0.44, p<0.05) and INF-g (r = 0.43, p<0.05). These data 
support previous reports that describe the proinflammatory potential of circulating NE 
(Spengler et al., 1990; Kavelaars et al., 1997; Johnson et al., 2005; Grisanti et al., 2010) 
and further suggest for the first time that the LC may be a significant source of social stress-
induced NE in the periphery.  
 It is also recognized that NE can regulate a number of peripheral effectors including 
Cort. Therefore, these studies also quantified plasma Cort following the acute defeat 
exposure in vehicle and DSP4-treated rats. Interestingly, plasma Cort following the acute 
defeat challenge were directly opposing to effects in plasma NE and inflammation. 
Specifically, Cort concentrations were selectively blunted in vehicle-treated rats with a 
history of defeat (Effect of Stress History: F(1,15) = 14.4, p<0.01; Figure 4.4). Treatment 
with DSP-4 blocked defeat-induced decreases in Cort in rats with a history of defeat (Effect 
of Treatment: F(1,14) = 12.3, p<0.01). To evaluate whether Cort responses in the plasma 
following the acute social defeat challenge were related to plasma inflammation, 
correlational analyses were conducted. These subsequent analyses demonstrated that Cort 
responses were negatively correlated with 9 of the 10 measured cytokines including IL-1b 
(r = -0.58, p<0.05), IL-6 (r = -0.60, p<0.05), and TNF-a (r = -0.59, p<0.05). It has been 
suggested that Cort can exert anti-inflammatory effects (Coutinho and Chapman, 2011). 
Although the current study did not directly assess the putative anti-inflammatory potential 




Moreover, these data suggest that in addition to regulating peripheral inflammation through 
the enhancement of circulating NE, the LC-NE system may further impact peripheral 
inflammation by indirectly modifying secondary systems that exhibit anti-inflammatory 
potential.  
 
4.3.6 Stress-induced neuroinflammation is enhanced in the CeA of DSP4-treated rats 
with a history of social defeat 
 In order to determine the putative role of the LC derived NE on stress-induced 
inflammation in the brain, Bio-Plex analyses were conducted in several LC projection 
regions including the CeA. The Bio-Plex data from this region indicated that social defeat-
induced inflammatory priming was also evident in the CeA following the acute defeat 
challenge. Similar to findings in the plasma, vehicle-treated rats with a history of social 
defeat exhibited modest yet consistent increases in CeA cytokines including IL-1b (Stress 
History x Treatment Interaction: F(1,16) = 5.5, p<0.05; Figure 4.5A), IL-6 (Stress History x 
Treatment Interaction: F(1,16) = 6.0, p<0.05; Figure 4.5B), INF-g (Stress History x 
Treatment Interaction: F(1,17) = 8.1, p<0.05; Figure 4.5C), and TNF-a (Effect of Stress 
History: F(1,17) = 11.9, p<0.01; Figure 4.5D) compared to vehicle-treated rats with a history 
of control. Importantly, this stress-induced neuroinflammatory priming was not just 
evident for pro-inflammatory cytokines, as many of the anti-inflammatory cytokines 
analyzed such as IL-1 receptor antagonist (IL-1RA; Effect of Stress History: F(1,17) = 9.8, 
p<0.01; Effect of Treatment: F(1,17) = 10.9, p<0.01; Figure 4.5E) and IL-4 (Stress History 
x Treatment Interaction: F(1,16) = 6.0, p<0.05; Figure 4.5F) were also elevated in vehicle-




control. Strikingly, treatment with DSP-4 sensitized neuroinflammatory responses to acute 
social defeat, but only in rats with a previous history of social defeat. Specifically, of the 
22 measured cytokines (Figure 4.5; Table 4.5), 21 cytokines were significantly enhanced 
in DSP4-treated rats with a history of social defeat which greatly exceeded that of vehicle-
treated rats with a history of defeat. Together these data suggest that the LC-NE system 
may serve to inhibit or regulate neuroinflammation within the CeA. Moreover, social 
defeat-induced sensitization in vehicle-treated rats with a history of social defeat suggests 
that a history of defeat may result in concomitant dysregulation of the LC-NE and 
neuroinflammatory systems.  
 
4.3.7 Acute defeat-induced neuroinflammation in the CeA is associated with loss of 
NE 
 HPLC analysis of CeA tissue homogenates was performed to verify the suspected 
effects of LC-NE on regulation of stress-induced neuroinflammation. Comparison of 
vehicle-treated rats indicated that a history of social defeat exposure resulted in significant 
reductions of NE in the CeA (Effect of Stress History: F(1,16) = 4.8, p<0.05; < 0.05; Figure 
4.6A). Notably, the reductions of CeA NE in vehicle-treated rats with a history of social 
defeat were strikingly similar to the NE content detected in rats treated with DSP-4.  To 
more clearly establish a relationship between CeA NE and inflammation, subsequent 
correlational analyses were conducted. These data suggested that NE was negatively 
associated with several cytokines. These associations were evident for both 
proinflammatory cytokines including TNF-a (r = -0.53, p<0.05; Figure 4.6B) and INF-g (r 




p<0.05; Figure 4.6D). Taken together these data support the suggestion that NE in the CeA 
likely exerts anti-inflammatory effects and that loss of NE through a history of social defeat 
or DSP-4 disinhibits inflammation in this region.  
 
4.3.8 A history of social defeat has opposing effects on acute defeat-induced 
neuroinflammation within the DR of vehicle and DSP4-treated rats 
 As discussed in Chapter 3, social defeat is known to produce region specific 
alterations in cytokine expression. Based on the previously described reduction of cytokine 
concentration in the DR, there was great interest to determine whether the LC-NE system 
contributed to these effects. Consistent with the findings described in Chapter 3, a history 
of social defeat exposure resulted in suppression of cytokines within the DR. For example, 
the concentration of IL-1b (Effect of Stress History: F(1,17) = 5.3, p<0.05; Figure 4.7A) was 
markedly reduced in the DR of vehicle-treated rats with a history of social defeat following 
the acute social defeat challenge compared to vehicle-treated rats with a history of control. 
Interestingly, this stress-induced reduction in cytokines was not evident for other 
proinflammatory cytokines. For example, the concentrations of TNF-a did not differ 
between vehicle-treated rats with a history of social defeat and vehicle-treated rats with a 
history of control (Effect of Stress History: F(1,17) = 0.2, p=0.7; Figure 4.7B). While the 
majority of pro-inflammatory cytokines did not differ between vehicle-treated rats, several 
anti-inflammatory cytokines exhibited expected social defeat-induced reductions in the 
DR. For example, IL-2 (Stress History x Treatment Interaction: F(1,17) = 13.1, p<0.01; 
Figure 4.7C) and IL-4 (Stress History x Treatment Interaction: F(1,17) = 6.0, p<0.05; Figure 




Unlike findings in the plasma and CeA, the effects of DSP-4 in the DR were largely 
cytokine specific. For example, DR concentrations of IL-1b in DSP4-treated rats were 
unchanged from that of vehicle-treated controls (Figure 4.7A). In contrast, TNF-a was 
enhanced in all DSP4-treated rats regardless of stress history (Effect of Treatment: F(1,17) 
= 9.1, p<0.01; Figure 4.7B). Notably, IL-2 (Figure 4.7C) and IL-4 (Figure 4.7D) patterns 
differed as well with DSP-4 producing selective enhancement of these cytokines in the DR 
of rats with a history of social defeat.  Based on the seemingly sporadic nature of these 
cytokine patterns following social defeat, it is likely that social defeat-induced cytokine 
responses within this brain region are largely independent from NE content within the DR.  
 
4.3.9 Acute defeat-induced cytokine concentrations are largely independent from NE 
content within the DR 
 Based on the intriguing findings regarding cytokine expression in the DR, HPLC 
analysis was conducted using the same tissue samples utilized for Bio-Plex analysis. 
Notably, NE content within the DR was unaffected by stress (Effect of Stress History: F(1, 
16) = 0.2, p=0.7) and DSP-4 treatment (Effect of Treatment: F(1,16) = 0.02, p=0.9; data not 
shown). Similarly, neither stress nor DSP-4 treatment altered 5-HT content in the DR 




 Dysregulation of the noradrenergic system has been clearly associated with the 




effective in alleviating the behavioral symptomatology in certain patient populations, these 
kinds of traditional anti-depressive therapies require weeks of continuous use and only 
produce remission in approximately 28% of people (Fava, 2000; Trivedi et al., 2006). 
Moreover, NE depletion studies are largely ineffective in inducing or worsening symptoms 
of major depression (Miller et al., 1996b; Miller et al., 1996a; Delgado, 2000), suggesting 
that rather than a direct effect of NE, antidepressant therapies targeting this system may 
rely on changes within a secondary system that is modulated by NE. Stress-induced 
inflammation represents one such secondary system. This suggestion comes from several 
studies that directly implicate inflammation in the emergence of depressive-like behaviors 
and findings from other groups showing that NE can regulate inflammatory responses in 
the periphery and the brain. However, up until this point no studies had been designed to 
directly assess the involvement of NE in stress-induced inflammatory responses. 
Therefore, the current study was unique as it demonstrated for the first time that the LC-
NE system is a significant source of plasma NE in response to social defeat stress and 
supports the notion that the LC noradrenergic system facilitates inflammatory priming in 
the periphery. Moreover, this study was further extended to identify the novel findings that 
a history of repeated exposure to social defeat produced brain region specific alterations in 
cytokine expression that are distinctly regulated by NE. 
It has long been recognized that the peripheral sympathetic nervous system is 
capable of regulating immunity by activating adrenergic receptors on the cell surface of 
macrophages. These effects of NE are known to result in the release of cytokines (Flierl et 
al., 2009; Li et al., 2015) and can further augment inflammatory responses to an immune 




recently, the contribution of central noradrenergic systems to these responses remained 
relatively unknown. Engler et al. provided the first report of LC-NE involvement in 
peripheral inflammatory responses. This particular study demonstrated that DSP-4 
treatment and the resulting loss of LC-NE inhibited lipopolysaccharide-induced cytokine 
release from splenocytes (Engler et al., 2010). Moreover, DSP-4 treatment functioned to 
reduce the percentage of natural killer cells within the spleen (Engler et al., 2010). Taken 
together these findings suggest that there are likely multiple overlapping mechanisms by 
which the LC-NE system can promote peripheral inflammation. In line with these findings, 
the particular study outlined in this Chapter determined that peripheral cytokine responses 
to social defeat were regulated by LC-NE projections as DSP-4 lesion effectively blunted 
plasma NE and inhibited acute defeat-induced release of plasma cytokines. Beyond the 
acute effects of stress on cytokine release, a history of stress exposure has been shown to 
promote the priming of peripheral inflammatory responses such that a subsequent stress or 
immune challenge promotes a larger and faster inflammatory response. Mechanistically, 
this inflammatory priming has been tied to enhanced secretion of cytokines from 
inflammatory cells that exhibit greater migratory and inflammatory capacity (Bierhaus et 
al., 2003; Nance and Sanders, 2007; Grisanti et al., 2010; Wohleb et al., 2014a). The 
sympathetic nervous system is suggested to be critical in the production of these effects as 
it innervates a number of lymphoid tissues (Felten et al., 1985; Wohleb et al., 2014a). While 
the study described in this Chapter did not directly assess the number and reactivity of 
inflammatory cell types, inflammatory priming was evident based on findings that stress-
induced cytokine release was augmented in rats with a history of stress compared with rats 




priming in the plasma provides direct support for the involvement of the LC-NE system in 
this process. 
Most of the data outlining the role of NE on inflammation has been determined by 
assessing peripheral responses. However, a few studies using cell culture have begun to 
elucidate the role of NE in central inflammatory responses. These studies have suggested 
that NE can produce inhibitory as well as facilitatory effects on inflammation depending 
on the cellular environment. Under normal resting conditions, NE is known to activate b2-
adrenergic receptors on the cell surface of microglia (Mori et al., 2002). Activation of these 
receptors in turn enhances cyclic adenosine monophosphate (cAMP) and ultimately results 
in the inhibition of pro-inflammatory cytokine release (Mori et al., 2002). However, in a 
pro-inflammatory environment, as is seen after stress or an immune challenge, microglia 
are capable of shifting the expression of cell surface receptors from a predominantly b2 to 
a predominantly a2-adrenergic receptor composition (Gyoneva and Traynelis, 2013). In 
contrast to the b2 receptors, activation of the a2 receptors on microglia fail to inhibit pro-
inflammatory cytokine release (Mori et al., 2002). Instead these receptors promote the 
expression of cathechol-O-methyl transferase (COMT) and B-cell lymphoma-extra large 
(Bcl-xl) (Mori et al., 2002). These particular findings suggest that microglia found in pro-
inflammatory environments are capable of recruiting pathways that protect against 
apoptotic events, such as the generation of free radicals, and facilitates the degradation of 
extracellular NE. In this way microglia become more resilient and are poised to maintain a 
proinflammatory environment.  
The study described in this chapter did not assess whether social defeat or DSP-4 




the CeA support the putative anti-inflammatory role of NE. Whether it was a history of 
social defeat or DSP-4 treatment, reductions in NE were clearly associated with increases 
in inflammatory responses within the CeA following the acute social defeat challenge. 
Importantly, these findings also support a role for NE withdrawal in neuroinflammatory 
priming or sensitization. In contrast, inflammatory responses in the DR were much less 
predictable. In general, exposure to social defeat resulted in modest inhibition of DR 
cytokines. Subsequent HPLC data further indicated that these effects appeared to be 
independent of NE. However, the lack of effects in NE could have resulted from a 
compensatory upregulation from other NE containing brain regions. While the LC is the 
major source of NE to the brain, it is not the sole source. There are a number of other NE 
containing nuclei which project to the CeA and DR including the ventromedial medulla 
(Zardetto-Smith and Gray, 1995) and lateral habenula (Aghajanian and Wang, 1977; Kalen 
et al., 1989). These NE inputs seem to differentially contribute to the NE content in these 
brain regions following stress and DSP-4 exposure. Specifically, the exhibited loss of NE 
in the CeA following both stress and DSP-4 treatment suggest that the ventral medulla 
which innervates this region did not come on-line to compensate for this loss. In contrast, 
normalized levels of NE in the DR suggest that the lateral habenula likely compensated for 


















Table 4.1 A history of social defeat and DSP-4 do not alter resting CeA cytokine 
concentration. Data presented as average percent of vehicle control ± SEM. 
 
Analyte Vehicle DSP-4 Main Effect of Treatment (Tx)/Stress 
 Control Defeat Control Defeat  







Stress: F(1,20)=0.04, p=0.83 
Tx: F(1,20)=0.51, p=0.48 







Stress: F(1,20)=0.01, p=0.93 
Tx: F(1,20)=1.70, p=0.21 









Tx: F(1,20)=0.45, p=0.51 







Stress: F(1,20)=0.20, p=0.66 
Tx: F(1,20)=0.0001, p=0.996 







Stress: F(1,20)=0.12, p=0.73 
Tx: F(1,20)=0.76, p=0.39 







Stress: F(1,20)=1.01, p=0.33 
Tx: F(1,20)=0.41, p=0.53 







Stress: F(1,20)=0.10, p=0.76 
Tx: F(1,20)=0.001, p=0.97 







Stress: F(1,19)=0.17, p=0.68 
Tx: F(1,19)=0.02, p=0.88 







Stress: F(1,20)=2.37, p=0.14 

























Table 4.2 DSP-4 and a history of social defeat differentially regulate resting cytokine 
concentrations in the DR. Data presented as average percent of vehicle control ± SEM. 
 
Analyte Vehicle DSP-4 Main Effect of Treatment (Tx)/Stress Control Defeat Control Defeat 







Stress: F(1,17)=0.36, p=0.55 
Tx: F(1,17)=11.56, p<0.01 







Stress: F(1,17)=0.04, p=0.85 
Tx: F(1,17)=4.99, p<0.05 







Stress: F(1,17)=0.02, p=0.90 
Tx: F(1,17)=8.16, p<0.05 







Stress: F(1,17)=0.03, p=0.87 














Table 4.3 Comparison of plasma, CeA, and DR in resting non-stress controls (NSC) and 
rats exposed to a single social defeat (SDC). Data presented as the mean pg/mL cytokine 
concentration ± SEM. ND is used in instances where cytokine values fell below the limit 







Plasma IL-1b IL-4 IL-6 IL-10 TNF-a 
NSC 48.4±4.8 20.2±2.4 232.8±24.7 172.2±15.9 37.0±3.5 
SDC 178.7±47.3* 1072.0±288.0* 208.1±66.1 353.1±93.0* 616.4±252.2* 
t-test 
results t(5)=2.7 t(5)=3.7 t(6)=0.7 t(5)=1.9 t(5)=2.27 
      
      
CeA IL-1b IL-4 IL-6 IL-10 TNF-a 
NSC 5.6±1.0 0.4±0.1 13.8±1.8 3.8±0.7 0.4±0.03 
SDC 11.7±2.4 1.7±0.3* 17.5±1.0 13.2±2.5* 32.4±6.9* 
t-test 
results 
t(4)=2.3 t(4)=4.3 t(4)=1.8 t(4)=3.6 t(5)=4.6 
      
     
DR IL-1b IL-2 IL-10 MCP-1 
NSC 18.6±0.7 31.8±2.6 66.2±2.2 36.1±1.2 
SDC 3.1±0.3**** 11.15±0.5** 46.3±3.4** 22.0±0.8**** 
t-test 
results 







Table 4.4 DSP-4 inhibits acute defeat-induced plasma cytokine release. Data presented as average 
percent of vehicle control ± SEM. #p=0.06, *p<0.05, **p<0.01 vs. vehicle control; αp<0.01, 
βp<0.001, γp<0.001 vs. vehicle defeat. 
 
Analyte 
Vehicle DSP-4 Main Effect of 













































Table 4.5 DSP-4 and a history of social defeat enhance cytokine concentration in the CeA after an acute defeat 
challenge. Data presented as average percent of vehicle control ± SEM. αp<0.05, βp<0.001, γp<0.001 vs. vehicle-treated 
rats with a history of defeat; *p<0.05, **p<0.01, ***p<0.01 vs. DSP4-treated rats with a history of control. 
 
Analyte Vehicle Control Vehicle Defeat DSP-4 Control DSP-4 Defeat Main Effect of 
IL-2 100.0 ± 11.8 193.9 ± 32.8 262.8 ± 84.7 701.6 ± 65.0γ** Stress x Tx: F(1,16)=6.0, p<0.05 
IL-5 100.0 ± 44.5 432.5 ± 223.9 658.3 ± 307.3 2346.9 ± 417.5β** Stress x Tx: F(1,15)=5.3, p<0.05 
IL-7 100.0 ± 33.7 762.0 ± 348.8 639.3 ± 265.5 2077.0 ± 183.0α* Stress: F(1,17)=13.2, p<0.01; Tx: F(1,17)=10.3, p<0.01 
IL-10 100.0 ± 18.7 197.0 ± 36.4 175.2 ± 33.6 299.3 ± 34.0 Stress: F(1,17)=9.7, p<0.01; Tx: F(1,17)=6.3, p<0.05 
IL-12 (p70) 100.0 ± 16.3 479.1 ± 236.2 601.3 ± 271.4 2140.6 ± 229.4β** Stress x Tx: F(1,16)=5.3, p<0.05 
IL-13 100.0 ± 15.2 286.9 ± 104.4 220.4 ± 70.8 543.6 ± 138.6 Stress x Tx: F(1,16)=5.1, p<0.05 
IL-18 100.0 ± 2.6 114.9 ± 7.5 123.7 ± 12.2 172.5 ± 9.0β* Stress: F(1,16)=9.2, p<0.01; Tx: F(1,16)=15.0, p<0.01 
EPO 100.0 ± 12.0 164.1 ± 24.4 152.0 ± 22.9 222.6 ± 22.1 Stress: F(1,17)=8.0, p<0.05; Tx: F(1,17)=5.4, p<0.05 
GRO-KC 100.0 ± 14.6 198.6 ± 63.3 230.8 ± 71.4 658.3 ± 90.8β** Stress x Tx: F(1,16)=5.2, p<0.05 
GM-CSF 100.0 ± 26.2 437.9 ± 237.6 560.4 ± 249.0 1973.8 ± 204.3β** Stress x Tx: F(1,16)=5.2, p<0.05 
M-CSF 100.0 ± 17.2 180.2 ± 37.9 182.0 ± 43.3 462.3 ± 59.3β** Stress x Tx: F(1,16)=5.0, p<0.05 
MIP-1a 100.0 ± 30.6 731.1 ± 403.2 1090.7 ± 501.3 3958.0 ± 481.5β** Stress x Tx: F(1,16)=5.7, p<0.05 
RANTES 100.0 ± 18.2 400.0 ± 183.9 472.5 ± 190.3 1595.2 ± 141.8β** Stress x Tx: F(1,16)=5.3, p<0.05 











Figure 4.1 DSP-4 study design and timeline for animals with a history of social defeat (A) 
or control (B). 10 days prior to the onset of stress all rats were implanted with 
intracerebroventricular (ICV) cannulas. Seven days prior to stress, DSP-4 or vehicle were 
administered. DSP-4 and vehicle-treated rats were subjected to either 5 daily exposures to 
social defeat or control. Six days after the final social defeat/control exposure, all rats, 
regardless of stress history, were exposed to an acute social defeat challenge immediately 
prior to euthanasia and tissue collection. A separate subset of rats was exposed to 5 daily 
control sessions and euthanized 6 days later under resting, non-stress conditions (subset 











Figure 4.2 DSP-4 suppresses acute defeat-induced plasma cytokine release. Following the acute social 
defeat challenge, vehicle-treated animals with a history of social defeat exhibited enhanced (A) IL-6, (B) 
INF-γ, and (C) TNF-α, compared with vehicle-treated controls consistent with stress-induced 
inflammatory priming. Strikingly, treatment with DSP-4 (panels A-F) suppressed stress-induced 
facilitation of IL-6, TNF-α, and INF-γ, as well as increases in (D) IL-1β, (E) IL-4 and (F) IL-13, 















Figure 4.3 DSP-4 treatment inhibits acute defeat-induced plasma NE induced by a history of social defeat. (A) Following 
the acute social defeat challenge, vehicle-treated rats with a history of social defeat exhibit a sensitized peripheral NE 
response. In contrast, acute defeat-induced plasma NE is blunted in rats treated with DSP-4. These acute defeat-induced 
plasma NE responses were positively correlated with a number of cytokines including (B) IL-6 and (C) INF-γ. αp<0.05 vs. 





Figure 4.4 DSP-4 inhibits stress-induced habituation of Cort responses. (A) Vehicle-
treated rats with a history of social defeat selectively exhibit a habituated Cort response 
following the acute defeat challenge. In contrast, treatment with DSP-4 inhibited Cort 
habituation in rats with a history of defeat. Acute defeat-induced Cort concentrations were 
negatively correlated with a number of acute defeat-induced cytokines including (B) IL-
1β, (C) IL-6, and (D) TNF-α. *p<0.05 vs. vehicle-treated rats with a history of control; 





Figure 4.5 DSP-4 exacerbates acute defeat-induced neuroinflammatory priming in the CeA. Following the 
acute social defeat challenge, vehicle-treated rats with a history of social defeat exhibited moderate but 
consistent increases in pro-inflammatory cytokines (A) IL-1β, (B) IL-6, (C) INF-γ, (D) TNF-α and anti-
inflammatory (E) IL-1RA and (F) IL-4 compared with vehicle-treated rats with a history of control. 
Treatment with DSP-4 produced modest increases in stress-induced cytokines in rats with a history of 
control, while the LC-NE lesion robustly exacerbated the neuroinflammatory priming evident in rats with a 
history of social defeat exposure for all cytokines except TNF-α. *p<0.05 vs. vehicle-treated rats with a 
history of control; ƒp=0.07, βp<0.001 vs. vehicle-treated rats with a history of defeat; γp=0.07 #p<0.05, 












Figure 4.6 DSP-4 and a history of social defeat reduce NE content within the CeA (A) 
which is negatively correlated with TNF-a (B), INF-g (C), and IL-4 (D). ƒp=0.07, #p=0.06 














Figure 4.7 A history of stress and DSP-4 treatment produce cytokine specific effects in the 
DR following acute defeat challenge. Following the acute defeat challenge, vehicle treated 
rats generally exhibited a reduction of (A) IL-1β, (B) TNF-α, (C) IL-2, and (D) IL-4. 
However, the magnitude of these reductions were largely cytokine dependent. While 
treatment with DSP-4 modestly enhanced IL-1β independent of stress history, TNF-α, IL-
2, and IL-4 were selectively enhanced in DSP-4 treated rats with a history of social defeat. 
#p<0.05 vs. DSP-4 treated rats with a history of control; βp<0.05 vs. vehicle treated rats 



































































































































The “How”: Discrete inflammatory sensitive mechanisms that may 
underlie behavioral and physiological deficits following stress 
 
5.1 Introduction 
 Thus far, Chapters 3 and 4 have focused on the “what” and “why” underlying stress-
induced inflammation. Specifically, these previous chapters have described the breadth of 
stress-induced cytokine release in the periphery and the brain, implicated these 
inflammatory responses in the emergence of depressive-like behaviors, and further 
suggested that NE derived from the LC may be directly involved in these processes. 
However, the looming question remains, how does stress-induced inflammation promote 
the emergence of behavioral dysfunction? What specific receptor systems are impacted? 
And importantly, if these receptor systems can be blocked, does this ameliorate the 
behavioral effects of stress exposure? 
 Several studies have begun to assess the specific neural effects of inflammation. 
These studies have largely reported that inflammation results in enhanced neural activation 
as evidenced by increased c-fos and miniature excitatory post synaptic potentials (Ming et 
al., 2013; Prager et al., 2013; Kurosawa et al., 2016). This cytokine-induced activation has 
been noted in a number of brain regions including the central amygdala (CeA) (Ming et 
al., 2013; Prager et al., 2013). As described in Chapter 1, the CeA has been extensively 
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studied over the past 6 decades. The vast literature generated over this time has 
demonstrated that the CeA plays an intricate role in regulating the behavioral and 
autonomic responses to fear (Fadok et al., 2018). In addition to executing unconditioned 
behavioral responses to fear, the CeA is also critical in fear learning (Ciocchi et al., 2010; 
Li et al., 2013a; Fadok et al., 2017) and is involved in the detection and evaluation of 
potentially aversive stimuli or situations (Ozawa et al., 2017). Stress is a robust activator 
of the CeA. In both humans and animals stress is well documented to promote 
hyperactivation of the CeA (Roozendaal et al., 1997; Bryant et al., 2008; Roozendaal et al., 
2009; Pitman et al., 2012) and a subsequent loss of inhibitory control (Zhang et al., 2018) 
which has been directly correlated with measures of anxiety (Swartz et al., 2014) and 
depression (Yang et al., 2010). Electrophysiological studies in slice preparations have 
indicated that amygdalar hyperactivation results from a depolarization in the resting 
membrane potential which effectively reduces the threshold for the generation of action 
potentials (Neugebauer et al., 2003). In addition to lowering the threshold for the 
generation of action potentials, it has been suggested that stress also enhances the 
sensitivity of the amygdala to the excitatory neurotransmitter glutamate likely due to 
increased expression of glutamatergic receptors (Mozhui et al., 2010).  
There are several different neuronal mechanisms by which this could occur. 
However, converging data in the hippocampus (Desai et al., 1999; Peters et al., 2010) and 
basolateral amygdala (Sharp, 2017) suggest that signaling through tyrosine receptor kinase 
(Trk)B may be directly responsible for these exhibited shifts in neuronal excitability. TrkB, 
also known as tropomyosin receptor kinase B, is the high affinity receptor for BDNF. 
Unbound TrkB exists as a silent monomer in the plasma membrane. However, upon 
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binding of BDNF or its low affinity ligand neurotrophin-3 (NT-3), TrkB homodimerizes 
resulting in the activation of the intracellular tyrosine kinase domain. This activation 
promotes the autophosphorylation of a number of tyrosine residues on the intracellular 
domain of this receptor which allows for the subsequent phosphorylation and activation of 
3 distinct signaling cascades: mitogen-activated protein kinase (MAPK)/extracellular 
signal-regulated kinase (ERK), calmodulin-dependent kinase II (CaMKII), and protein 
kinase B (Akt) (Figure 5.1) (Kandel et al., 2000a). In general, BDNF and subsequent 
activation of the TrkB receptor have long been implicated in the modification of synaptic 
pathways by altering pre- and post-synaptic terminals to enhance the overall sensitivity of 
neurons to excitatory amino acid neurotransmitter glutamate  (Martin and Finsterwald, 
2011). It is through these actions that BDNF is suggested to contribute to LTP (Martin and 
Finsterwald, 2011) and enhancing electrical excitability (Li et al., 1998).   
However, detailed signaling studies have indicated that these particular cellular 
signaling effects are directly dependent on specific TrkB signaling cascades. For example, 
TrkB signaling through MAPK and ERK has been shown to promote neuronal activation 
as evidenced by the induction of cfos (Kidambi et al., 2010; Shan et al., 2015). Moreover, 
activation of ERK has been directly implicated in producing depolarization of resting 
membrane potentials (Stamboulian et al., 2010). Similar effects on neuronal activation and 
enhanced excitability have also been reported to occur following the activation of CaMKII 
(Wang et al., 2003b; Lee et al., 2009; Lucchesi et al., 2011; Klug et al., 2012). Although 
MAPK and CaMKII are distinct branches and are dependent upon the activation of 
different phosphate residues on the TrkB receptor, these two pathways converge onto the 
cAMP response element binding protein (CREB). This convergence likely explains the 
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strikingly similar molecular effects elicited by these two pathways. Unlike MAPK and 
CaMKII,  Akt, the third and final branch of the TrkB signaling cascade, functions to inhibit 
c-fos activation (Yokoyama et al., 2013) by facilitating the trafficking of inhibitory g-
aminobutyric acid (GABA) receptors to the plasma membrane (Wang et al., 2003a). 
Notably, Akt is in direct opposition to MAPK as the upstream adaptor proteins responsible 
for the activation of both of these pathways compete for binding at the tyrosine residue 515 
on the TrkB receptor (Gervais et al., 2006; Yokoyama et al., 2013).  
In addition to producing opposing cellular signaling effects, MAPK/ERK, CaMKII, 
and Akt also produce opposing behavioral effects. Specifically, MAPK/ERK and CaMKII 
have been implicated in the emergence of anxiety- (Maldonado et al., 2014; Tran and 
Keele, 2016) and depressive-like behaviors (Di Benedetto et al., 2013; Li et al., 2013b). 
Furthermore, activation of these two specific branches of the TrkB signaling cascade in the 
amygdala directly underlie the acquisition and expression of fear related behavioral 
responses (Rodrigues et al., 2004; Di Benedetto et al., 2009; Maldonado et al., 2014). In 
contrast activation of the Akt signaling cascade has been implicated in anti-depressant (Shi 
et al., 2012; Leibrock et al., 2013) and anxiolytic effects (Leibrock et al., 2013). Based on 
these vastly different molecular and behavioral effects, it is probable that stress-induced 
activation of these particular branches of the TrkB signaling cascade may directly underlie 
stress resiliency and susceptibility such that preferential signaling through MAPK/ERK 
and CaMKII may promote stress susceptibility while preferential signaling through Akt 
may confer resilience.  
Another important regulator of stress susceptibility and resiliency is autonomic 
balance. In healthy individuals the autonomic nervous system, which is comprised of 
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sympathetic and parasympathetic branches, is well balanced. The sympathetic branch of 
the autonomic nervous system is best known for its implication in producing the “fight or 
flight” response. The “fight or flight” response is a general term describing a variety of 
physiological effects that occur following the subjective perception of threat, fear, or stress. 
In general, this response is meant to ready an organism to either confront the threat or 
retreat. To this end the sympathetic nervous system enhances blood pressure and heart rate, 
results in dilation of the pupils, and temporarily shuts down digestive function. In contrast, 
the parasympathetic nervous system is best known for its involvement in processes falling 
under the colloquial terms “rest and digest”. This is a very simplistic view of the autonomic 
nervous system and suggests that these systems function exclusively and independently 
from one another. However, under normal healthy resting conditions, the sympathetic and 
parasympathetic nervous systems act in concert to maintain a number of physiological 
processes including micturition, peristalsis, pupillary responses, and maintenance of blood 
pressure and heart rate (Kandel et al., 2000b).   
Stress is well documented to produce long lasting disruptions of the autonomic 
nervous system resulting in an imbalance between sympathetic and parasympathetic 
control. Direct measures of sympathetic and parasympathetic tone are nearly impossible to 
obtain. However, studies in humans and animals have determined that measurement of 
heart rate variability (HRV) can be utilized to indirectly determine sympathetic and 
parasympathetic control of the heart. In general, HRV can best be conceptualized as the 
fluctuation of time between heart beats. In the normal healthy heart, HRV is chaotic 
(Goldberger, 1991) due to the intricate and dynamic interplay between sympathetic and 
parasympathetic input to the heart. It is thought that this “chaos” is integral in the ability 
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for the cardiovascular system to rapidly adapt (Beckers et al., 2006). However, in response 
to stress, HRV can become drastically reduced as the intervals between heart beats become 
monotonous and uncharacteristically regular (Kim et al., 2018). Stress-induced reductions 
in HRV have been shown to occur either as a result of parasympathetic withdrawal, 
enhanced sympathetic outflow, or a combination of the two (Gorman and Sloan, 2000). 
Importantly, reductions of HRV have been directly associated with behavioral states such 
as aggression, anxiety, and depression and is suggested to be accompanied by higher 
mortality rates due to cardiovascular complications such as the emergence of coronary 
heart disease and arrhythmias (Gorman and Sloan, 2000).  
Several studies have begun to further assess the involvement of HRV in stress 
responsivity and more importantly stress susceptibility and resiliency. An important 
advancement in this particular field of research was published in 2015 by Minassian et al. 
(Minassian et al., 2015). In what is known as the Marine Resilience Study, Minassian et al 
demonstrated that individuals exhibiting reduced HRV prior to deployment were more 
likely to meet PTSD diagnostic criteria upon their return (Minassian et al., 2015). These 
findings were later expounded upon in a follow up study named Warriors Achieving 
Resilience. Findings from this particular study confirmed those reported by Minassian et 
al (Pyne et al., 2016). However, this particular study indicated that the basal reductions in 
HRV prior to deployment were directly associated with lower resting vagal tone (Pyne et 
al., 2016). Taken together, these data suggest that individual differences in HRV may not 
only underlie the development of stress-induced pathology but may also serve as a 
preliminary screen to determine stress susceptibility and resiliency. Notably, studies 
assessing emotional processing and HRV have indicated that individuals that exhibit lower 
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HRV also exhibit impaired neuronal regulation of the amygdala  (Sakaki et al., 2016). 
While it is unclear if the amygdala is directly involved in reduced HRV and vagal 
withdrawal, it has been demonstrated that electrical stimulation of the CeA results in an 
increase in blood pressure and heart rate (Iwata et al., 1987).  
 Based on the strong link between the CeA and behavior as well as HRV, it was 
hypothesized that the CeA may be a crucial hub that integrates and controls a variety of 
physiological and neuronal responses that ultimately predict and underlie stress 
susceptibility and resiliency. Therefore, identification of specific signaling pathways that 
are disrupted in the CeA of stress susceptible individuals is critical to further elucidate the 
neuronal mechanisms underlying the emergence of anxiety- and depressive-like behavioral 
states. As outlined earlier in this chapter, TrkB is an ideal target to begin this investigation 
due to the inherent opposition that exists between the MAPK/ERK and Akt signaling 
cascades. In order to address these distinct hypotheses, two studies were designed as 
illustrated in Figure 5.2.  
 
5.2 Methods 
 The sections contained below describe detailed methods involved in the completion 
of these studies. Detailed methods for social defeat, sucrose preference, and tissue 
collection are not discussed to limit repetitive discussion. However, these sections are 






5.2.1 Ferret Odor 
  Unpublished data from our group has suggested that behavioral and Cort responses 
to ferret odor can effectively predict subsequent susceptibility and resiliency to social 
defeat. This particular behavioral assay involves placing a rat into a large Plexiglas 
cylinder. The cylinder itself has a diameter of approximately 7.75 inches and is 16 inches 
in height. These dimensions provide the rat enough space to freely turn around and ensures 
that the rat cannot escape. A small metal clip fastened to a rubber coated wire is attached 
to the side of the cylinder and freely dangles in close proximity to the rat. After the rat is 
placed into this tank, a 1x1 inch ferret scented towel is inserted into the clip. Video 
recordings of this exposure are captured for subsequent analyses of freezing behavior. 30 
minutes after the initiation of this exposure, a small amount of blood (approximately 100 
µL) is obtained via tail bleed using small volume EDTA lined tubes. Plasma is then 
collected via centrifugation at 3200 rpm and 4oC for 15 minutes. The resulting plasma is 
subsequently stored at -80oC until Cort analyses are conducted using a standard Cort 
ELISA (Enzo Life Sciences; Farmingdale, NY). It is important to note that this 30-minute 
time point for Cort analysis does not reflect peak Cort measures. Peak Cort responses have 
been consistently reported to occur approximately 1 hour after the initiation of stress 
(Dorey et al., 2012; Gong et al., 2015). Therefore, these Cort measures do not assess 
differences in maximal release but rather serve as an assessment of general physiological 
reactivity.  
Data collected by previous members of the Wood lab determined that analysis of 
freezing behavior across the first 5 minutes of the ferret odor exposure and plasma Cort 
were the most reliable predictors of subsequent susceptible and resilient subpopulations. 
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Specifically, it was determined that rats demonstrating low freezing and low Cort responses 
during the exposure to ferret odor also demonstrated active coping resilient phenotypes 
during social defeat. Conversely, rats demonstrating high freezing and high Cort responses 
went on to exhibit passive coping susceptible phenotypes during social defeat. The 
interaction between ferret odor responses and social defeat behavior for these unpublished 
data were determined post hoc and were not utilized as a predictive measure as this 
particular study was meant to evaluate the potential for ferret odor to be used as a 
prescreening method. However, these post hoc evaluations did indicate that this 
prescreening method was approximately 95% accurate in determining a rats natural 
tendency towards stress susceptibility or resiliency. 
Based on the suggested utility of this paradigm, the studies described in this chapter 
were the first to utilize this method to predict behavioral responses to social defeat. For 
both of the studies outlined in Figure 5.2, ferret odor was conducted prior to any other 
surgical or behavioral manipulation. Rats in both studies were exposed to the ferret scented 
towel for a total of 10 minutes. In accordance with the methods for the unpublished results, 
behavioral responses during this 10-minute period were video recorded for subsequent 
analysis. After the 10-minute exposure, rats were returned to their home cage and allowed 
to rest until blood collection at 30 minutes. Plasma was collected and later analyzed for 
Cort using the same Cort ELISA (ENZO Life Science; Farmingdale, NY) as the 
unpublished data. For the purposes of these studies, freezing behaviors were analyzed with 
the use of ANY-maze (Stoelting Co.; Wood Dale, IL). ANY-maze is a program which 
analyzes a myriad of behavioral responses based on parameters set by the experimenter. 
For the purposes of ferret odor, a protocol was created with freezing thresholds of 40 (on) 
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and 60 (off) with a minimum freezing duration of 1 ms. To ensure that these settings would 
provide accurate data, this particular protocol was utilized to analyze previously hand 
scored videos. The average difference in freezing responses between these two methods 
were 5.8 ± 0.4 s (average ± SEM). Notably, this difference was determined by comparing 
freezing behaviors across the 1st 5 minutes of exposure for a total of 33 animals, suggesting 
that the ANY-maze protocol does accurately detect freezing behaviors.  
In order to separate animals into susceptible and resilient subgroups, cumulative 
freezing responses during the 1st 3, 4, and 5 minutes and obtained plasma Cort 
concentrations (ng/mL) were analyzed using the statistical software jmp (SAS Institute; 
Cary, NC). A distribution analysis was conducted for each of these factors. Any data points 
flagged as outliers (values exceeding twice the standard deviation) were excluded from the 
analysis and the distribution was recalculated. Rats demonstrating freezing and Cort 
responses in the bottom 50th percentile were classified as low responders. Conversely, rats 
demonstrating freezing and Cort responses in the top 50th percentile were classified as high 
responders. Importantly, these classifications were later verified using behavioral 
responses during defeat. Moreover, this post hoc verification method was further used to 
classify rats that were originally deemed outliers or those with freezing and Cort responses 
that fell exactly on the 50% cut off.  
   
5.2.2 Surgery 
 Rats receiving surgery were transported from the animal colony to our designated 
surgical suite and allowed to habituate from transport for a minimum of 30 minutes. 
Aseptic techniques were strictly enforced to minimize possible infection. To this end, all 
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surgical tools, gauze, blue absorbent pads, and cotton swabs were autoclaved prior to 
surgery. Additional materials required for surgery including syringes, scalpels, needles, 
drapes, silk suture, polyglycolic acid sutures, and gloves, were purchased from the supplier 
to be individually wrapped and sterile. A certified and calibrated vaporizer was utilized to 
deliver anesthesia (Isothesia Isoflurane; Henry Schein; Melville, NY). Rats were placed 
into a knockdown chamber which was subsequently filled with 5% isoflurane for 2 
minutes. After this initial knock down period, rats were removed from the chamber, 
weighed, and placed either into a nose cone (transmitter surgery) or fastened into the 
stereotaxic device (cannula surgery). Isoflurane was then reduced to 2.5% for the duration 
of the surgery. Breathing was closely monitored for anesthesia-induced respiratory 
depression. In the event that an animals breathing began to slow substantially, the 
percentage of isoflurane was dropped no lower than 1.5% until breathing had normalized. 
Body temperature was constantly monitored via rectal thermometer and regulated with a 
digital heating pad. Approximately 5 minutes prior to the completion of surgery, Flunixin 
(2.5 mg/kg; Henry Schein; Melville, NY), a nonsteroidal anti-inflammatory and analgesic, 
was injected subcutaneously. Following surgery, all rats were placed into a clean cage with 
nesting material and given dietary support of Bacon Softies (Bio-Serv; Flemington, NJ) 
and Diet Gel (Clear H2O; Portland, ME). Pain medication and dietary support were 
administered on the day of and 24 hours following surgery to minimize discomfort from 
surgical procedures. 
 
Cannula Surgery.  All rats for the molecular and behavioral studies were bilaterally 
implanted with stainless steel guide cannulas directed toward the CeA. For this particular 
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surgery, each rat was secured into the stereotax such that head movement to the right and 
left was limited. Once the animal was securely in place, hair on the scalp was removed and 
the area was cleaned three times with alternating applications of betadine and alcohol. At 
this point, a small incision was made at the top of the scalp exposing the skull. Excess 
tissue was removed with the scalpel and any bleeding as a result of tissue removal was 
absorbed with sterile cotton swabs. Sterile stainless-steel guide cannulas (26 gage, 8 mm 
below pedestal; PlasticsOne; Roanoke, VA) were fastened into the cannula arm attached 
to the stereotax. Prior to drilling holes for the cannula, head placement was verified by 
measuring Bregma and pseudo-Lambda. In the event that the Medial/Lateral measurement 
between these two landmarks differed by more than 0.3mm, the rats head was adjusted and 
measurements were reacquired. Coordinates for the bilateral CeA cannula placement were 
calculated relative to Bregma as -2.3 Anterior/Posterior, ± 4.1 Medial/Lateral, and were 
implanted at a depth of 6.2 mm relative to the surface of the brain. In addition to the 
cannulas, two small support screws were fastened into the skull. Cannulas were semi-
permanently adhered to the skull using dental cement (Lang Dental; Wheeling, IL).  
 
Transmitter Surgery. Rats in the behavioral and cardiovascular study were also implanted 
with HDS-11 telemetry devices (Data Sciences International; St. Paul, MN). Transmitter 
surgeries occurred immediately prior to cannula implantation. After the initial knockdown 
and weighing, animals were placed onto a sterile pad on the surgical table. The nose was 
gently inserted into the nose cone and the abdomen was exposed. Hair from the abdomen 
and a small portion of hair from the right pectoral area was removed. Both areas were 
thoroughly cleaned using three alternating applications of betadine and alcohol. An 
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incision was made into the skin of the abdomen exposing the abdominal muscle. 
Connective fascia was gently separated from the skin and the abdominal muscle 
surrounding the incision to enhance ease for opening the abdominal cavity and facilitate 
abdominal wound healing (Franz et al., 2001).  
 The abdominal cavity was slowly opened using small scissors. Organs were gently 
moved to the right and the left to expose the descending vena cava and abdominal aorta. A 
4 x 4 inch pad of sterile gauze was tightly rolled and inserted into the abdominal cavity to 
keep the organs out of the way. After insertion, the roll of sterile gauze was soaked in sterile 
0.9% injectable saline. Connective tissue was gently separated away from the surface of 
the vena cava and the abdominal aorta using dry sterile cotton swabs. A portion of the aorta 
immediately below the renal bifurcation was gently separated from the vena cava using 
forceps. A piece of sterile suture was then threaded underneath using catheter forceps. This 
process was repeated just above the iliac bifurcation. A small amount of injectable saline 
was applied to the exposed aorta to rehydrate the vessel. During this time, the sterile 
transmitters, the catheter inducer, and vet bond were prepared. After this preparation and 
removal of all unnecessary surgical tools, the vessel was occluded using the two strands of 
suture threaded underneath the abdominal aorta. The inducer was quickly inserted into the 
vessel and the catheter was gently inserted and glued into place. The entire process of 
occlusion, insertion, gluing, and de-occlusion occurs over a period of 45 seconds. To ensure 
the catheter remains anchored to the abdominal aorta, a small cellulose patch is glued over 
the top of the insertion site. The rolled gauze is then removed from the abdominal cavity 
and the main body of the transmitter is inserted. The two ECG leads that are attached to 
the transmitter are then exposed through the abdominal muscle. The muscle is then sutured 
 
123 
closed with silk suture. During this process the transmitter is attached to the abdominal 
muscle as the suture is guided through a number of rubber channels on the surface of the 
device. This ensures that the transmitter remains in place and reduces strain on the catheter.  
 The exposed ECG leads are subsequently sutured in two distinct locations. The first 
is sutured to the muscle just below and to the left of the xiphoid process, the cartilaginous 
section at the lower portion of the sternum. The other lead is sutured to the pectoral muscle 
just below the clavicle. This particular lead placement is known as the Modified Lead II 
configuration (Berry, 2012). Although single ECG leads can provide useful data regarding 
cardiac rhythm and heart rate, accurate visualization of the different components of the 
ECG wave requires the presence of at least two ECG leads (Berry, 2012). Adherence of 
the negative lead to the pectoral muscle and the positive lead on the lower left portion of 
the rib cage has been demonstrated to provide the most clear temporal resolution of 
individual ECG waves (Berry, 2012). Once the ECG leads are fastened into place with silk 
suture, the skin is sutured closed using the absorbable polyglycolic acid sutures. 
 
5.2.3 Drug Preparation 
Several studies have begun to show the utility of N-[2-[[(Hexahydro-2-oxo-1H-
azepin-3-yl)amino]-carbonyl]phenyl]benzo[b]thiophene-2-carboxamide (ANA-12) in 
ameliorating anxiety- (Greenberg et al., 2013; Azogu and Plamondon, 2017a, b) and 
depressive-like behaviors (Shirayama et al., 2015; Zhang et al., 2015b; Zhang et al., 2015a; 
Zhang et al., 2016). Previously available Trk antagonists function to inhibit Trk 
phosphorylation by directly competing with BDNF for the receptor binding pocket. Since 
the binding pocket of TrkA, B, and C are highly conserved, these competitive antagonists 
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display low selectivity for specific Trk receptor subtypes (De Smet et al., 2014). Therefore, 
ANA-12 is a great advance as it selectively binds to the allosteric sites of the TrkB receptor 
(Cazorla et al., 2011). The initial characterization of this compound indicated that ANA-
12 binds to both TrkB allosteric sites with a Kd of 10 nM for the high affinity site and 12 
µM for the low affinity site (Cazorla et al., 2011). While several studies have directly 
injected ANA-12 into discrete brain regions, the concentrations utilized vary between 
studies and dose responses have not been openly published. Based on these limitations, a 
pilot study was conducted to determine the dose of ANA-12 that produced maximal 
inhibition of social defeat-induced TrkB phosphorylation. Rats in this study were exposed 
to 5 days of social defeat. 500 nL of ANA-12 at a dose of 0, 0.25, 1, 2.5, and 10 µg (40% 
dimethyl sulfoxide in 0.9% saline) were infused 30 minutes prior to social defeat on days 
1, 3, and 5. Analysis of phosphorylated and total TrkB 4 hours after the final infusion (3.5 
hours after the final defeat) on day 5 indicated that ANA-12 produced a dose dependent 
reduction of ANA-12 (Figure 5.3A). Notably, the 2.5 µg dose produced maximal inhibition 
of defeat-induced phosphorylation (Figure 5.3A). Subsequent non-linear analysis further 
identified that ANA-12 in CeA homogenates has an IC50 of approximately 0.6 µg (Figure 
5.3B). Importantly, these effects in phosphorylated TrkB did not result from differences in 
total TrkB (Effect of dose: F(4, 18)=0.09, p=0.99; Figure 5.3C) or due to differences in the 
housekeeping protein b-actin (Average b-actin signal ± SEM; 0 µg dose 397.6 ± 143.6; 
0.25 µg dose 249.0 ± 50.22; 1 µg dose 342.5 ±126.8; 2.5 µg dose 324.2 ± 114.6; 10 µg 
dose 355.1 ± 202.2;  Effect of Dose F(4, 18)=0.2, p=0.96). 
Based on the pilot study discussed above, 500 nL containing 2.5 µg of (ANA-12) 
or vehicle (40% dimethylsulfoxide in 0.9% saline) were bilaterally infused into the CeA in 
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order to assess whether CeA TrkB signaling contributes to the development of stress-
induced behavioral dysfunctions and disruptions in cardiovascular regulation. Drug and 
vehicle infusion were conducted using a micropump that was set to deliver the 500 nL 
across a period of 1 minute. The effectiveness of ANA-12 to inhibit defeat-induced 
phosphorylation of TrkB was verified using western blot analyses in tissues collected 4 
hours after the final social defeat challenge. This particular time point was chosen as the 
initial characterization of ANA-12 indicated that this drug produces maximal effects 4 
hours after infusion (Cazorla et al., 2011). Details regarding the western blot analyses are 
presented in section 5.2.7 of this chapter.  
In addition to verifying the effectiveness of ANA-12 on TrkB phosphorylation, a 
subset of animals were studied to determine drug spread. ANA-12 is still a relatively new 
compound having first been described in 2011. As such biotinylated and fluorescently 
tagged ANA-12 has not become commercially available. In order to estimate drug spread, 
500 nL of a 1% solution of Chicago sky blue in vehicle (40% DMSO in 0.9% saline) was 
bilaterally infused into the CeA at a rate of 0.5µL per minute immediately prior to 
euthanasia. Brains were collected, blocked into anterior and posterior sections, and flash 
frozen in ice cold 2-Methylbutane. Collected anterior brains were subsequently sliced on a 
cryostat to the most rostral level of the CeA at which time 30 µm slices were collected and 
mounted onto Superfrost Plus Microscope Slides (Fisher Scientific; Waltham, MA). Slides 
were stained with a Neutral Red solution, dehydrated, fixed in Histo-Clear (National 
Diagnostics; Atlanta, GA), and coverslipped. After allowing the slides to dry for 24 hours, 
slices were imaged using a Zeiss axioscope 20 microscope with brightfield/darfield 
capabilities and camera attachment. The resulting photos were then analyzed for drug 
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spread using ImageJ (NIH Research Services Branch; Bethesda, MD). Each image was 
carefully photographed to capture the rhinal fissure and the descending limb of the corpus 
collosum. The distance between these two structures remains relatively constant 
throughout the development of the CeA at approximately 1.75 mm (Paxinos and Watson, 
2007). Therefore, these structures were used as the set point for size in ImageJ. To better 
visualize the area of drug spread, each image was first converted to black and white and 
the threshold was adjusted to 194 and 250.  These adjustments in color were consistently 
applied to each image to ensure accurate comparability. The area of drug spread, indicated 
by the darkest area in the photo was then outlined and calculated by ImageJ (Figure 5.4). 
Based on this method, it was determined that the drug encompassed an area of 
approximately 0.57 ± 0.08 mm2 (average ± SEM). Since the area of the CeA is 
approximately 1 mm2 at its largest and most developed point, these data suggest that the 
drug did not spread to neighboring structures and was well maintained in the CeA. 
  
5.2.3 Cardiovascular Measurements 
 This section gives specific details on the acquisition and calculation of 
cardiovascular data obtained from rats with implanted HDS-11FO transmitters. All 
cardiovascular data were generated using Ponemah version 6.3 acquisition and analysis 
software (Data Sciences International, St. Paul, MN). 
 
Determination of HRV. In order to determine long term shifts in HRV, cardiovascular 
data were obtained for the first 5 minutes of every hour. This persistent monitoring began 
at the start of the light cycle (7 am) 48 hours prior to the first social defeat or control 
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exposure. This 48-hour period was used to determine the baseline resting blood pressure 
and HR during both the dark and the light cycle for each individual rat. These hourly 
cardiovascular recordings were continued throughout the 5-day social defeat or control 
exposure period and ended on day 8 of the study (3 days after the final social defeat or 
control exposure, see Figure 5.2).  Ponemah is designed to conduct frequency analysis of 
HRV. Frequency analysis has long been used as a tool to measure HRV as this particular 
method of calculation provides a more precise assessment of autonomic function (Ori et 
al., 1992). There are three major components to frequency analysis of HRV: high frequency 
(HF) domain, low frequency (LF) domain, and the LF:HF ratio. In general it is thought that 
the HF is indicative of vagal parasympathetic activity while the LF domain is a nonspecific 
index of sympathetic activity (Ori et al., 1992). Therefore, the LF:HF ratio is an estimate 
of sympatho-vagal balance (Ori et al., 1992). In order to conduct these analyses, all 
acquired ECG data were separated into 1 minute and 40 second bins. Fast Fourier 
transformation of these segments was conducted within the Ponemah program and spectral 
power was quantified with frequency bands of 0.04 to 1.0 Hz corresponding to the LF 
domain while bands of 1.00 to 3.00 Hz corresponded to the HF domain in accordance with 
previously published work (Kuwahara et al., 1994; Wood et al., 2012; Carnevali et al., 
2013; Finnell et al., 2018). 
 
During Defeat.  The major benefit of using the HDS-11F0 transmitters is that it allows for 
the collection of blood pressure and HR in awake freely moving animals. The only 
requirement is that the animals are on the corresponding receiver. Therefore, it is possible 
to detect cardiovascular measures during a variety of behavioral assays and challenges 
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including social defeat. Our group has previously shown that stress-induced cardiovascular 
responses differ greatly between behaviorally susceptible and resilient rats (Wood et al., 
2012; Finnell et al., 2018). To determine the effects of stress and drug treatment on blood 
pressure and heart rate, cardiovascular recordings were obtained on day 1 and day 5 of 
social defeat or control exposure. These recordings were obtained in 1-minute segments 
for 1 hour prior to any drug or stress manipulation (baseline), 30 minutes post drug or 
vehicle infusion, and during the 30-minute social defeat or control period. Mean arterial 
pressure (MAP) and HR for each rat were subsequently calculated as a change from 
baseline.  
 
Arrhythmia Analyses. In addition to providing accurate blood pressure and HR 
measurements, the HDS-11F0 transmitters generate blood pressure and ECG traces. These 
two waveforms can be viewed simultaneously providing a beat by beat record of 
cardiovascular events. One important aspect of these ECG and blood pressure traces is that 
it allows for the identification and verification of arrhythmic events. Notably, previous 
work from our group has shown that stress produces differential effects on arrhythmic 
events in susceptible and resilient rats during the stress challenge (Finnell et al., 2018). 
Based on the suggestion that the CeA may promote a number of cardiovascular 
abnormalities including the generation of arrhythmias (Markgraf and Kapp, 1988; 
Markgraf and Kapp, 1991), the current study utilized the ECG and blood pressure traces 
obtained during days 1 and 5 to analyze the emergence of arrhythmias using he Lambeth 
Convention (Walker et al., 1988; Curtis et al., 2013). Based on these well established and 
widely used methods, continuous cardiovascular traces during baseline, post-injection, and 
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defeat for day 1 and day 5 were visually examined for disturbances in blood pressure. When 
a disturbance was identified, the ECG trace was evaluated to determine whether the 
identified blood pressure disturbance corresponded to a true arrhythmic event.  
During the analysis, several different types of arrhythmias were noted. Premature 
ventricular contractions (PVCs) were by far the most common type of arrhythmic event. 
PVCs occur as a result of a spontaneous contraction of the ventricles which is evidenced 
by the presence of a sporadic QRS wave following a normal sinus beat in the ECG trace. 
Although these arrhythmias are generally benign, individuals with high PVC burden are at 
a greater risk for developing cardiomyopathy (Cantillon, 2013). Another class of 
ventricular arrhythmia commonly detected in the cardiovascular traces obtained in this 
study were bigeminies. Bigeminal arrhythmias can occur due to sporadic ventricular 
contractions or result from failures in impulse generation or conduction (Wing and Phibbs, 
1977). In general, bigeminal rhythms look like repeating heart beats with one long and one 
short beat occurring in close temporal proximity. Unlike PVCs, bigeminal rhythms are 
more likely to result in cardiac mortality including the emergence of sudden cardiac arrest 
(Lerma and Glass, 2016).  
In addition to quantifying the number of each arrhythmia that occurred during 
baseline, post-injections, and during defeat/control exposure on day 1 and 5, arrhythmic 
burden was calculated. Arrhythmic burden can most easily be conceptualized as a 
nonspecific index of arrhythmic risk. Using the conventions described by Khoo et al. (Khoo 
et al., 2006), arrhythmias were assigned point values as outlined in Table 5.1. These point 
values are indicative of the overall risk of developing subsequent cardiovascular 
disfunction and mortality. Therefore, the total arrhythmic burden represents the sum of 
 
130 
weighted PVCs and bigeminial occurrences during each phase of exposure on day 1 and 
day 5. 
 
5.2.4 Elevated Plus Maze (EPM) 
 The EPM is a widely used behavioral assay for anxiety-like responses. Since the 
first description of this model in 1984 by Handley et al (Handley and Mithani, 1984), over 
7000 publications have utilized this method for the determination of anxiety-like responses 
in rodents. Unlike other behavioral assays for anxiety-like responses that require exposure 
to a noxious stimuli, the EPM capitalizes on a rodents natural tendency to prefer dark 
enclosed spaces and avoidance of exposed open spaces (Barnett, 2017). Notably, this 
particular behavioral method has been shown to have high face, construct, and predictive 
validity which explains the widespread use of this model (Walf and Frye, 2007). For the 
purpose of this study, rats were exposed to the EPM for a total of 5 minutes. Rats were 
placed into the center of the plus shaped maze facing an open arm. Behavioral responses 
during this 5-minute exposure were video recorded for later analysis. The plus maze was 
cleaned between animals using 5% ammonium hydroxide solution to remove any latent 
odors from the previous animal.   
 Behavioral analysis was conducted with the use of ANY-maze (Stoelting Co.; 
Wood Dale, IL). A new protocol was created to quantify entries into the open and closed 
arms. Instead of using the center point of the animal to designate entries or exits, the 
detection settings were modified to quantify the entire animal. An entry was scored when 
60% of the animal was present within a specific zone (open arm N, open arm S, closed arm 
E, closed arm W, center). This particular measure was chosen as rats in the current study 
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would often stretch across a number of zones to investigate an open arm. By using the 
whole animal and setting the threshold to 60%, these inspections were not included as arm 
entries. All EPM data were analyzed using the same protocol to ensure cohesiveness 
between animal sets. In order to assess anxiety-like states, the ratio of open to closed arm 
time was calculated in accordance with other published work (Handley and Mithani, 1984; 
Walf and Frye, 2007).  
 
5.2.5 Tissue Homogenization 
 CeA punches collected in the molecular study were homogenized according to the 
protocol outlined in Chapter 2 with one exception. In order to measure TrkB, homogenates 
needed to be separated into membrane and cytosolic fractions. In order to accomplish this, 
lysates were transferred to a clean fresh tube immediately following physical disruption 
with the bullet blender. Bead free samples were then centrifuged at 14000 rcf and 4oC for 
15 minutes. The resulting supernatant (cytosolic fraction) was transferred to a clean labeled 
tube and stored at -80oC for future analysis. The pelleted membrane fraction was 
resuspended using cold phosphobuffered saline and stored at -80oC. Additional 
information regarding lysis buffer preparation can be found in Chapter 2.  
 
5.2.6 Bio-Plex 
 Chapters 3 and 4 clearly showed the utility of Bio-Plex analyses to simultaneously 
detect and quantify data for a number of cytokines from a single sample. This particular 
study was not aimed at detecting cytokines. However, based on the popularity of this 
method Bio-Rad has expanded upon this technique and now has kits available to study a 
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number of cellular signaling targets. The current study utilized this method to quantify 
phosphorylated and total Akt, CREB, ERK 1/2, and MAPK in CeA samples obtained in 
the molecular study (4 hours after the final social defeat or control exposure). All data 
reported in this chapter were ultimately calculated as the ratio of phosphorylated to total 
protein for each target.  
Detection of phosphorylated TrkB signaling effectors. Similar to the initial cytokine 
Bio-Plex, this study was the first to utilize this particular method to quantify 
phosphorylated TrkB signaling effectors in brain homogenates. Therefore, a pilot study 
was run to determine the amount of protein that needed to be loaded onto the plate. Pilot 
tissue collected at the same 4-hour time point following social defeat were loaded onto the 
Bio-Plex plate at with a final concentration of 20, 50, 100, 200, 275, 500, 750, 1000, 1250, 
and 1500 µg/mL. In general, the protocol for the molecular Bio-Plex was extremely similar 
to that of the cytokine Bio-Plex with the exception that the protocol spans over two days. 
Day 1 consisted of bead, sample, and control preparation. The samples were then allowed 
to incubate at room temperature overnight on a plate shaker set to 400 rpm. Antibodies and 
the fluorescent tag were then added during day 2 of the assay in an identical manner to that 
of the cytokine Bio-Plex (Chapter 2). The plate was read using the same Bio-Rad Luminex 
system to determine the fluorescence associated with each bead. The resulting data were 
graphed against the log transform of the protein concentration loaded and the resulting 
curves were analyzed for the EC50.  The EC50 represents the concentration of a drug or a 
compound that produces half of the maximal response. Based on these analyses the EC50 
values varied between targets (Figure 5.5 A-C). Based on these curves it was decided that 
a protein concentration of 700 µg/mL, equivalent to 35µg of protein, would be used on the 
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Phospho-Plex kits as this allowed for the visualization of relative increases and decreases 
for each target.  
 
Detection of total TrkB signaling effectors. Similar to the Phospho-Plex, a pilot study 
was conducted to determine the ideal amount of protein to be utilized for the detection of 
total Akt, CREB, ERK 1/2, and MAPK. The pilot study was run nearly identically to that 
described in the Phospho-Plex section with exception that protein concentration ranged 
from 20, 50, 100, 200, 275, to 500 µg/mL. As with the Phospho-Plex, EC50 values varied 
between targets (Figure 5.5 D-F). Ultimately it was decided that 200 µg/mL, equivalent to 
10 µg of protein, would be ideal to visualize relative increases and decreases of each target.  
 
5.2.7 Western Blot Analysis 
 Western blot analyses were conducted in this study to determine the concentration 
of BDNF, phosphorylated, and total TrkB in CeA homogenates collected 4 hours after the 
final social defeat or control exposure. Western blot is a widely utilized method for 
detecting and visualizing specific proteins of interest. Briefly, samples containing 1x b-
mercaptoethanol with a loading buffer are heated to 75oC for 5 minutes. This results in a 
denaturization or linearization of the protein within the sample and also induces a negative 
charge on the protein. The samples are then carefully loaded onto a polyacrylamide gel 
containing sodium dodecyl sulfate. An electrical current is then passed through the gel. 
This electrical current interacts with the negatively charged protein and induces protein 
migration down the gel. Smaller proteins tend to move faster as they can more easily pass 
through the pores of the gel. As a result, proteins with larger molecular weights will remain 
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closer to the top, while smaller proteins will be closer to the bottom of the gel. Once the 
proteins have been separated by size, they are subsequently transferred to a membrane. The 
current study utilized a polyvinylidene difluoride (PVDF) membrane. Similar to the gels, 
these membranes contain pores. In order to open the pores of the membrane it is first soaked 
in methanol. The gel and membrane are then placed into a transfer cassette. Similar to the 
separation of the proteins within the sample, an electrical current is sent through the 
cassette. In this case the negative current propels the negatively charged protein to move 
forward into the membrane. Once the protein has transferred, the membrane can then be 
probed with a number of antibodies to determine the presence and relative concentration 
of specific protein targets. 
 As stated earlier, the current study utilized this method to determine the presence 
and relative concentration of BDNF, phosphorylated, and total TrkB. In order to achieve 
this, individual western blots were conducted. For the detection of BDNF, 20 µg of CeA 
cytosolic fractions were loaded onto the gel. After transfer, membranes were incubated 
overnight at 4oC with primary antibodies consisting of rabbit anti-BDNF (1:1000; EMD 
Millipore; Burlington, MA) and mouse anti-GAPDH (1:1000; Abcam; Cambridge, UK). 
The following morning, the primary antibodies were removed and the membranes were 
thoroughly washed. Fluorescent secondary antibodies were then applied to the membrane 
(goat anti-rabbit 680, goat anti-mouse, 800; Li-Cor Biosciences, Lincoln, NE) at a 
concentration of 1:15000 and allowed to incubate at room temperature for 1 hour. The 
secondary antibody was then removed, the membranes were washed a final time, and then 
immediately imaged using a Li-Cor Odyssey Imaging system. Detection of phosphorylated 
and total TrkB was nearly identical. For these analyses 20 µg of collected CeA membrane 
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fractions were utilized. pTrkB was detected using rabbit anti-pTrkB (1:500; Abcam, 
Cambridge, UK) and mouse b-arrestin (1:5000; Fisher Scientific; Waltham, MA). Total 
TrkB was detected using rabbit anti-TrkB (1:1000; Abcam; Cambridge, UK) and mouse 
b-arrestin (1:5000; Fisher Scientific; Waltham, MA). 
 
5.3 Results 
5.3.1 Behavioral and cort responses during ferret odor accurately predict coping 
responses during defeat 
 Exposure to ferret odor activates stress sensitive brain regions such as the CeA 
(Butler et al., 2011). Recent data from our lab suggests that the behavioral and 
cardiovascular responses to ferret odor can be predictive of subsequent susceptibility or 
resiliency to social defeat stress (unpublished data). Specifically, these data suggest that 
high freezing and cort plasma levels in response to ferret odor are associated with the 
passive coping susceptible phenotype exhibited during social defeat. In contrast, low 
freezing and low cort were associated with the active coping resilient phenotype. Based on 
these unpublished findings this study utilized a ferret odor test to predict behavioral 
responses to social defeat, resulting in an even distribution of passive and active coping 
rats in each defeat-treatment group. In line with our previous findings, rats were separated 
into “low” and “high” responders using freezing behaviors across the 1st 5 minutes and 
plasma cort concentrations collected 30 minutes after exposure. As expected plasma cort 
concentrations between these two groups were significantly different (t(46)=4.1, p<0.001) 
with high responders exhibiting approximately twice the amount of cort compared to low 
responders (Figure 5.6A). Comparisons of cumulative freezing behaviors across the 1st 5 
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minutes did indicate an effect of time (F(4, 245)=16.6, p<0.0002; Figure 5.6B). While an 
effect of grouping did not reach statistical significance (F(1,245)=2.2, p = 0.1; Figure 5.6B), 
the graph clearly shows that freezing behaviors in high and low responder rats begin to 
diverge starting at the 3rd minute of exposure. These data agree with our previous findings 
that also determined that individual differences in freezing behaviors could first be 
visualized at this particular time point. It is important to note that the selected 30-minute 
time point for cort analysis does not reflect peak cort concentrations (Dorey et al., 2012; 
Gong et al., 2015). Therefore, these data do not assess differences in maximal release but 
rather serve as an assessment of general physiological reactivity. 
 The accuracy of high and low responder classifications using ferret odor was 
confirmed by evaluating the behavioral responses during social defeat. Average defeat 
latencies for each rat were calculated across the 5-day social defeat period. Rats classified 
as low responders during ferret odor demonstrated longer defeat latencies compared with 
rats designated as high responders (average defeat latency ± SEM (s); low responder: 338.6 
± 48.4; high responder: 170.0 ± 28.4; t(8)=2.8, p<0.05). According to our previously 
published work (Wood et al., 2013; Wood et al., 2015; Finnell et al., 2017b), these defeat 
latencies in low and high responders are indicative of active and passive coping 
phenotypes, respectively. Based upon this behavioral verification, low and high responder 
groups for the remainder of the publication are classified as active and passive coping.     
 
5.3.2 Stress-induced alterations of TrkB signaling 
 Prior to starting the extensive cardiovascular and behavioral study it was critical to 
verify (1) that social defeat enhanced the phosphorylation of TrkB and its downstream 
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signaling effectors and (2) that ANA-12 inhibited these effects. Analysis of phosphorylated 
TrkB indicated a significant stress by treatment interaction (F(2, 19)=4.5, p<0.05; Figure 
5.7A, B). Strikingly, exposure to social defeat in vehicle-treated passive coping rats 
resulted in a nearly 3-fold increase in phosphorylated TrkB within the CeA compared with 
vehicle-treated control and active coping rats (Figure 5.7A). As expected, treatment with 
ANA-12 inhibited this defeat-induced enhancement of TrkB phosphorylation in passive 
coping rats (Figure 5.7A). Importantly, these effects were not due to differences in total 
TrkB protein levels (Effect of Stress: F(2, 15)=0.5, p=0.6; Effect of Treatment: F(1, 15)=0.2; 
p=0.7; Table 5.2). These notable effects in phosphorylated TrkB functioned to verify the 
effectiveness of social defeat in the activation of this particular receptor and confirmed that 
ANA-12 infusion could inhibit these processes. However, it remained unclear which 
signaling cascades were coupled with this defeat-induced phosphorylation.  
In order to address this question, signaling Bio-Plex kits were utilized to probe for 
both phosphorylated and total Akt, CREB, ERK 1/2, and MAPK. Interestingly, TrkB 
signaling effectors were differentially affected by coping during defeat and treatment. 
Surprisingly, repeated ANA-12 treatment selectively and robustly increased the ratio of 
phosphorylated to total Akt in non-stress controls (Stress x Treatment Interaction: F(2, 
24)=5.0, p<0.05; Figure 5.7B), while there was no effect of social defeat. Repeated stress 
exposure in vehicle-treated rats did, on the other hand, result in an enhancement in 
phosphorylated MAPK (Effect of Stress: F(2, 25)=4.1, p<0.05; Figure 5.7C) and ERK1/2 
(Effect of Stress: F(2, 27)=3.7, p<0.05; Figure 5.7D). Notably, these effects were most 
pronounced in passive coping rats predicted to display susceptibility to the behavioral and 
physiological effects of stress. Although statistical analysis was unable to identify an 
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overall effect of ANA-12 treatment, there were no statistical differences in phosphorylated 
MAPK and ERK1/2 between ANA-12 treated groups (p³0.09). Similarly, statistical 
analysis was unable to identify treatment (F(1, 27)=0.9, p=0.3) or stress effects (F(2, 27)=2.1, 
p=0.1) in phosphorylated CREB at this timepoint (data not shown) However, these data 
largely mirror findings in phosphorylated MAPK and ERK1/2 with passive coping vehicle-
treated rats displaying trends towards greater ratios of phosphorylated versus total CREB. 
Notably, these effects were not associated with differences in BDNF at this specific time 
point (Effect of Stress: F(2, 22)=0.1, p=0.9; Effect of Treatment: F(1, 22)=0.3, p=0.6; Table 
5.2). Taken together, these data suggest that coping during social defeat is associated with 
differences in CeA TrkB signaling. Moreover, based on the extended timepoint at which 
these data were collected (4 hours after the final infusion), these findings further suggest 
that CeA TrkB signaling in passive coping rats is likely dysregulated. Based on the reported 
contribution of CeA TrkB signaling through MAPK/ERK in the emergence of depressive- 
and anxiety-like phenotypes, it is plausible that this signaling cascade may underlie 
susceptibility to the behavioral and physiological consequences of stress in passive coping 
rats. This question was directly probed in the subsequent sections that outline findings from 
the behavior and cardio study (Figure 5.2).  
 
5.3.4 CeA TrkB signaling is critical for the emergence of active coping phenotypes 
during defeat 
To further characterize the effects of CeA TrkB signaling on social defeat behavior, 
average defeat latencies and upright postures during defeat were quantified for rats in the 
behavioral and cardiovascular study. These rats were grouped into passive and active 
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coping prior to social defeat exposure based on their responsiveness during ferret odor as 
described. As expected, vehicle-treated rats that were predicted to exhibit active coping 
behaviors demonstrated significantly greater defeat latencies compared with vehicle-
treated rats predicted to be passive coping (Treatment x Group Interaction: F(2, 24)=7.4, 
p<0.05; Figure 5.8A). Surprisingly, treatment with ANA-12 significantly reduced defeat 
latencies in rats predicted to exhibit active coping (Figure 5.8A). These data suggest that 
inhibition of CeA TrkB signaling promotes submissive behaviors in rats otherwise 
predicted to be resilient. Similar effects were also demonstrated with regard to defensive 
upright postures.  
Analysis of upright posture on day 1, another behavior exhibited by the active 
coping phenotype (Wood et al., 2010), indicated a significant interaction between coping 
groups and treatment (Treatment x Coping interaction: F(1, 14)=6.3, p<0.05) such that 
vehicle-treated active coping rats exhibited a greater amount of time in upright postures 
compared with vehicle-treated passive coping rats and ANA-12 treated rats of both 
groupings (Figure 5.8B). Upright posture on day 5 of social defeat demonstrated similar 
trends with vehicle-treated active coping rats exhibiting the greatest duration of upright 
posture during defeat compared with vehicle-treated passive coping rats (Effect of Group: 
F(1, 12)=5.1, p<0.05; Figure 5.8C). Similar trends were evident on day 5 in ANA-12 treated 
rats. However, these effects did not reach statistical significance (Effect of Treatment: F(1, 
12)=0.3, p<0.06; Figure 5.8C). Similar to defeat latency, upright postures on day 1 and 5 
in vehicle-treated active and passive coping rats are in line with our previous publications 
(Wood et al., 2013; Wood et al., 2015; Finnell et al., 2017b) further verifying the 
effectiveness of ferret odor exposure as a method for prescreening coping responses during 
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defeat. Importantly, findings in ANA-12 treated rats indicate that CeA TrkB signaling 
seems to be crucial in the expression of active coping behaviors as these rats exhibited 
enhanced submissive behaviors and reduced defensive postures.  
 
5.3.5 Coping and ANA-12 differentially affect stress evoked blood pressure and HR  
Day 1 (acute response to novel social stress). After baseline resting cardiovascular data 
was collected, cardiovascular responses during day 1 began with the determination of post-
injection MAP and HR across all stress and treatment groups. Notably, there were no 
differences in MAP (Effect of stress: F(2, 30)=0.02, p=1.0; Effect of Treatment: F(1, 30)=0.33, 
p=0.6) or HR (Effect of stress: F(2, 31)=0.6, p = 0.6; Effect of Treatment: F(1, 31)=0.1, p=0.8) 
between stress and treatment groups during the 30 minute post-infusion period (Table 5.3). 
Notably, there were significant effects of coping and treatment on MAP and HR during the 
first social defeat or control exposure (Figure 5.9). Specifically, vehicle-treated active 
coping rats exhibited significantly enhanced stress evoked MAP above that of controls and 
passive coping rats (Effect of Stress: F(2, 496)=70.1, p<0.0001; Figure 5.9A). Interestingly, 
treatment with ANA-12 produced differential effects on MAP depending on stress and 
coping condition. In controls, ANA-12 did not alter MAP (Effect of Treatment: F(1, 354)=0.4, 
p=0.5; Figure 5.9B) and only modestly reduced defeat-induced MAP in active coping rats 
(Effect of Treatment: F(1, 287)=1.9, p=0.2; Figure 5.9C). In striking contrast, ANA-12 
treatment in passive coping rats robustly enhanced defeat-induced pressor responses during 
the social defeat exposure on day 1 (Effect of Treatment: F(1, 255)=40.3, p<0.0001; Figure 
5.9D). The initial social defeat exposure also produced significant enhancement in HR in 
both vehicle-treated active and passive coping rats above that of controls (Effect of Stress: 
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F(2, 430)=57.6, p<0.0001; Figure 5.9E). ANA-12 also produced robust, yet distinct effects 
on heart rate. Specifically, tachycardic responses were largely blunted in controls (Effect 
of Treatment: F(1, 375)=4.0, p<0.05; Figure 5.9F) and active coping rats (Effect of Treatment; 
F(1, 256)=78.9, p<0.0001; Figure 5.9G) treated with ANA-12. Notably, defeat-induced HR 
on day 1 was unaffected by ANA-12 treatment in passive coping rats (Effect of Treatment: 
F(1, 202)=1.9, p=0.2; Figure 5.9H). These data not only highlight differences in 
cardiovascular reactivity of passive and active coping rats to the pressor and tachycardic 
responses to defeat, but for the first time suggest that CeA TrkB signaling may be 
intricately involved in these responses.  
 
Day 5 (acute response to repeated social defeat stress). First, it was established that 
MAP did not differ between stress (Effect of Stress: F(2, 31)=1.8, p=0.2) and treatment 
(Effect of Treatment: F(1,31)=0.7; p=0.4) during the 30-minute post-infusion period (Table 
5.3). However, there was a significant stress by treatment interaction (F(2,31)=3.9, p<0.05) 
in tachycardic responses to the infusion such that ANA-12 treated passive and active 
coping rats demonstrated greater HR during the 30-minute post-infusion period compared 
to vehicle-treated passive and ANA-12 treated control rats (Table 5.3).  
The hemodynamic response to stress, on the other hand, was maintained similar to 
day 1 upon the 5th exposure to social defeat as indicated by the robust pressor response to 
social stress in both passive and active coping groups treated with vehicle (Figure 5.10A). 
Notably, these pressor responses in vehicle-treated passive coping rats exhibited enhanced 
sensitivity to the pressor-inducing effects of social defeat during the 5th exposure. In 
contrast, ANA-12 treatment did not alter MAP in non-stress control (Effect of Treatment: 
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F(1, 350)=0.04; p=0.9; Figure 5.10B) and active coping rats (Effect of Treatment: F(1, 
299)=0.7, p=0.4; Figure 5.10C) while moderately enhancing MAP upon the start of stress 
in passive coping rats (Effect of Treatment: F(1, 222)=5.5, p<0.05; Figure 5.10D).  
 Notably, tachycardic responses to social defeat followed similar trends. In vehicle-
treated rats, social defeat enhanced HR to a comparable extent in passive and active coping 
rats (Effect of Stress: F(2, 468)=53.0, p<0.0001; Figure 5.10E). ANA-12 treatment in non-
stress controls functioned to reduce HR (Effect of Treatment: F(1, 359)=22.3, p<0.0001; 
Figure 5.10F). In contrast, ANA-12 treatment in active (Effect of Treatment: F(1, 251)=15.8, 
p<0.0001; Figure 5.10G) and passive coping rats (Effect of Treatment: F(1, 224)=46.3, 
p<0.0001; Figure 5.10H) functioned to enhance tachycardic responses. These HR data 
suggest that repeated inhibition of CeA TrkB signaling via ANA-12 may enhance 
cardiovascular reactivity to stress exposure. However, findings in MAP suggest that these 
effects are isolated to HR and may be associated with differential activation of CeA 
microcircuits in active and passive coping rats.  
 
5.3.6 ANA-12 treatment completely inhibits social defeat-induced arrhythmias  
 Based on the intriguing effects of ANA-12 treatment and social defeat on MAP and 
HR, it was hypothesized that ANA-12 may also impact the emergence of social defeat 
evoked arrhythmias. Blood pressure and ECG waveforms during the baseline, post-
injection, and defeat periods of each day were evaluated for the presence of PVCs and 
Bigeminal beats. Example wave forms of normal sinus rhythms, PVCs, and bigeminal 
beats are provided in Figure 5.11A-C. Interestingly, arrhythmic burden during defeat on 
day 1 was significantly enhanced by social defeat exposure (F(2,17)=3.9, p<0.05; Figure 
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5.11D). Post-hoc analyses indicated that these effects were strongest in vehicle-treated 
active coping rats. Notably, these effects were largely driven by the emergence of PVCs 
(Figure 5.11E) as there were virtually no bigeminal beats detected during defeat on day 1 
(Effect of Stress: F(2,19)=1.1, p=0.4; Figure 5.11F). However, effects in stress-induced 
PVCs were not strong enough to reach statistical significance (Effect of Stress: F(2,19)=2.3, 
p=0.1). Arrhythmias on day 1 were largely unaffected by ANA-12 treatment (Arrhythmic 
burden Effect of Treatment: F(1,17)=0.0006; p=1.0; PVCs Effect of Treatment: F(1,16)=0.1, 
p=0.7; Bigeminal beats Effect of Treatment: F(1,19)=0.3, p=0.6).  
 While arrhythmic effects during day 1 were relatively nominal, arrhythmic events 
during the 5th social defeat exposure were significantly more robust. Analysis of arrhythmic 
burden revealed a striking stress by treatment interaction (F(2,16)=5.2, p<0.05) such that 
social defeat in vehicle-treated passive coping rats exhibited significantly greater 
arrhythmic burden during defeat on day 5 compared with all other stress and treatment 
groups (Figure 5.11G). This enhancement of arrhythmic burden in vehicle-treated rats was 
associated with an increase in PVCs (Effect of Stress: F(2,15)=3.4, p=0.06; Figure 5.11H) 
and bigeminal beats (Effect of Stress: F(2, 17)=5.7, p<0.05; Figure 5.11I). In line with 
arrhythmic burden, these effects were strongest in vehicle-treated passive coping rats 
indicating greater cardiovascular reactivity to social defeat. Notably, inhibition of CeA 
TrkB signaling with ANA-12 completely inhibited these effects in both active and passive 
coping rats (PVCs Effect of Treatment: F(1,15)=8.6, p<0.05; Bigeminal beats Effect of 
Treatment: F(1,17)=6.8, p<0.05). Importantly, arrhythmic burden during baseline and post-
injection did not differ between stress or treatment groups on either day 1 (Baseline Effect 
of Stress: F(2, 20)=1.0, p=0.3; Baseline Effect of Treatment: F(1, 20)=0.8, p=0.4; Post-injection 
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Effect of Stress: F(2, 19)=0.1, p=0.7; Post-injection Effect of Treatment: F(1, 19)=0.4, p=0.5; 
data not shown) or day 5 (Baseline Effect of Stress: F(2, 29)=0.3, p=0.5; Baseline Effect of 
Treatment: F(1, 29)=0.0, p=0.8; Post-injection Effect of Stress: F(2, 19)=0.3, p=0.6; Post-
injection Effect of Treatment: F(1, 19)=0.9, p=0.3; data not shown). Taken together, these 
data suggest that repeated exposure to social defeat results in an overall enhancement of 
arrhythmic events that are directly associated with the coping behaviors adopted during 
stress. Findings that arrhythmic events at baseline and post-injection do not differ between 
groups, suggests that these effects are explicitly driven by social defeat exposure and do 
not result from baseline increases in arrhythmic events. Moreover, these arrhythmogenic 
effects of social defeat were completely blocked by ANA-12 treatment suggesting that CeA 
TrkB signaling is integral to these effects.  
 
5.3.7 Quantification and evaluation of depressive- and anxiety-like behaviors 
 In order to evaluate depressive- and anxiety-like behaviors, the current study 
employed the use of a sucrose preference test and EPM. Findings from these assays 
suggested that stress and ANA-12 treatment differentially contribute to the development 
of depressive- and anxiety-like behaviors following the cessation of social defeat. 
Specifically, inhibition of CeA TrkB signaling via ANA-12 inhibited the emergence of a 
depressive-like phenotype in active and passive coping rats (Effect of Treatment: F(1, 
35)=11.1, p<0.01; Figure 5.12A). These depressive-like effects were strongest in the 1
st hour 
of sucrose preference. Although, these effects dissipated by the 3rd hour, data collected at 
this time did suggest that there was still a trend for treatment (Effect of Treatment: F(1, 
35)=3.4, p=0.07) with passive coping rats exhibiting an overall reduction in sucrose 
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consumption (average percent sucrose consumed ± SEM; vehicle control 92 ± 1.9; vehicle 
active coping 92.2 ± 1.8; vehicle passive coping 85.8 ± 5.0). Importantly, these effects did 
not result from differences in the total volume consumed (Effect of Stress: F(2, 49)=0.7, 
p=0.5; Effect of Treatment: F(1, 49)=0.9; data not shown). 
 The current study evaluated open and closed arm time (raw and the ratio) as well 
as the percentage of open arm entries in order to determine the emergence of anxiety-like 
behaviors. Analysis of open arm time confirmed that exposure to stress produced anxiety-
like behavioral phenotypes (Effect of Stress: F(2, 32)=3.6, p<0.05; Figure 5.12B).  Although 
variable, these data suggest that anxiety-like behaviors following social defat are enhanced 
in passive coping rats. Treatment with ANA-12 did not protect against the development of 
anxiety-like behaviors (Effect of Treatment: F(1, 32)=0.9, p=0.3). Interestingly, data 
evaluating the percentage of open arm entries suggested that ANA-12 may have increased 
the anxiety-like behavioral effects of social defeat (Effect of Treatment: F(1, 30) = 3.9, 
p=0.06; Figure 5.12C). In contrast to these two measures, there were no differences in the 
duration spent in the closed arm of the EPM (Effect of Stress: F(2, 33)=1.3, p=0.3; Effect of 
Treatment: F(1,33)=0.7; Figure 5.12D). Instead, there was a significant stress by treatment 
interaction for time spent in the center of the maze (F(2,31)=3.8, p<0.05). Although it is 
currently unclear what these data mean in the scope of anxiety-like behaviors, passive 
coping vehicle-treated rats spent greater durations in the center of the maze compared with 
all other stress and treatment groups (Average time in center ± SEM (s); vehicle control 
19.5 ± 4.0; vehicle active coping 21.0 ± 4.0; vehicle passive coping 30.5 ± 8.5; ANA-12 
control 28.5 ± 3.4; ANA-12 active coping 19.9 ± 7.9; ANA-12 passive coping 9.5 ± 2.3). 
Importantly, there were no differences in distance traveled between stress (F(2, 34)=2.9, 
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p=0.1) and treatment groups (F(1, 34)=0.03; p=0.9; data not shown), suggesting that these 
effects are not due to reduced locomotor activity.  
 
5.3.8 12-hour dark cycle HRV 
 To evaluate if social defeat and ANA-12 produced overall disruptions in 
cardiovascular health, resting dark cycle blood pressure, HR, and HRV were measured 
throughout the 5-day social defeat period and for 3 days after the final social defeat 
exposure. HRV in terms of LF, HF, and LF/HF ratio across the 8 days of social defeat did 
not differ greatly between stress and treatment groups (Table 5.4).  
 
5.4 Discussion 
The CeA has been extensively studied over the past 6 decades. The comprehensive 
literature generated over this prolonged period of time has suggested that the CeA functions 
as an integrative hub to coordinate a number of behavioral and physiological responses 
during stress and fear (Ressler, 2010). These effects are attributed to CeA neuromodulation 
of a number of brain regions including the periaqueductal gray (Rizvi et al., 1991), dorsal 
motor nucleus of the vagus (Gray and Magnuson, 1987), hypothalamus (Cassell et al., 
1986; Gray et al., 1989; Callahan et al., 2013), locus coeruleus (McCall et al., 2015), 
nucleus tractus solitarius (Saha, 2005), and rostral ventrolateral medulla (Saha, 2005). 
Although CeA neurons are primarily inhibitory GABAergic, several studies have 
determined that a significant population CeA projection neurons also express corticotropin-
releasing factor (CRF) and enkephalin (Cassell et al., 1986; Gray and Magnuson, 1992). 
Mounting evidence has suggested that stress indiscriminately enhances the activation of 
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CeA neuronal populations (Takahashi et al., 2011; Fang et al., 2018) likely resulting in a 
concomitant release of GABA, CRF, and enkephalin. In this way the CeA can 
simultaneously facilitate and impede neuronal activation in specific projection regions 
resulting in the induction of complex behaviors and physiological responses. Although the 
current studies did not differentiate between neuronal cell types, findings reported in this 
manuscript indicate that CeA TrkB signaling may be critical in this process. Administration 
of ANA-12 and effective inhibition of TrkB phosphorylation and signaling directly 
inhibited the emergence of upright defensive postures, enhanced submissive tendencies 
during defeat, and protected against the emergence of depressive-like behavior while 
anxiety-like behaviors were largely unaffected.  Similar to the broad behavioral effects, 
ANA-12 treatment functioned to enhance defeat-induced blood pressure and HR while 
simultaneously inhibiting defeat-induced arrhythmias. Importantly, data obtained in the 
current studies suggest that individual differences in stress coping and susceptibility may 
be directly related to differences in stress-induced CeA microcircuitry.  
Several studies have begun to assess whether active/passive phenotypes are indeed 
associated with differences in the activation of CeA microcircuits. For example, a study by 
Reyes et al in 2015 demonstrated that passive coping during social defeat was directly 
associated with enhanced activation of CeA CRF afferents and LC neurons. In contrast, 
rats demonstrating active coping phenotypes did not exhibit this maintained activation 
(Reyes et al., 2015). Similar effects have also been reported with regard to the 
periaqueductal gray (Keay and Bandler, 2001), a brain region involved in behavioral 
freezing responses (Watson et al., 2016). Although the contribution of the CeA in these 
responses remains unclear, it has been documented that the medial and lateral divisions of 
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the CeA distinctly project to this region (Li and Sheets, 2018). Notably, the medial and 
lateral subdivisions of the CeA are the primary sites of CRF containing cells (Cassell et al., 
1986) which have specifically been implicated in discriminative fear responses (Sanford et 
al., 2017) and directly mediate the adoption of defensive active coping behaviors (Fadok 
et al., 2017). Although findings from the current study cannot definitively implicate CeA 
TrkB signaling on CRF projecting neurons, the inhibition of active coping defensive 
behaviors induced by ANA-12 treatment does suggest that these neuronal populations were 
likely affected and are intricately involved in the behavioral responses to social defeat.  
In addition to mediating the behavioral response to stress and fear, the CeA is well 
known to contribute to stress or fear-induced cardiovascular activation via connectivity 
with the nucleus tractus solitarius and rostral ventrolateral medulla (Saha, 2005). In 
general, stimulation studies have determined that CeA activation differentially regulates 
these brain regions resulting in the inhibition of the nucleus tractus solitarius while 
promoting the activation of the rostral ventrolateral medulla (Saha, 2005). By blocking 
bottom-up peripheral parasympathetic feedback and enhancing peripheral sympathetic 
outflow, the combined effects on these two brain areas results in an increase in blood 
pressure and heart rate. While findings from the current study support the involvement of 
these particular circuits in the pressor and tachycardic responses to social defeat on day 1 
and day 5, CeA TrkB signaling in these responses seems to be isolated to passive coping 
rats and further suggests differential activation of CeA microcircuits. 
In contrast, stress-induced CeA TrkB signaling was intricately involved in the 
arrhythmogenic effects of social defeat. The current study indicated that social defeat 
directly increases in the frequency of PVCs and bigeminal rhythms. These effects are likely 
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driven by CeA connectivity with the dorsal motor nucleus of the vagus. Serving as the 
major source of parasympathetic outflow to the periphery, the dorsal motor nucleus of the 
vagus exhibits control over a vast number of physiological systems and processes including 
ventricular excitability (Machhada et al., 2015). In general, it has been demonstrated that 
vagal withdrawal shortens ventricular refractive periods and lowers the threshold for the 
generation of ventricular beats (Machhada et al., 2015). Stress and CRF are both capable 
of inducing vagal withdrawal (Wood and Woods, 2007) allowing for the possibility that 
CeA CRF fibers may directly contribute to these effects. Notably, findings from the current 
study support a role for the CeA TrkB signaling in defeat-induced arrhythmic events as 
ANA-12 infusion directly into the CeA 30 minutes prior to the social defeat challenge 
completely blocked defeat-induced PVCs and bigeminal events.  
Based on the strong effects noted during defeat, it was predicted that ANA-12 
treatment would protect against the emergence of depressive- and anxiety-like responses. 
Surprisingly, analysis of behavior following social defeat indicated that ANA-12 was 
largely ineffective in blocking the emergence of an anxiety-like behavioral phenotype. 
Numerous studies have suggested that the CeA is intricately involved in the emergence of 
anxiety-like behaviors (Swartz et al., 2014; Gilpin et al., 2015; Babaev et al., 2018). 
Anxiety is often thought of as a heightened state of vigilance with a consistent feeling of 
apprehension. However, anxiety can also be thought of as a state of sustained fear. 
Sustained fear describes behavioral and emotional states that are associated with the 
anticipation of an unpredictable or potential threat. In contrast, phasic fear describes 
emotional and behavioral states that are directed at a specific threat. Studies in humans and 
rodents have suggested that these two processes involve distinct yet interrelated neural 
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circuits. Specifically, it has been shown that phasic fear is directly driven by the amygdala 
while sustained fear is driven by the bed nucleus of the stria terminalis (BNST) (Davis et 
al., 2010; Münsterkötter et al., 2015). Although the study in humans was not able to 
implicate specific divisions of the amygdala in these responses (Münsterkötter et al., 2015), 
rodent studies have established that phasic fear is directly associated with activation of the 
CeA (Davis et al., 2010). This differentiation between evoked fear and anxiety-like 
behavioral responses and the distinct involvement of the CeA and BNST in these effects 
has been well supported in the literature (Gafford and Ressler, 2015). Based on these data 
and suggestions it would be interesting to expand upon these findings to determine if 
repeated social defeat exposure and ANA-12 would affect the expression of phasic fear at 
this extended time point. 
The molecular data collected in the current study suggest that stress exposure may 
have resulted in persistent alterations of CeA neuronal function. This assumption is 
supported by analysis of CeA homogenates collected 4 hours after the final drug infusion. 
At this particular time point, rats with a history of social defeat demonstrated significant 
enhancements in phosphorylated TrkB, MAPK, and ERK 1/2. Unexpectedly, ANA-12 
treated controls that demonstrated only modest increases in phosphorylated TrkB exhibited 
significant increases in phosphorylated Akt. As discussed in the introduction, MAPK/ERK 
and Akt are competing signaling pathways (Gervais et al., 2006; Yokoyama et al., 2013) 
that produce vastly different molecular and behavioral effects. Notably, these stress and 
treatment effects were not associated with differences in BDNF at this particular time point. 
It is entirely plausible that a history of social defeat may have altered BDNF release into 
the CeA and that the chosen time point is simply not ideal to visualize these differences. 
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However, studies assessing the effects of BDNF in the CeA are equivocal and are highly 
dependent upon the methods utilized (Pandey et al., 2006; Taylor et al., 2011). However, 
the sustained phosphorylated TrkB, MAPK, and ERK at this extended time point do 
suggest that social defeat may have altered intracellular mechanisms responsible for 
regulating TrkB signaling. Protein tyrosine phosphatases (PTPs) a large family of protein 
phosphatases that function to dephosphorylate and thus inhibit TrkB signaling (Sapieha et 
al., 2005; Gatto et al., 2013). This particular protein family is widely expressed throughout 
the brain (Lorenzetto et al., 2014) and demonstrates sensitivity to stress (Yang et al., 2012; 
Dabrowska et al., 2013). Notably, stress-induced reductions of PTPs are functionally 
associated with enhanced glutamate sensitivity (Dabrowska et al., 2013) and extended 
durations of ERK1/2 activation  (Yang et al., 2012).  In addition to the documented effect 
of stress, inflammation has also been shown to inhibit PTPs (Grinnell et al., 2012; Seo et 
al., 2013; Duan et al., 2014). Several of our previous studies have demonstrated that social 
defeat in males and witness stress in females is associated with a significant enhancement 
of neuroinflammation within the CeA (Finnell et al., 2018; Finnell et al., 2019). Notably, 
these inflammatory profiles were associated with the emergence of cardiovascular 
dysfunction, anxiety- and depressive-like behaviors (Finnell et al., 2018). Based on the 
strong relationship between inflammation and stress-induced behavioral dysfunction, it 
would be intriguing to develop a study to further characterize the relationship between 



















Table 5.1 Arrhythmic burden scoring guide. This table consists of 
the points assigned to each arrhythmia for the calculation of 
arrhythmic burden. 
 
Points Assigned Arrhythmic Beat 
0 Normal Sinsus/Absence of Arrhythmias 
1 Isolated PVC 
2 2 or 3 consecutive PVCs (Salvo) 






Table 5.2 Summary of additional western blot analyses for total TrkB and BDNF and 
comparison of housekeeping proteins used for normalization. Data expressed as an average 
± SEM.  
Primary Targets (normalized signal to appropriate housekeeping proteins) 
Target 
Vehicle ANA-12 Statistical 
Analysis Control Active Passive Control Active Passive 
Total 
TrkB 
















37.5 ±    
5.2 
51.0 ±    
4.3 
49.6 ±    
5.9 
53.9 ±  
13.1 
47.4 ±    
1.9 




















































Table 5.3 MAP and HR during the post-infusion period on day 1 and day 5. Data expressed 
as the average change from baseline ± SEM in mmHg or beats per minute. *p<0.05 vs 
vehicle passive and ANA-12 control. 
Day 1 Statistical 








































































Table 5.4 Social defeat and ANA-12 treatment do not change resting HRV. Data presented 
as the average percent of baseline ± SEM. 
 
Day 1 Vehicle ANA-12 
Control Defeat Control Defeat 
LF 105.4 ± 9.9 99.2 ± 4.5 104.1 ± 6.8 87.9 ± 5.0 
HF 134.7 ± 20.1 111.4 ± 16.1 118.3 ± 19.4 96.0 ± 19.9 
LF:HF 88.4 ± 6.0 98.4 ± 3.7 106.2 ± 4.7 112.1 ± 7.3 
Day 3 
LF 93.8 ± 4.5 103.0 ± 6.0 79.8 ± 6.0 90.0 ± 4.4 
HF 107.6 ± 14.3 114.5 ± 17.1 83.3 ± 15.6 80.6 ± 10.3 
LF:HF 108.1 ± 2.6 106.1 ± 5.3 110.9 ± 11.6 110.3 ± 10.8 
Day 5 
LF 95.6 ± 4.9 103.0 ± 5.9 104.3 ± 4.7 99.2 ± 3.6 
HF 105.9 ± 15.0 117.5 ± 15.6 109.0 ± 19.8 87.0 ± 5.8 
LF:HF 97.9 ± 5.0 106.1 ± 5.3 110.9 ± 11.6 110.3 ± 10.8 
Day 8 
LF 99.7 ± 9.1 106.4 ± 6.1 105.1 ± 5.2 95.1 ± 4.2 
HF 112.5 ± 16.9 105.4 ± 19.1 134.0 ± 36.1 99.2 ± 8.3 








Figure 5.1 Schematic of TrkB signaling cascade. Following BDNF 
binding and TrkB homodimerization and autophosphorylation, three 
distinct signaling cascades are initiated. Notably, MAPK/ERK and 











Figure 5.2. Study design, timeline, and samples sizes of the cell signaling (A) and  














-10 1 2 3 4 5
Cannula
Surgery
Social Defeat/Control Euthanasia 4hrs
post defeat
Molecular Study:






Figure 5.3 ANA-12 dose dependently reduces phosphorylated TrkB without altering total TrkB.  Treatment with ANA-12 
produced dose dependent inhibition of defeat-induced TrkB phosphorylation in the CeA (A). Maximal inhibition was 
demonstrated at the 2.5 µg dose. Analysis using non-linear regression indicated that the IC50 for ANA-12 was approximately 








Figure 5.4 Representative image of the imageJ manipulation utilized to determine ANA-






Figure 5.5 Comparison of phosphorylated and total Bio-Plex cell signaling targets. Side by side comparison of 
phosphorylated Akt (A), ERK (B), and MAPK (C) indicitated a different EC50 value for each of these targets (dotted line). 
Similar effects were also noted for total Akt (D), ERK (E) and MAPK (F).  










































































































































Figure 5.6 Ferret odor-induced plasma Cort concentrations (A) and freezing behaviors (B) 
in low and high responder rats. Following statistical separation, rats classified as “low 
responders” exhibited significantly lower ferret odor-induced plasma Cort concentrations 
compared with high responders. Analysis of freezing behavior indicated behavioral 
responses during ferret odor begin to diverge starting at the 3rd minute of exposure. Similar 
to plasma cort, rats assigned to the low responder group demonstrated lower freezing 










































































Figure 5.7. Social defeat and ANA-12 treatment differentially affect phosphorylation of 
TrkB (A-B), Akt (C), MAPK (D), ERK1/2 (E), and CREB (F). Social defeat in vehicle-
treated rats was associated with a significant enhancement of phosphorylated TrkB in the 
CeA. This was associated with an overall increase in phosphorylated MAPK, ERK1/2, and 
CREB that was exaggerated in rats demonstrating a passive coping phenotype. While 
ANA-12 treatment in socially defeat rats largely blocked these effects, ANA-12 in non-
stress controls was associated with a robust and selective enhancement of Akt. ap<0.05 vs 
all other stress and treatment groups; *p<0.05, **p<0.01 vs vehicle controls; #p<0.05 vs. 









Figure 5.8. ANA-12 treatment inhibits the emergence of an active coping phenotype during social defeat. Vehicle-treated rats 
predicted to exhibit active coping during defeat demonstrated enhanced defeat latencies (A) and greater upright postures on 
day 1 (B) and day 5 of defeat (C) compared to vehicle-treated rats predicted to exhibit passive coping behaviors. Inhibition of 
CeA TrkB with ANA-12 signficantly reduced defeat latency and upright postures on both day 1 and day 5. **p<0.01 vs vehicle 















































































Figure 5.9. Social defeat and ANA-12 treatment differentially affected MAP and HR 
on day 1 of defeat. During the 1st social defeat exposure, vehicle-treated active coping 
rats demonstrated significantly greater MAP compared with both control and passive 
coping groups (A). Treatment with ANA-12 did not alter pressor responses in control 
rats (B) and only modestly reduced these effects in active coping rats (C). In contrast, 
ANA-12 treatment facilitated pressor responses in passive coping rats (D). Unlike 
MAP, HR on day 1 was enhanced to a similar extent in vehicle-treated active and 
passive coping rats (E). While ANA-12 did not alter tachycardic responses in control 
(F) and passive coping groups (H), treatment significantly blunted HR in active coping 
rats (G). ap<0.05 vehicle active coping vs. vehicle control; #p<0.05 vehicle passive 
coping vs. vehicle controls; *p<0.05 vs. stress matched vehicle-treated group 
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Figure 5.10. ANA-12 facilitates pressor and tachycardic responses selectively in 
passive coping rats on day 5 of defeat. The 5th social defeat exposure in vehicle-treated 
rats induced similar enhancements in MAP between passive and active coping rats 
(A). Treatment with ANA-12 did not alter pressor responses in control (B) or active 
coping rats (C) but selectively facilitated pressor responses in passive coping rats (D). 
Similar effects were seen in HR on day 5. Social defeat induced similar tachycardia 
between active and passive coping groups (E). Unlike MAP, HR was significantly 
blunted in ANA-12 treated controls (F) and facilitated in passive coping rats (H). HR 
in ANA-12 treated active coping rats did not change (G).  ap<0.05 vehicle active 
coping vs. vehicle control; #p<0.05 vehicle passive coping vs. vehicle controls; 










































































































































































































Figure 5.11. ANA-12 completely inhibits social defeat-induced arrhythmias. Blood 
pressure (top panel) and ECG traces (bottom panel) were evaluated for normal sinus 
rhythm (A), PVCs (B), and bigeminal beats (C). In response to the 1st social defeat 
exposure, active coping vehicle-treated rats exhibited an enhancement an arrhythmic 
burden (D) that was associated with an increase in PVCs (E). Defeat on day 1 did not 
produce bigeminal beats (F). While arrhythmic events on day 1 were modest, exposure 
on day 5 produced robust enhancement of arrhythmic burden that was significantly 
pronounced in passive coping vehicle-treated rats (G). This increase in arrhythmic 
burden was directly associated with enhancement of defeat-induced PVCs (H) and 
bigeminal beats (I). Notably, treatment with ANA-12 completely inhibited the 
arrhythmogenic effects of stress in active and passive coping rats. *p<0.05, **p<0.01, 
















































































































































Figure 5.12. ANA-12 treatment inhibits the emergence of depressive-like behavior 
but does not affect anxiety-like behaviors following social defeat. Social defeat in 
vehicle-treated passive and active coping rats resulted a significant reduction of 
sucrose preference (A). Treatment with ANA-12 inhibited the emergence of this 
depressive-like behavior in both active and passive coping groups. Exposure to 
social defeat further induced the emergence of anxiety-like behaviors in the EPM 
as evidenced by reduced time in open arms (B) and reduced percentage of open arm 
entries (C). These effects seemed to be more pronounced in rats demonstrating 
passive coping during defeat. Treatment with ANA-12 did not improve anxiety-
like behaviors and seemed to further reduce the percentage of open arm entries. 
Comparison of closed arm time between stress and treatment groups indicated that 

































































































Bringing it all together: The past, present, and future 
As outlined in Chapter 1, the primary goal of the work described in this dissertation 
was to elucidate mechanisms underlying stress-induced depressive like behaviors as it 
pertains to inflammation. Currently, there are a number of different hypotheses regarding 
the specific mechanisms underlying stress-induced behavioral dysfunction. Many of these 
hypotheses have largely focused on alterations in one specific neurotransmitter or 
neuromodulatory system such as glutamate, GABA, BDNF, 5-HT, CRF, and NE. 
However, this is a very narrow view of the complex dysregulation that occurs following 
stress exposure and suggests that many of these systems function exclusively and 
independently from one another. In reality, it is known that these systems overlap and work 
in concert. The most direct evidence for this assumption stems from the broad off target 
effects produced following treatment with anti-depressant therapies. For example, selective 
serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs) and 
tricyclics (TCAs) have all been shown to positively impact BDNF (Balu et al., 2008), 
glutamate (Musazzi et al., 2010; Musazzi et al., 2013), and GABA (Bhagwagar et al., 
2004). Notably, these effects occur as a direct result of drug treatment rather than resulting 
as a secondary consequence of mood improvement. While it is likely that each one of these 
discrete systems contribute to the complex neuronal and behavioral dysfunction that results 
from stress, it is highly unlikely that stress preferentially and selectively disrupts just one 
of these systems. 
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In contrast to these very narrow hypotheses, inflammation represents a broad 
approach to studying stress-induced behavioral dysfunction. As outlined in Chapters 3 and 
4, exposure to stress produces a global shift of inflammatory processes in the periphery and 
the brain. These effects are indiscriminate occurring across a number of cytokine families 
and are not isolated to pro- or anti-inflammatory subtypes. Notably, these stress-induced 
inflammatory effects are enduring (Voorhees et al., 2013; Wohleb et al., 2013; Wood et 
al., 2015; Finnell et al., 2017b; Finnell et al., 2017a; Finnell et al., 2018) and findings from 
Chapters 3 and 4 further demonstrate that these systems in the periphery and the brain are 
significantly sensitized. Sensitization of microglia and macrophages are dependent upon 
shifts in cellular metabolism, epigenetic regulation, and transcription (Cheng et al., 2014; 
Saeed et al., 2014; Neher and Cunningham, 2019). This molecular process in microglia and 
peripheral inflammatory cell types is suggestive of inflammatory reprogramming of innate 
immune memory.  
Immune memory is a major consequence of adaptive immune responses. In terms 
of disease or infection, immunological memory describes the cellular process which allows 
the immune system to respond more rapidly and effectively to previously encountered 
pathogens (Dominguez-Andres and Netea, 2019). This process forms the basis for the 
efficacy of vaccines. Although it was originally thought that these processes required the 
persistent presence of a specific antigen, it has recently been reported that shifts in 
metabolism and transcription induced by antigen detection are stored and passed on by 
progenitor cells (Christ et al., 2018; Kaufmann et al., 2018; Mitroulis et al., 2018). In this 
way immune cell adaptations can be maintained for months (Dominguez-Andres and 
Netea, 2019) or years (Janeway et al., 2001). Importantly, recent findings in mice have 
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suggested that sustained immune memory is also present in microglia and may last for up 
to 6 months (Wendeln et al., 2018). As it pertains to stress and microglia, it is currently 
unclear how long these adaptations remain. However, given the slow microglial turnover 
rate (28% per year) and an average lifecycle of 4.2 years (Réu et al., 2017), it is very 
probable that these cellular effects last well beyond the cessation of stress.  
Notably, findings in Chapter 4 of this document directly implicates LC-derived NE 
in peripheral and central sensitization. In the periphery, NE is well known to exert 
proinflammatory effects by directly stimulating cytokine release (Flierl et al., 2009; Li et 
al., 2015) and promoting immune cell sensitization (Spengler et al., 1990; Kavelaars et al., 
1997; Grisanti et al., 2010). In agreement with these previous reports, data in Chapter 4 
demonstrated that LC derived NE was directly associated with social defeat-induced 
peripheral inflammation. In contrast, loss of LC-NE seemed to disinhibit inflammatory 
responses in the brain resulting in robust neuroinflammatory tone within the central 
amygdala (CeA). This disinhibition of neuroinflammation following withdrawal of NE 
seems to be isolated to brain regions that are predominantly innervated by the LC. Region 
specificity of stress-induced neuroinflammation has frequently been reported throughout 
the brain. For example, in the prefrontal cortex (de Pablos et al., 2006) and ventral 
hippocampus (Pearson-Leary et al., 2017) stress exposure significantly enhances 
neuroinflammation. In contrast, findings from the dorsal hippocampus suggest that this 
region is largely immune to the inflammatory inducing effect of stress (Pearson-Leary et 
al., 2017). Importantly, the prefrontal cortex and the ventral hippocampus receive dense 
projections from the LC (Oleskevich et al., 1989; Zhang et al., 2013) while LC projections 
to the dorsal hippocampus are minimal (Oleskevich et al., 1989). Taken together, these 
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data support a role for LC derived NE in the production of region-specific inflammatory 
responses following stress exposure. However, future studies will need to be conducted to 
verify this claim.  
Although more work needs to be completed in order to fully characterize the 
involvement of the LC-NE system in region specific inflammatory responses following 
stress, inflammation in the brain is known to affect nearly every major neurotransmitter 
and neuromodulatory system (Miller et al., 2013; Finnell and Wood, 2018). Microglia have 
been directly and indirectly tied to these effects. For example, microglial cytokine release 
can indirectly alter 5-HT and NE systems by enhancing IDO (Robinson et al., 2005) and 
MAOs (Dhabal et al., 2018). More direct effects have been demonstrated by studying M1 
type pro-inflammatory microglia. Specifically, it has been shown that stimulated M1 type 
microglia have the capacity to directly release glutamate (Barger et al., 2007) and its co-
agonist D-serine (Wu et al., 2004). In this way, microglia can enhance glutamate within 
the synaptic cleft and resulting in the activation of neurons. In addition, microglia have 
been shown to induce remodeling of synaptic terminals often resulting in elongation and 
thinning of dendritic spines. These effects have been linked to enhanced expression of 
metalloprotease-9 (Stelzhammer et al., 2015) and kB kinase (Christoffel et al., 2012; 
Christoffel et al., 2015) and inhibition of BDNF (Xie et al., 2017). However, inflammation 
and resulting effects on neurotransmitter systems are highly region and stimulus dependent. 
In the context of the amygdala, inflammation has been shown to enhance resting activity 
(Inagaki et al., 2012) and signaling via ERK (Carrasquillo and Gereau, 2007), a major 
signaling cascade induced by BDNF. 
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In the CeA, the MAPK/ERK signaling cascade has been shown to enhance neuronal 
excitability (Stamboulian et al., 2010), activation (Kidambi et al., 2010; Shan et al., 2015), 
and directly regulate the acquisition and expression of fear related behavioral responses 
(Rodrigues et al., 2004; Di Benedetto et al., 2009; Maldonado et al., 2014). In agreement 
with these data, findings from Chapter 5 determined that the expression of defensive 
behaviors and cardiovascular abnormalities during defeat were directly associated with 
functional enhancement in CeA TrkB phosphorylation and preferential signaling through 
MAPK/ERK. Interestingly, these effects were not associated with enhanced BDNF at this 
time point. While the study described in Chapter 5 did not directly assess inflammation, 
findings from Chapter 4 suggest that exposure to 5 consecutive days of social defeat 
robustly enhances inflammatory tone within the CeA. One potential mechanism underlying 
stress-induced TrkB activation in the absence of BDNF is through alterations in protein 
tyrosine phosphatases (PTPs). PTPs are a large class of protein kinases that function to 
dephosphorylate and thus inhibit TrkB. These proteins are sensitive to inflammation are 
robustly inhibited by cytokines (Grinnell et al., 2012; Seo et al., 2013; Duan et al., 2014). 
While PTPs are widely expressed throughout the brain and have long been studied in the 
periphery, the central effects of these compounds are still largely unknown. Moreover, only 
one study has assessed the effects of stress on PTPs (Dabrowska et al., 2013). This paucity 
of information regarding PTPs in the brain has largely stemmed from the lack of effective 
molecular tools. Studies assessing PTPs in the periphery rely on western blots. However, 
the antibodies currently available do not provide good detection in brain homogenates 
limiting their application.  
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While there is clearly more work to be done to further clarify the effects of stress-
induced inflammation, contribution of LC-NE, and putative inflammatory sensitive 
neuronal mechanisms involved in the emergence of behavioral dysfunction, equal attention 
should be paid to these effects in females. This is of particular importance as women are 
twice as likely to develop depression and anxiety compared with men  (Kessler et al., 1993; 
Hankin et al., 1998). Moreover, ovarian hormones are intricately involved in the regulation 
of a number of physiological systems including inflammation (Villa et al., 2016). While 
these effects are well established, the paucity of information regarding the effects of social 
stress in females has largely been attributable to inherent difficulties in conducting 
traditional social stress models in female populations. For example, use of social defeat in 
females either requires the use of a different species (highly territorial Syrian hamsters or 
California mice), use of lactating female residents, or genetic modification of male 
residents to induce abnormal aggression (Huhman et al., 2003; Trainor et al., 2010; Trainor 
et al., 2011; Jacobson-Pick et al., 2013; Ver Hoeve et al., 2013; Shimamoto et al., 2015; 
Duque-Wilckens et al., 2017; Takahashi et al., 2017). However, a new social stress model 
has recently emerged that is a modification of the traditional social defeat paradigm. In this 
model, a rat is placed behind a partition and is forced to observe the repeated defeat of a 
paired male conspecific. We have recently shown that this witness stress model can be 
effectively utilized with females and results in significant behavioral, cardiovascular, and 
neuroinflammatory disruptions in the CeA that mimic findings in susceptible males 
exposed to social defeat (Finnell et al., 2018). Notably, witness stress in females produced 
strikingly robust cardiovascular and behavioral profiles during defeat that exceeded those 
described in Chapter 5 of this document. Based on the putative role of the CeA in during 
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defeat behavior and cardiovascular function, these data suggest that CeA micro circuitry 
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